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UPBEAT-UK: a programme of research into the relationship
between coronary heart disease and depression in primary
care patients
André Tylee,1 Elizabeth A Barley,2 Paul Walters,3 Evanthia Achilla,1
Rohan Borschmann,4 Morven Leese,1 Paul McCrone,1 Jorge Palacios,1
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NHS Foundation Trust and Bournemouth University, Dorset, UK
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5Academic Unit of Primary Health Care, School of Social and Community Medicine,
University of Bristol, Bristol, UK
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Amsterdam, the Netherlands
*Corresponding author anthony.mann@kcl.ac.uk
Background: Depression is common in patients with coronary heart disease (CHD) but the relationship is
uncertain. In the UK, general practitioners (GPs) have been remunerated for finding depression in CHD
patients; however, it is unclear how to manage these patients.
Objectives: Our aim was to explore the relationship between CHD and depression in a GP population and
to develop nurse-led personalised care (PC) for patients with CHD and depression.
Design: The UPBEAT-UK study consisted of four related studies. A cohort study of patients from CHD
registers to explore the relationship between CHD and depression. A metasynthesis of relevant literature
and two qualitative studies [patients’ perspectives and GP/practice nurse (PN) views on management of
CHD and depression] helped develop an intervention. A pilot randomised controlled trial (RCT) of PC
was conducted.
Setting: Thirty-three GP surgeries in south London.
Participants: Adult patients on GP CHD registers.
Interventions: From the qualitative studies, we developed nurse-led PC, combining case management
and self-management theory. Following biopsychosocial assessment, a PC plan was devised for each
patient with chest pain and depressive symptoms. Nurses helped patients address their most important
related problems. Use of existing resources was promoted. Nurse time was conserved through telephone
follow-up.
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Main outcome measures: The main outcome of the pilot study of our newly developed PC for people
with depression and CHD was to assess the acceptability and feasibility of the intervention and to decide
on the best outcome measures. Depression, measured by the Hospital Anxiety and Depression Scale –
depression subscale, and chest pain, measured by the Rose angina questionnaire, were the main outcome
measures for the feasibility and cohort studies. Cardiac outcomes in the cohort study included: attendance
at rapid access chest pain clinics, stent insertion, bypass graft surgery, myocardial infarction and
cardiovascular death. Service use and costs were measured and linked to quality-adjusted life-years
(QALYs). Data for the pilot RCT were obtained by research assistants from patient interviews at baseline, 1,
6 and 12 months for the pilot RCT and at baseline and 6-monthly interviews for up to 36 months for the
cohort study, using standard questionnaires.
Results: Personalised care was acceptable to patients and proved feasible. The reporting of chest pain in
the intervention group was half that of the control group at 6 months, and this reduction was maintained
at 1 year. There was also a small improvement in self-efficacy measures in the intervention group at
12 months. Anxiety was more prevalent than depression in our CHD cohort over the 3 years. Nearly half of
the cohort complained of chest pain at outset, with two-thirds of these being suggestive of angina.
Baseline exertional chest pain (suggestive of angina), anxiety and depression were independent predictors
of adverse cardiac outcome. Psychosocial factors predicted the continued reporting of exertional chest pain
across the 3 years of follow-up. Costs were slightly lower for the PC group but QALYs were also lower.
Neither difference was statistically significant.
Conclusions: Chest pain, anxiety, depression and social problems are common in patients on CHD
registers in primary care and predict adverse cardiac outcomes. Together they pose a complex
management problem for GPs and PNs. Our pilot trial of PC suggests a promising approach for treatment
of these patients. Generalisation is limited because of the selection bias in recruitment of the practices and
the subsequent participation rate of the CHD register patients, and the fact that the research took place
in south London boroughs. Future work should explicitly explore methods for effective implementation of
the intervention, including staff training needs and changes to practice.
Trial registration: Current Controlled Trials ISRCTN21615909.
Funding: This project was funded by the National Institute for Health Research (NIHR) Programme Grants
for Applied Research programme and will be published in full in Programme Grants for Applied Research;
Vol. 4, No. 8. See the NIHR Journals Library website for further project information.
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Care Excellence
OR odds ratio
PC personalised care
PCRN-GL Greater London Primary Care
Research Network
PHQ-9 Patient Health Questionnaire
PN practice nurse
PPI patient and public involvement
PWP psychological well-being
practitioner
QALY quality-adjusted life-year
QOF Quality and Outcomes Framework
RCT randomised controlled trial
REC Research Ethics Committee
RR relative risk
RRR relative risk ratio
sCHD symptomatic coronary heart disease
SD standard deviation
SF-12 Short Form questionnaire-12 items
SPQ Social Problems Questionnaire
TAU treatment as usual
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Plain English summary
Many people with coronary heart disease (CHD) are depressed and research on people who have had aheart attack found that depression increases the chance of further heart attacks. The UPBEAT-UK
team conducted research with people on general practitioner CHD registers in 33 south London practices
to: examine any link between CHD, depression and worse future heart disease; and develop case
management by practice nurses for people with CHD and depression.
We followed 803 people with CHD for up to 3 years, assessing them for depression, chest pain and
worsening of heart disease, and also measured care costs. We asked patients, GPs and nurses how people
with CHD and depression should be treated. From this, we developed care designed for each person called
‘personalised care’ (PC). We tested it in 41 people (while 40 people received their usual care from GPs)
with chest pain and depression, to assess how acceptable it is, whether or not it helps and what the
costs would be. PC was acceptable to people, and those who received it reported less chest pain 6 and
12 months later. Costs were lower following PC but the difference was not statistically significant.
Just under half of those with CHD had chest pain. Depression was frequent, but anxiety was more
common and increased the chances of both heart attacks and death.
We conclude that further research is needed to understand the links between anxiety, chest pain and heart
disease, and to further develop our promising findings that PC can be helpful in reducing chest pain in
general practice.
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Scientific summary
Background
Coronary heart disease (CHD) and depression are predicted to be the two leading causes of health-related
disability worldwide by 2020. In 2007, the annual societal costs of depression in England were estimated
to be £7.5B, projected to be £12B by 2026. The King’s Fund estimated that £1 in every £8 spent on
long-term conditions is for comorbid mental health. Depression is more prevalent in patients with CHD but
the nature of this relationship is uncertain. Previous research conducted in secondary care on patients after
cardiac events, such as myocardial infarction (MI), has shown that depression post MI worsens cardiac
outcome, increasing the likelihood of cardiac events and cardiac-related death. Established treatments for
depression, such as selective serotonin reuptake inhibitors and cognitive–behavioural therapy, have only a
moderate effect in CHD patients and no effect on cardiac outcomes. There is an ongoing debate about
whether or not case finding for depression in CHD should be conducted in GP practices in England and
Wales, and whether or not general practitioners (GPs) should be remunerated for this. It is also unclear
how GPs should best manage these patients. Furthermore, it is unclear whether or not the association
between depression and adverse cardiac outcome seen in secondary care also exists in primary care. There
is no knowledge of the long-term outcome of depression in this patient group or whether or not the
association with adverse cardiac outcome remains constant over time. GP CHD registers, by their very
nature, may represent a population of people who have survived previous cardiac events and hence have a
milder, but still progressive, cardiac disorder, allowing various factors to be studied in the prognosis
of depression.
Objectives
The UPBEAT-UK study was designed to determine the prevalence, incidence and course of depression in
patients on GP CHD registers, and describe the course and pattern of cardiac outcomes (including chest
pain, cardiac interventions, MI and cardiovascular mortality) and costs, testing for any association
between depression and adverse cardiac outcomes. The UPBEAT-UK study was also designed to elicit
the perspectives of patients with CHD and depression, understand the perspectives of their GPs and
practice nurses (PNs) about current management, and develop and test the acceptability, feasibility and
cost-effectiveness of a new intervention for CHD register patients with chest pain and depression that
could be delivered within current primary care practice.
Method
The UPBEAT-UK study consisted of four related work packages:
1. a metasynthesis of previous research and a qualitative study of GP and PN views on current
management of patients with CHD and depression
2. a qualitative study of patients’ perspectives of their biopsychosocial needs
3. a pilot trial to assess the acceptability, feasibility and cost-effectiveness of an intervention based on
nurse-led personalised care (PC) for people with CHD experiencing current chest pain and depression
and determine best outcome measures
4. a 3-year cohort study of patients on GP CHD registers to explore prevalence, incidence, course and
costs of depression, course and pattern of chest pain and cardiac outcomes, and the relationship
between depression and cardiac outcomes.
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Setting
Thirty-three GP surgeries in south London.
Participants
Adults aged ≥ 18 years, registered on GP CHD Quality and Outcomes Framework registers. Patients from
16 surgeries were recruited to the cohort study and patients from an additional 17 practices were recruited
for the pilot randomised controlled trial (RCT). Patients from the cohort study were recruited for the
qualitative study, as were GPs and PNs for the qualitative study of professionals.
Intervention
We applied the Medical Research Council framework for the development of complex interventions to
develop an evidence-based intervention informed by patient and clinician preferences and established
theory. This was a primary care-based nurse-led PC intervention. Following a face-to-face assessment,
nurses trained in behaviour change techniques facilitated patients to address the problems that they
perceived as most important to them and which related to their CHD or depression. Existing resources for
CHD or depression-related problems were identified and used by nurses. Follow-up was by telephone.
Main outcome measures
l Pilot RCT: acceptability (Patient Satisfaction Questionnaire, participation rates), feasibility (recruitment
and randomisation), potential range of effects [Hospital Anxiety and Depression Scale – depression
subscale (HADS-D), Rose angina questionnaire], costs and quality-adjusted life-years (QALYs).
l Cohort: depression (HADS-D), chest pain (Rose angina questionnaire) and a range of cardiac outcomes
including attendance at rapid access chest pain clinics, coronary artery stent insertion and bypass
grafting, MI and cardiovascular death (extracted from the GP records) and costs.
l Data sources: data were obtained from patient interviews, GP records and national and local
authority sources.
Results
Metasynthesis and qualitative study of general practitioners and
practice nurses
We identified seven qualitative and 10 quantitative studies, none of which concerned depression and
comorbid physical illness. It appeared that GPs and PNs were aware of a relationship between mood and
social problems but were unsure of their role in addressing this.
General practitioners and PNs considered that distress after a cardiac event resolves spontaneously; if it
endured, or became severe, it was treated as depression. Psychosocial problems were viewed as
contributing to depression in CHD, but clinicians expressed uncertainty about their role and responsibility
in addressing these problems. An individualised approach was favoured, but clinicians were unsure how to
achieve this.
Qualitative study of patients
Thirty patients with depressive symptoms on the CHD register, some of whom reported chest pain,
were interviewed. A theme of loss, both before and after the onset of CHD, underpinned accounts
(e.g. interpersonal loss, loss of health and of control). Participants felt ‘depressed’ by what they perceived
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as a ‘medicalisation’ of loneliness and by the experience of ageing and ill health. Some believed that their
GP would not be able to help with their complex health and social issues. Talking therapies and
interventions providing social interaction, support and exercise (e.g. cardiac rehabilitation) were thought
helpful, whereas antidepressants were not.
Pilot randomised controlled trial
Seventeen practices were approached by the Greater London Primary Care Research Network and all
agreed to participate. Practice recruitment was quicker than expected, indicating that a definitive trial
would be feasible. Of 3325 patients on CHD registers, 1001 consented to contact, of whom 81 were
eligible and randomised (41 intervention, 40 control), although three patients were wrongly randomised as
they had no chest pain. Recruitment for a definitive RCT seems promising, although it would be from a
large pool of potential participants and randomisation was largely successful. As this was a pilot trial, it
was not powered to detect efficacy of the intervention. We therefore do not report p-values and report
findings, which should be explored further in a definitive RCT. Both groups showed improvement in
depression (HADS-D score) at all time points, with mean scores moving from moderate depression at
baseline to mild depression at 12 months. A mixed-effects model showed no significant differences
between groups over time for any measure of depression and confidence intervals (CIs) were wide, so an
effect in favour of either group cannot be ruled out. The most notable difference between PC and
treatment as usual (TAU) was in chest pain on the Rose angina questionnaire. The percentage of patients
no longer reporting chest pain was 37% in PC versus 18% in usual care at 6 months, and 31% in PC
versus 19% in usual care at 12 months. PC participants also made fewer accident and emergency (A&E)
visits (24% PC vs. 38% TAU), although missing data concerning the reason for these visits makes this
difficult to interpret. Self-efficacy was also improved more in PC. Health economic analyses showed that
total costs in the intervention arm were lower than usual care but QALYs were also lower. These
differences were not statistically significant. Overall, PC seemed to be acceptable and feasible.
Cohort study
Sixteen south London practices, with 142,648 patients, participated in the cohort study. Of this population,
2% (2938/142,648) were on GP CHD registers. A total of 803, after invitation by GP letter, participated,
representing 27% (803/2938) of those on the CHD registers. The mean age of participants was 71 years,
70% were male and 87% were white. Participants reported multiple social problems, multimorbidity and
disabilities, including problems with general pain and discomfort (53%, 425/803), poor mobility (49%,
391/803) and difficulties with intimate relationships (38%, 302/803). A total of 573 patients (71.3%)
provided complete data to 36 months and a further 136 provided data up to 48 months. The analyses
reported here are of data up to 36 months.
Of these patients, 7% had depressive disorder at baseline and 13% had depressive symptoms. There were
12% who had an anxiety disorder comprising: panic disorder (< 1%), generalised anxiety disorder (3%),
and mixed anxiety and depressive disorder (8%). Twenty-five per cent of patients had anxiety symptoms
yet only 3% of people were recorded as having anxiety in the GP records. The incidence of depression was
130 per 1000 person-years at risk for men and 90 for women, so males were nearly 1.5 times more likely
to develop depression. Over 36 months, just over half of patients had a cardiac intervention (e.g. stent
insertion or graft), 11% had a MI and 5% of patients died from a cardiovascular cause. Incidence rates of
cardiac death were 12.7 per 1000 person-years for men and 9.3 per 1000 person-years for women.
Standardised mortality ratios compared with the general population were 1.13 (95% CI 0.62 to 1.90) and
1.87 (95% CI 0.81 to 3.70) for men and women, respectively.
In total, 44% of the cohort complained of chest pain at outset, 66.8% of these being exertional, which is
suggestive of angina. Baseline exertional chest pain (Rose category 2) was associated with all cardiac
outcomes. For rapid access chest pain clinics, relative risk ratio (RRR) 4.00 (95% CI 1.84 to 8.72); cardiac
interventions (RRR 7.51, 95% CI 3.74 to 15.10); MI and cardiovascular death (RRR 3.72, 95% CI 1.54
to 9.01).
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Anxiety was an independent predictor of MI and cardiovascular death (RRR 3.93, 95% CI 1.95 to 7.90).
Depression did not predict any cardiac outcomes.
We found there were different risk profiles for continued reporting of non-exertional (Rose category 1)
and exertional (Rose category 2) chest pain across the 3 years of follow-up. Risk factors for the former
were: female sex [odds ratio (OR) 2.80, standard deviation (SD) 7.19], asthma (OR 3.34, SD 1.98) and
anxiety (OR 1.33, SD 0.62). Good quality of life was protective (OR 0.98, SD 0.01). For exertional pain, the
risk factors were: exertional pain at baseline (OR 28.07, SD 7.14) and anxiety (OR 0.65, SD 0.38). Good
quality of life was similarly protective for exertional pain (0.98, SD 0.01).
The average cost over the 36 months for patients with depressive symptoms at baseline was double that
for patients without depressive symptoms at baseline. Inpatient services dominated costs at baseline and
follow-up. Statistically significant predictors of higher societal costs were: depressive disorder (measured by
the Clinical Interview Schedule – Revised), white ethnicity, housing problems, relationship problems,
self-reported current cancer and baseline health-care costs.
Conclusions
Nearly half of all patients on GP CHD registers were found to have current chest pain and this was strongly
associated with concurrent social problems. Patients who reported chest pain at the outset of the study
were more likely to have further chest pain over the following 3 years and to have more adverse cardiac
outcomes, such as needing stent insertion, bypass graft surgery, having a MI or dying of a cardiac cause.
Although depression was common, episodic and associated with increased costs, anxiety disorder was
more common and found to be a stronger predictor of worse cardiac outcome and mortality than
depression, so there is a pressing need to better understand this link. More sophisticated models linking
the patterns of depression, anxiety and chest pain are needed to understand the associations between
anxiety, chest pain and adverse cardiac outcomes. We have a unique cohort data set to allow us to
achieve this.
General practitioners and nurses seem currently uncertain how best to manage patients’ symptoms in the
context of the many psychosocial problems in their CHD patients. PC promoting self-management proved
to be acceptable and feasible, improved patient self-efficacy, reduced chest pain and was associated
with fewer overall costs than usual care (e.g. fewer A&E attendances). PC combining case management
and self-management with an extra emphasis on anxiety needs to be further piloted and definitively tested
with PNs, working closely with colleagues in practices. Many nurses told us they had little extra current
capacity, so this would need to be built into practice plans. PC combining self-management with an
extra emphasis on anxiety could also be piloted and definitively tested with psychological well-being
practitioners in Improving Access to Psychological Therapy, although they would need training and
supervision in long-term conditions and behavioural change techniques. Future work should explicitly
explore methods for effective implementation of the intervention, including staff training needs and
changes to practice.
Trial registration
This study is registered as ISRCTN21615909.
Funding
Funding for this study was provided by the Programme Grants for Applied Research programme of the
National Institute for Health Research.
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Chapter 1 Overview of the programme
We have previously published the rationale and protocol for the UPBEAT-UK programme,1 how wesubsequently developed the intervention for the pilot randomised controlled trial (RCT) from the
findings of the earlier work packages2 and the final protocol for the pilot RCT.3 This chapter opens
with a statement on patient and public involvement (see Patient and public involvement). We have then
summarised the introductory sections of the published introductory papers1–3 (see Background), which
has been updated with references to more recent literature. In Aims and objectives of the programme,
the key objectives of the four work packages are outlined. Finally, all currently published papers from the
UPBEAT-UK study are listed in Acknowledgments.
Patient and public involvement
We were able to recruit patient and public involvement representatives from mental health organisations
(Service User Research Enterprise and Charlie Waller Memorial Trust), but we were unfortunately unable to
recruit any patient representatives with coronary heart disease (CHD) to our programme over its duration,
despite frequent attempts at contacting relevant organisations, such as the British Heart Foundation,
through our research team members, including our cardiologist member. However, it would have been
quite a commitment for a patient representative to give up 5–7 years and this may have been the limiting
factor. This has been a disappointment, particularly as there could be an increasing role for providing such
support from relevant third-sector organisations. The patient and public involvement initiative was in its
infancy when these studies were set up; 10 years on we may have had a more positive response from
patient-based voluntary organisations that would have become more familiar with the required task.
Background
Coronary heart disease and depressive disorders are two of the leading causes of burden of disease and
disability, as measured by disability-adjusted life-years. It has been estimated, using data from the World
Health Organization, that by 2030, unipolar depressive disorders and CHD will be the second and third
leading cause of burden of disease, respectively, trailing only human immunodeficiency virus/acquired
immunodeficiency syndrome.4 Surprisingly, however, while there are several guidelines worldwide for the
management of both conditions separately, there are no clear guidelines on how best to manage patients
who have both comorbid conditions. A key recommendation of a specially convened US Preventive Task
Force on the management of depression and CHD was to conduct RCTs of stepped care to generate
much-needed evidence.5 So far, RCTs have shown that treating depression in CHD slightly improves
depressive symptoms and quality of life, but has no effect on mortality.6 Furthermore, cardiac rehabilitation
(CR) together with mental health treatments may reduce depression, CHD events and mortality risk.7
Despite this, limitations in the current literature show that further research is needed to improve
psychological and cardiac outcomes in these patients.
Coronary heart disease
Coronary heart disease, especially when chest pain is present, often causes functional limitation, distressing
symptoms, is often life-threatening and requires long-term management, mostly in primary care. Many
patients with CHD have a documented history of myocardial infarction (MI) or coronary artery disease
shown at angiography. CHD also causes 70% of heart failure with fatigue and shortness of breath. CHD
mainly comprises three groups of patients with: chronic stable angina (with exertional chest pain), post MI,
and heart failure with a hierarchy of physical and emotional effects. The researchers at Imperial College
London, on behalf of the Public Health Observatories of England, have developed a prevalence model.8
They estimate the prevalence of CHD in primary care trusts and at local authority level to be 5.80%,
although this number rises to 16.08% in people aged 65–74 years, and 21.91% in those ≥ 75 years.
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In the south London primary care trusts of Lambeth, Southwark and Lewisham, the prevalence is 3.30%,
3.50%, and 3.85%, respectively (≥ 15% in those aged 65–74 years and ≥ 22% in those ≥ 75 years).8
Depression
Depression is a major public health problem responsible for around 100 million lost working days in
England and Wales each year and costing £9B per annum.9 In the UK, depression is a common reason for
consulting a general practitioner (GP). Up to one-third of people who visit the GP have mental health
problems, and 90% of those are treated only in primary care.10
Depression incurs a 50% increase in the cost of long-term medical care after controlling for the severity of
the physical illness,11 and this may relate to the link between depression and adverse health risk behaviours
such as smoking, diet, lack of exercise and poor self-care. Depression may exacerbate the perceived
severity of symptoms and this, in turn, can bring about an increase in health service utilisation. Treating
depression and improving outcomes for depression has been shown to reduce health costs in people with
physical illness.11 Furthermore, collaborative care and individualised management of patients with
depression and chronic conditions, such as diabetes and CHD, has shown to improve both medical
outcomes and depression.12
Depression and coronary heart disease comorbidity
Depression occurs in up to 20% of patients with CHD and depression increases the incidence and
recurrence of CHD, acute coronary syndromes and mortality.5 A systematic review by Nicholson et al.13
places the pooled relative risk (RR) of future CHD associated with depression at 1.81; however, the
authors stop short of calling depression an independent risk factor for developing CHD, owing to
the heterogeneity of studies.
The clear association that exists between these two conditions has led to a long discussion about the
precise nature of the relationship. Ageing (which increases the odds of both conditions), lifestyle factors,
inflammation pathways, heart rate variability, impaired arterial repair and several genes, are just some of
the mechanisms that could play a role.14 Nevertheless, the link is well established. A review by the
American Heart Association15 recently recommended that depression be considered an independent risk
factor for adverse outcomes in patients with acute coronary syndrome, given the strength of the evidence
in the current literature.
The presence of concurrent physical illness, such as CHD, is known to reduce the likelihood of major
depression being recognised by GPs.16 Diagnosing depression in elderly primary care patients is hampered
by conditions such as heart disease and the drugs to treat these conditions, which can have
mood-destabilising effects.17 The natural history, morbidity and mortality of depression in primary care
CHD populations are unknown.
As GP practices keep separate registers for their patients with heart failure, this programme of research is
solely concerned with CHD and patients on CHD registers rather than patients on heart failure registers.
This also means that the focus of research in terms of physical symptoms is purely on chest pain rather
than on fatigue and dyspnoea.
Managing depression and coronary heart disease
Although there are several treatment options for managing depression in primary care that are endorsed
by the National Institute for Health and Care Excellence (NICE)18 [e.g. antidepressant medication,
supervised exercise, guided self-help, problem-solving, computerised cognitive–behavioural therapy (CBT),
group or individual CBT or interpersonal therapy], the treatment preferences of CHD patients are
unknown, as are primary care professional treatment preferences. A recent US working party on the
management of depression in CHD concluded that RCTs comparing stepped depression care with
treatment as usual (TAU) for patients with CHD and depression are needed.5
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It remains unclear how GPs and practice nurses (PNs) should best manage patients with depression and
CHD. Previous research, which has been largely from the USA, has focused on treating depression with
antidepressant medication, psychological treatment, case management and collaborative care. Because
of the absence of available evidence in this area, we decided to conduct a systematic review and
metasynthesis of available evidence in work package 1.
Medication and psychological treatment
Two large US-based trials19,20 have also provided an indication in post-hoc subgroup analyses that there
may have been cardiovascular benefit from the management of the depression using antidepressant
medication and it has been suggested that this may be owing to an effect on platelet activation.21,22
Mortality seems to have been reduced in those whose depression improved or in those who took sertraline
(Zoloft®, Pfizer) in one study.23,24 This evidence was influential in the introduction of financial incentive
payments to English GPs for screening consecutive CHD patients for comorbid depressive disorder under
the General Medical Services Quality and Outcomes Framework (QOF), although this was abandoned
in 2013.
Case management
Case management has been shown to improve outcomes for depression in primary health-care settings,25
but there has been no research to determine the cost-effectiveness in patients with CHD. Case
management is ‘taking responsibility for following-up patients; determining whether patients were
continuing the prescribed treatment as intended; assessing whether depressive symptoms were improving;
taking action when patients were not adhering to guideline-based treatment or were not showing
expected improvement’.26 It consists of five essential components:25
1. identification of patients in need of services
2. assessing individual patient’s needs
3. developing personalised treatment plans
4. co-ordination of care
5. monitoring outcomes and altering care when favourable outcomes are not achieved.
Collaborative care
An early, large US-based multicentre study of stepped collaborative depression care showed positive results
regarding depression in older people as did another US trial of collaborative depression care in diabetics
in motivated patients.27,28 However, the latter trial did not improve diabetic outcome.28 Subsequently,
during the life of the UPBEAT-UK programme, Katon et al.,12 using collaborative care, were able to
demonstrate in a groundbreaking study the improvement of depression, systolic hypertension, glycosylated
haemoglobin and blood lipids. As they applied rigorous nurse care to the depression, hypertension,
diabetes and lipid abnormalities, it is not clear to what extent the management of depression contributed
to the improvement of the physical outcome measures. Since then, and again in the lifetime of the
UPBEAT-UK programme, it has been demonstrated that collaborative care as a model works in an English
setting for depressive disorder, albeit with a modest effect size.29 Collaborative care usually requires the
collaboration of psychiatrists or other mental health professionals working together with their primary care
colleagues to supervise case management by dedicated case workers. These care workers are usually
mental health professionals brought in for the purpose of overseeing the case management and liaising
with the patient’s primary and secondary care workers.
The overall design of the UPBEAT-UK programme led to a pilot RCT in order to inform a future definitive
RCT of the cost-effectiveness of PN-led personalised case management in primary care for patients with
CHD and depression. A pilot RCT was necessary to determine whether or not case management by PNs for
this population would be a feasible and acceptable intervention compared with TAU in terms of both
depression and cardiac outcomes.
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The first step was to judge the acceptability, feasibility and likely effect of case management to inform
whether or not to conduct a future definitive RCT. As any future potential definitive RCT would be a
complex intervention, it was necessary to follow Medical Research Council (MRC) guidelines30 for the
development of a complex intervention using a programme of related work packages to develop and test
a new nurse-led personalised case management practice for depression and CHD in primary care. The
overall scientific framework for the UPBEAT-UK programme was the MRC framework for the development
and testing of complex interventions.30 This framework has four stages:
Stage 1: development concerns the identification of existing evidence in order to develop the intervention
to a point where it can be expected to have a beneficial effect. Conducting a systematic literature review
or metasynthesis is recommended if such a review does not already exist. This is followed by the
identification and development of theory with a rationale for the proposed intervention and likely change
process. The development of theory may build on existing evidence and be supplemented with new (often
qualitative) research. This should then lead to a testable model with a specific intervention, process and
likely outcomes.
Stage 2: feasibility and piloting involves assessing the feasibility and acceptability of the new complex
intervention and of the evaluation methods, including acceptability, compliance, delivery, randomisation,
recruitment, retention, and observed variability around changes in the primary outcome to inform the
power calculation for a subsequent definitive RCT. The pilot RCT examines key criteria for a definitive RCT.
Stage 3: evaluation involves the evaluation of the intervention using appropriate design usually by a
definitive RCT.
Stage 4: implementation involves the routine implementation of the new intervention, surveillance,
monitoring and long-term follow-up.
Stages 1–4 should be seen as cyclical rather than linear, with results from any stage informing not just
subsequent stages but previous stages in continuous improvement and increasingly higher-level
evaluation.30 The UPBEAT-UK programme mainly involves stages 1 and 2 outlined above.
The four inter-related UPBEAT-UK work packages are:
1. a review of previous work in the area and qualitative study of GP and PN treatment preferences for this
patient group
2. a qualitative study of patients with CHD and comorbid depression treatment preferences
3. a pilot RCT of nurse-led case management for depressed primary care patients with CHD
4. a 4-year cohort study of patients with CHD.
In this introductory chapter, the detailed methods will be described in each work package chapter.
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Aims and objectives of the programme
Work package 1
A review and metasynthesis of the existing literature and a qualitative study of health professionals’
perceptions of distress and depression in patients with CHD.
Objectives
1. To review and conduct a synthesis of existing literature on primary care management of CHD
and depression.
2. To explore primary care professionals’ views on distress and depression in patients with CHD.
3. To explore their current management strategies and attitudes to a range of treatments in relation to
this patient group.
4. To provide guidance on the design and implementation of a PN-led case management
depression intervention.
Work package 2
Study of patients’ perceptions of distress and depression in patients with CHD.
Aims
The aim was to elicit patients’ perceptions of their psychological state as linked to their CHD and explore
their views on appropriate treatments for distress or depression in the context of their CHD.
Sample
Up to 50 people were to be purposively sampled from the cohort study based on age, sex, practice, CHD
status, and depression severity.
Work package 3
Pilot RCT of primary care case management for depressed patients with symptomatic CHD (sCHD).
Objectives
The objectives of this pilot were:
1. Clinical efficacy of case management.
To explore whether or not case management for primary care patients with sCHD and depression,
when delivered by nursing professionals, may be more effective than TAU.
2. Sample size calculation.
To calculate estimates of the location of the mean and variability around the mean [standard deviation
(SD)] for the primary outcome measure (depression).
3. To enable selection of the most appropriate primary and secondary outcome measures.
4. Integrity of the study protocol.
To test all procedures for a definitive effectiveness RCT, for example:
i. inclusion/exclusion criteria
ii. training of staff in the administration and assessment of the intervention
iii. to test data collection forms and questionnaires
iv. to ensure the acceptability of the questionnaires to participants, along with comprehensibility,
appropriateness, clarity and consistency
v. patient information documents and consent forms were also tested, as was inter-rater reliability
between researchers.
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5. Randomisation procedure.
To test the randomisation process and acceptability of randomisation to primary care professionals
and participants.
6. Recruitment and consent.
To test the recruitment method and the consent rate for participants, and explore barriers to
recruitment of both practices and participants.
7. To determine the acceptability of the intervention and the trial to practices and participants.
To determine the possible sources of contamination, and to develop a standardised manual for case
management for use in the definitive RCT. To make an informal assessment of the degree to which the
intervention can be standardised and whether or not therapist effects are likely to be a major factor.
Work package 4
Cohort study
Objectives
The objectives were:
1. to determine prevalence, incidence rate and risk factors of depression in primary care patients with CHD
2. to explore and describe the course, relationship, prognosis and current management of physical and
depressive symptoms in primary care patients with CHD and comorbid depression over a 3- to 4-year period
3. to determine the effect of comorbid depression on mortality, symptom severity, quality of life, disability,
pain, service use (at all levels) and service costs, and lost employment costs in primary care patients
with CHD.
OVERVIEW OF THE PROGRAMME
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Chapter 2 General practitioners’ and practice
nurses’ perceptions of distress and depression in
patients with and without symptomatic coronary
heart disease: literature review and qualitative
interview study (work package 1)
Plan
In the previous, introductory, chapter, we described the existing evidence demonstrating putative
mechanisms linking CHD and depression. We have described how depression has previously been
associated with worse cardiac prognosis and an increased cardiac mortality. We described a need to
better understand the relationship between the two disorders and a pressing global public health need
to improve integrated primary care for people with both disorders.
In this chapter we describe how we gathered evidence from primary care professionals – GPs and
PNs – concerning their current practice, views and experience of managing depression in people with CHD,
which would chiefly be people who were included on their general practice-based QOF CHD registers.
We also asked a sample of south London GPs and PNs how they currently managed such patients and if
there was a need for an enhanced, probably PN-led, intervention in their own general practice for their
registered CHD patients complaining of chest pain and depression and if so, what they would want from
such a new stepped care intervention.
Prior to commencing this qualitative study, we searched for and synthesised existing qualitative and
quantitative research in general practice on the management of people with depression and CHD and
used this to inform the design of our own qualitative study, especially the topics for discussion. The
evidence we gathered from the metasynthesis and both qualitative studies with professionals and patients
would subsequently be used to inform the development of our UPBEAT-UK pilot/feasibility intervention
according to MRC guidelines30 for the development of complex interventions. How the findings from these
earlier studies informed the development of our feasibility/pilot study is described in Chapter 4.
Methods
Metasynthesis of published qualitative and quantitative research
Review aim
We considered that issues important to the effective primary care-based management of depression in
general are likely be important when managing depression in people who also have CHD, but that there
may also be additional factors to consider when both conditions are comorbid in an individual. By
systematically investigating similarities and differences in previous findings across published studies of
primary care professionals’ experience of managing depression, our metasynthesis could provide
high-quality evidence to inform our proposed qualitative study focused on primary care professionals’
depression management for people with CHD. This review, therefore, aimed to identify barriers to and
facilitators of the effective management of depression in people with or without comorbid physical health
problems in primary care settings.
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Review methods
Terms relating to depression, primary care and primary care professionals’ attitudes to depression were
combined to form a search strategy (see Appendix 1), which was adapted for four databases (MEDLINE,
EMBASE, PsycINFO and British Nursing Index and Archives). We also searched the reference lists of
identified papers. This review was conducted early in the programme (search date 30 June 2008). We
planned to use the findings to inform the GP and PN interviews reported in Qualitative interview study of
general practitioners’ and practice nurses’ views and experience of managing depression in coronary heart
disease. Hence we have not updated this review, but note that the paper in which the results were
published31 has been highly cited. To obtain the most relevant and up-to-date evidence, we included only
publications concerning studies that had been conducted in the UK and published after 2000. This was a
pragmatic method of including a manageable number of studies and ensured we obtained data on current
and relevant attitudes (2000 is after the publication of the National Service Framework for Mental
Health32). We only included studies set in the UK as we felt that these would be most likely to inform an
intervention that could be implemented in UK primary care; that is, studies conducted in other settings
were excluded as we felt it would be difficult to understand the impact of different health-care delivery
systems on their findings, which would impair their translation to UK primary care. Both qualitative and
quantitative studies were included. We assessed the identified abstracts for relevance and then we quality
rated them according to standard recognised criteria.33,34 We did not use quality judgements to exclude
papers but tested the strength of findings by examining whether or not they were supported by studies in
the upper tertile of scores.35 We extracted key themes and synthesised them using principles drawn from
meta-ethnography24 and guidelines for producing narrative syntheses.36
Review results
Our first finding was that no relevant paper concerning GP or PN views about depression and comorbid
physical illness of any kind was identified, despite our use of a comprehensive search strategy.
Seven qualitative37–43 and 10 quantitative studies of the management of primary depression were
included.44–53 Figure 1 shows the flow of studies through the review process.
Summary of review findings
Details of our metasynthesis findings have been published in an open access journal by Barley et al.31 in
2011. Table 1 shows the included studies. The key themes and how they translate across the included
studies are detailed in Table 2. Both tables were also published Barley et al.2 In summary, we identified
seven key themes, which were all supported by at least one good-quality study and by both qualitative and
quantitative data. The first theme concerned professionals’ understanding of depression; depression was
either seen as a normal response to life events, or biomedical explanations were given. The second theme
concerned how clinicians recognise depression and highlighted how they struggle to distinguish between
‘normal’ distress and depression requiring treatment. Management options for depression made up the
third theme, with clinicians expressing a preference for talking therapy over antidepressants, but also for
being able to take a personalised approach. Shame and stigma around depression arose as a fourth
theme; it was felt that this prevented some patients seeking help, but the authors of one study considered
that this may be constructed to hide a reluctance to explore depression, with patients arising from a desire
to avoid feelings of powerlessness when management options seem limited. A lack of interprofessional
working within primary care was the main finding within our fifth theme. Our sixth theme showed that
clinicians may have ambivalent attitudes to managing depression; this was reflected in our final theme
which showed that although primary care clinicians felt that they needed more training in mental health,
when this was offered, they did not take it up. Key findings in relation to these themes were that GPs and
PNs consider depression and its diagnosis to be complex. There was ambivalence about the use of case
finding tools in primary care settings, such as those that were recommended at the time for use in people
with CHD and diabetes in the QOF.56 However, most studies identified in our search did not discuss these
as they had been conducted and published prior to the introduction of financial incentives under the QOF
of the UK GP contract56 in 2006 when their use became routine.
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Full-text articles assessed
for eligibility
(n = 53)
Studies included in
synthesis
(n = 17)
Records after duplicates removed
(n = 826)
Records screened
(n = 826)
Records excluded
(n = 773)
Full-text articles excluded
(n = 36)
• Conducted outside the 
   UK, n = 25
• Did not report discrete data
   for the professional, 
   condition or country in which
   it was conducted, n = 5
• Did not concern attitudes to 
   depression specifically, n = 4
• Described a study already
   included, n = 1
• Was of care workers, not GPs
   or PNs, n = 1
Records identified through
database searching
(n = 1056)
Additional records identified
through other sources
(n = 0)
FIGURE 1 Flow of studies through review process. Reproduced from Barley et al.31 © 2011 Barley et al; licensee
BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution
License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
in any medium, provided the original work is properly cited.
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TABLE 1 Characteristics of included studies
Reference
Participants
(response rate) Aim
Setting and sample
selection
Methods of collecting
clinician data and
research perspective
(quality assessment)
Qualitative studies
Johnston et al.,
200737
32 GPs (24%) Identify issues of
importance to GPs in
depression management
28 GP practices in and
around Southampton
(plus two GPs in
Leicester)
Semistructured
interviews; grounded
theory (10/10)
Murray et al.,
200638
18 GPs, 7 PNs Identify perceptions of
depression older people
18 south London primary
care teams in five
Boroughs, purposive
sampling based on
setting (socioeconomic/
ethnic groups served) and
practice type
In-depth, semistructured
interviews; grounded
theory (9/10)
Burroughs
et al., 200639
9 GPs, 3 PNs Explore how primary care
professionals and patients
view late-life depression
One PCT in NW England,
purposive sampling but
criteria not stated
Semistructured
interviews; constant
comparison (7/10)
Maxwell et al.,
200540
20 GPs Explore GPs’ experience of
recognising and managing
depression
11 practices from a
‘random’ sample of 55 in
Scotland – four NHS
board areas
Semistructured
interviews; critical realist
perspective (5/10)
Pollock and
Grime, 200341
19 GPs Investigate GPs’ views on
consultation time and
depression management
Eight West Midland
practices – purposeful
selection based on
socioeconomic/
geographical setting and
patient list size
Semistructured
interviews (8/10)
Chew-Graham
et al., 200242
35 GPs in
teaching
practices (66%)
Explore GPs’ attitudes to
the management of
depression in deprived vs.
affluent populations
22 inner city GPs vs. 13
suburban and semirural
GPs in NW England,
purposive sampling based
on practice size
Semistructured
interviews; constant
comparative qualitative
analysis (9/10)
Rogers et al.,
200143
10 GPs Explore GPs’ views on
depression management
Eight practices in Greater
Manchester (inner city/
suburban)
In-depth, semistructured
interviews (5/10)
Quantitative studies
Kendrick et al.,
200544
17 GPs Explore associations
between GP treatment,
depression severity and
patient characteristics
Six GP practices in
Southampton (nine
practices approached)
Questionnaire (devised
for this study) ratings of
patient characteristics
and GP treatment
decisions completed
following consultation
(3/7)
Shiels et al.,
200445
Four GPs –
three principals,
one assistant
Compare GPs’ and male
patients’ assessments of
depression
One practice in a
prosperous rural area of
Cheshire
Questionnaire (devised
for this study) completed
following consultation
(3/7)
Naji et al.,
200446
442 PNs
(56.2%)
Assess PNs’ knowledge,
attitudes, training and
management of depressed
patients
One in two sample of
Scottish general practices
(428 practices)
Questionnaire – DAQ54
plus some questions
developed for this study,
postal survey (5/7)
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TABLE 1 Characteristics of included studies (continued )
Reference
Participants
(response rate) Aim
Setting and sample
selection
Methods of collecting
clinician data and
research perspective
(quality assessment)
Manning and
Marr, 200347
202 GPs (50%) Compare expectations of
GPs and patients in the
management of relapse of
depression
GP practices ‘across the
UK’
Questionnaire – devised
for this study by a
market research
company, postal request
sent with link to online
questionnaire (2/7)
Byng et al.,
200348
274 GPs Describe GPs’ beliefs about
their management of
depression
All GPs in Lambeth,
Southwark and Lewisham
Health Authority (inner
city)
Likert scale questionnaire –
(devised for this study, but
piloted on 15 GPs) (4/7)
Oladinni,
200249
61 GPs (60%) Assess the attitudes of GPs
towards depression
Inner city GP surgeries in
Lambeth (group and
single handed),
‘randomly’ selected
Questionnaire (DAQ) –
postal survey (2/7)
Telford et al.,
200250
1703 GPs (48%) Survey GPs’ perception of
the availability/quality
of primary care and
community-based services
for depressed people.
Identify barriers to
provision of services
11 health authorities –
one from each English
region and one each
from Northern Ireland,
Wales and Scotland.
Urban, rural, deprived
and privileged
Questionnaire – devised
for study, piloted on
131 GPs; postal survey
(4/7)
Rothera et al.,
200251
263 GPs (72%) Examine the attitudes and
practice of GPs in managing
late-life depression
All 116 practices in
Nottingham Health
Authority
Postal survey (adapted
for study from previous
research) – responses to
attitude statements and
clinical vignettes (4/7)
Dowrick et al.,
200052
40 GPs Test hypotheses that
measures of GPs’
confidence in identifying
depression predict ability to
identify depression and
that GPs who prefer
antidepressants prescribe
more than those who
prefer psychotherapy
Practices in Liverpool and
Manchester
Questionnaire (DAQ),
prescribing information,
Likert scale depression
ratings (3/7)
Livingston et al.,
200053
31 GPs, 24 PNs
(12% of
practices
approached)
Assess acceptability and
feasibility of an educational
package concerning
management of depression
in old age
14 practices in West
Essex, East Hertfordshire,
Redbridge
Vignettes and
questionnaire (adapted
DAQ for older people)
(baseline data only used
in synthesis) (4/7)
DAQ, Depression Attitude Questionnaire; NW, North West; PCT, primary care trust.
Source: reproduced from Barley et al.31 © 2011 Barley et al.; licensee BioMed Central Ltd. This is an open access article
distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),
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TABLE 2 Extracted key themes and how they translate across the included studies
Summary second order
constructs
Extracted key themes (authors’ ‘own words’
or paraphrase)55
Summary translation across
studies
Professionals’
understanding of
depression
Constructing and resisting boundaries between
depression, the self and ‘normal’ sadness37
Depression as a normal response to life events42
Inconsistency between beliefs and practice43
Concerns surrounding the medicalisation of
social problems40
Depression as ‘understandable reaction to distressing
circumstances’38
Aetiology of depression49
Nature of depression49,52,53
Depression may be seen as a
normal reaction to distressing
events or as pathology.
Understandings of depression may
conflict with management
strategies
Recognising depression Potential for secondary gain42
GPs’ accounts of diagnosing and caring for patients
with depression40
GPs’ experiences of the diagnosis and management
of depression43
consultation length/time and disclosure41
Presenting complaints38
Distinguishing between depression and
physical illness42
Avoidance of psychosocial problems38
Making the diagnosis39
Accuracy of diagnosis44–46,52
Recognising depression is a
complex process involving
non-explicit subjective processes.
Some see patients as reluctant
to talk about their mood.
Somatisation is common.
Somatisation and/or comorbidity
may complicate diagnosis.
Receiving or giving a diagnosis of
depression may benefit patients
and GPs
Management strategies
and tools
GP goals and management approach37
GPs’ accounts of diagnosing and caring for patients
with depression40
GPs experience of the diagnosis and management
of depression43
Importance of listening37
Time as a barrier to listening42
Time and consultation length, disclosure,
antidepressants, time management41
Management of late-life depression in primary care39
Antidepressant use44,47–49,52
Role of specialist services50
Managing depression46
Clinicians used antidepressants,
talking therapies, listening and
specialist services. Listening to
depressed patients takes time; this
may be a barrier to effective
treatment, but one in-depth study
contested this
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TABLE 2 Extracted key themes and how they translate across the included studies (continued )
Summary second order
constructs
Extracted key themes (authors’ ‘own words’
or paraphrase)55
Summary translation across
studies
Stigma and shame Stigma and shame38
depression still carries a stigma in this age group39
Depression is perceived as
stigmatising for some elderly
people, especially those from
ethnic minority groups
Relationships between
professionals
Primary care relationships39
PNs’ position in the practice38
Confusion over the role of and lack of access to
specialist services43,46,50
scarcity of counselling resources41
There is confusion between
primary care staff concerning their
roles and responsibilities in the
diagnosis and management of
depression, and about the role
of specialist services, which seems
focused around lack of access
Attitudes to managing
depression
GP responses to chronic depression37
Interactional difficulties with depressed people42
Pessimistic about outcome43
Positive about outcome40,41
Lack of confidence in managing depression39,46,48,53
Ambivalence49,51
GPs and PNs experience frustration
in managing depression. Some are
confident about outcomes, but
commonly there is ambivalence
Training needs without understanding the framework which
underpins GPs views on ‘depression’ . . . educational
interventions directed at GPs will not improve
patient outcome42
Lack of training and knowledge39,46,50,51,53
education efforts should focus on increasing GPs’
sense of therapeutic optimism and providing them
with sufficient skill in and knowledge of a range of
psychological procedures52
GPs would benefit from educational programmes
that promote awareness of current
treatment guidelines47
Many PNs and some GPs say they
need more training in managing
depression, but this is not a
priority for them. Training should
be grounded in professionals’
understandings of depression and
should seek to improve attitudes
to working with depressed people
Source: reproduced from Barley et al.31 © 2011 Barley et al.; licensee BioMed Central Ltd. This is an open access article
distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
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Not all information was available for each study. Quality assessment score: higher score represents higher
quality, qualitative studies scores out of 10 on critical appraisal skills programme checklist;33 quantitative
observational studies scores out of seven on a scale devised for this study (see Appendix 2; also published
in our metasynthesis paper31).
All translated second-order constructs were supported by at least one good-quality study (bold references
are studies scoring in top tertile of quality scores: qualitative studies ≥ 8/10, quantitative studies ≥ 4/7)
and by both qualitative and quantitative studies.
The management of depression in a general practice setting is perceived as particularly complex when
patients also present with concurrent social problems. GPs and PNs are very aware of the relationship
between social problems and mood, but they are unsure of its exact nature and of their role in managing
it. This uncertainty may be exacerbated by a lack of attention in guidelines concerning the influence of
social problems on response to treatment.54
There are ambivalent attitudes among GPs and PNs towards working with depressed people. This was
reflected in a lack of confidence among some clinicians in their ability to manage mental health problems
and the use of a limited number of management options. Most of these data are from GPs, perhaps
because PNs may be less likely to manage depression than GPs; however, where depression is comorbid
with physical illness PNs’ views may be more important since they are taking an increasing lead in long-term
condition management and particularly since practices began to be reimbursed for screening their diabetic
patients and patients with CHD for depression under QOF, although this payment has since ceased.
There was also evidence that GPs avoid giving a diagnosis of depression based on a belief that some
patients, especially older people and those of Caribbean or South Asian ethnicity, will feel stigmatised by
it. One high-quality study39 suggested, however, that concern about stigmatisation might be constructed to
hide a reluctance to explore depression in order to avoid feelings of powerlessness when management
options seem limited. At the time of the review, there were no data available to determine whether or not
the same issues are important when managing patients with depression and comorbid physical illness.
We, therefore, used the findings of this review to inform our planned study of GPs’ and PNs’ views and
experience of managing depression in CHD.
Our review had demonstrated variation both between and within studies in views expressed concerning
the management of depression in general. When considering the management of depression comorbid
with CHD, we therefore decided to use a semistructured interview design. This would allow us to focus the
interview on the topics that we considered important for informing our future intervention, while allowing
participants to highlight topics important to them. Similarly, we realised that it would be important to use
an iterative process for the data collection and analysis so that new themes arising in early interviews could
be tested with later participants. The review findings also informed our topic guide (see Appendix 3). With
the plan to develop a new intervention in mind, we ensured that each interview would cover three broad
areas: defining depression in CHD, current management of depression in CHD and future management of
depression in CHD. The key findings from our review related to each broad area were then used as
prompts during the interview. In this way, we were able to test whether or not the findings of our review
were relevant when considering depression in people who also had comorbid CHD and which issues
would need to be addressed by the future CHD-specific intervention. For instance, when asking clinicians
about how they defined depression in CHD, if they did not mention social problems (which we had
found in our review to be important), we planned to prompt them to consider this issue. Hence, our
metasynthesis allowed us to conduct a more relevant and focused qualitative study, which is described in
the following section.
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Qualitative interview study of general practitioners’ and practice nurses’
views and experience of managing depression in coronary heart disease
Study aim
This qualitative interview study was designed to help understand GPs’ and PNs’ views and experience of
managing depression specifically when it is comorbid with CHD and to determine their preferences for our
planned UPBEAT-UK nurse-led pilot intervention for people with CHD reporting chest pain, which could be
angina or non-anginal chest pain, and depression.
Study methods
The initial sampling frame was the 16 GP practices participating in our cohort study, the design of which is
described in Chapter 5. In recruiting the participants from these practices, we used a purposive, maximum
variation approach to recruitment based on ethnicity, age, practice setting (inner city vs. suburban) and
size (single handed vs. group). After several interviews, we noticed that participants often mentioned their
involvement in our cohort study and we became concerned that this was an indication of heightened
awareness of depression in CHD. From then on, only those clinicians from UPBEAT-UK practices who were
not personally involved in the cohort study were interviewed. We also used a snowballing technique to
identify GP and PN participants independent of the UPBEAT-UK research programme, that is, practices that
we had not recruited to the cohort study.
We conducted individual semistructured interviews using a topic guide (see Appendix 3) based on the
findings of our metasynthesis. We revised the topic guide iteratively: for instance, early participants
introduced the problems of ‘erectile dysfunction’ and ‘housebound patients’ so we explored these topics
with later participants. In order to ground opinions in practice, we asked participants to recall specific
patients. We audio-recorded the interviews and transcribed them verbatim following written
informed consent.
We conducted the interviews and analysis concurrently, and stopped recruitment at data saturation;
that is, when no new themes or information emerged. We applied a staged procedure of thematic analysis
to the data57 adding rigour to the process with the techniques of constant comparison.58 Three researchers
(EB, JM and PW) independently coded the first interview and met to discuss preliminary descriptive codes.
Following this, two of the researchers (EB and JM) independently applied these and, where appropriate,
new codes to the following four transcripts when consistency in coding was achieved. Descriptive codes
were collated into themes and a preliminary explanatory framework devised. This was then used as the
basis for coding and for informing future interviews. Data for each theme were gathered and coded using
computer software (NVivo version 8; QSR International, Warrington, UK). The robustness of themes was
tested by examining differences and similarities between coded data.
Study results
In total, EB interviewed 10 GPs and 12 PNs. Male and female GPs were recruited but no male PNs were
identified. GPs and PNs appeared to have similar views. We have published the findings of this study,
including illustrative quotes and participant details, in open access journal papers by Barley et al.2,59
in 2012. The identified themes and topics discussed are listed in Box 1 and the main findings are
summarised below.
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BOX 1 Themes identified and topics discussed during the GP and PN interviews
Theme: understandings of depression
Distress vs. depression.
Distress or depression in CHD.
l vs. ‘general depression’.
l vs. depression in other chronic diseases.
l CHD severity.
l Why some CHD patients become depressed.
l Disease impact.
l Individual difference.
l Social factors.
l Illness perceptions.
Impact of understandings on decisions to treat.
Theme: recognising and screening for depression
QOF questions.
l Benefits of QOF questions.
Reservations about QOF.
Clinical judgement.
Theme: assessing the severity of depression
Theme: current management of depression in CHD
Management goals.
Current management options.
Choosing management options.
l Antidepressants.
l Talking therapy.
l Informal counselling.
l Exercise.
l Specialist NHS and community services.
l Other issues influencing management choices.
Theme: other issues in CHD depression
Erectile dysfunction.
Housebound patients.
Theme: future intervention for depression in CHD
Type of intervention.
Timing of intervention.
Who would deliver the intervention.
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Summary of study results
Current attitudes and practices
General practitioners and PNs expressed diverse views, which indicates uncertainty about this topic.
However, for most of the themes, a majority view could be identified, even if some individuals also offered
alternative opinions. For instance, most of the participants appeared to consider CHD depression similar
to other types of depression. Distress and depression were viewed, by most, as lying on a continuum
of severity and/or chronicity. Individuals may ‘naturally’ become distressed following a diagnosis of CHD
or a cardiac event, but only when the distress becomes severe and enduring is it seen as depression
requiring treatment.
Most participants used the QOF questions to screen for depression, followed by a more detailed
questionnaire, such as the Patient Health Questionnaire (PHQ-9) or the Hospital Anxiety and Depression
Scale (HADS); however, use of additional questionnaires was not routine, even when responses to the QOF
questions were positive (indicating possible risk of depression or a need for further exploration). In several
practices, PNs did not have access to the detailed questionnaires, suggesting that there may be
ambivalence towards their use. That most participants stressed the importance of their clinical judgement
both in assessing depression and making management decision supports this. These findings are also
supported by a recent study which also showed that although GPs used the questionnaires, they preferred
to rely on their ‘practical wisdom and clinical judgement’ to guide their assessments.60
The clinicians identified a range of management options for CHD depression. Antidepressants and talking
therapies were most often cited. This is not surprising since each of these treatments or a combination is
known to be effective for depression in other populations. There is also some evidence that selective
serotonin reuptake inhibitors may have a direct beneficial effect on platelets,61 although only one GP
in our study, who is also an academic, mentioned this. However, in CHD depression, many considered
antidepressants as a last resort. This appeared to be owing to a perceived reluctance in CHD patients to
accept them, either because of fear of stigma associated with mental health problems or to a general
dislike of medications, which is exacerbated when patients are already taking multiple medications for their
heart condition. Data from patients are required to assess the validity of this perception.
Talking therapies were favoured; however, only a few GPs differentiated between types of therapy.
This suggests a lack of clarity about the aims and process of different therapies, which may reduce their
ability to make appropriate referrals. Some patients had been observed to reject talking therapy,
again out of fear of being stigmatised. However, the main barrier to the use of talking therapy was a lack
of availability. This has been reported previously.42 It appears that the government’s Improving Access to
Psychological Therapies (IAPT) programme has not yet reached these south London practices.62
Access to other management options that clinicians felt would improve aspects of CHD depression, such
as exercise on referral schemes, clubs to reduce loneliness and agencies to help with financial or housing
problems, varied widely between the practices. Furthermore, there was variation between clinicians in their
knowledge of the availability of such options. This may reflect variation in clinicians’ attitudes to managing
problems that they believe are social in origin. Previous research39 has identified ‘therapeutic nihilism’ in
which clinicians feel helpless in the face of the complex social problems which impact on their patients’
health. This attitude was seen in several participants in this study, although others actively sought to
address social difficulties; one GP even expressed enjoyment in this aspect of her work. This latter attitude
is encouraged in the government White Paper Our Health, Our Care, Our Say: A New Direction for
Community Health Services.63 This calls for greater integration of health and social care for patients with
long-term conditions. One method may be ‘social prescribing’, which signposts patients to non-medical
facilities and services available in the wider community, such as financial advice agencies and social clubs,
which they can access to address the factors that influence their well-being. One practice involved in this
study was providing this service, but our findings suggest that there is considerable scope to develop this
for CHD depression in south London.
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Informal counselling activities, such as reassurance and education, were performed by all the participants
to some extent. With a few exceptions, most GPs were unwilling or unable to give much time to this.
Some PNs reported that they did have the time, but even among these, there was doubt about how useful
this was and many were left wondering how to progress and so would welcome guidance. Other nurses
were open that they did not enjoy dealing with mental health problems or that they did not consider it to
be part of their role either owing to lack of training or interest. These nurses would avoid raising the
possibility of depression for fear of ‘opening a can of worms’ with which they felt unable to cope.
Future coronary heart disease depression intervention
This study has identified issues that should be addressed when designing a new CHD depression
intervention. Findings from this study, along with those from previous work, may inform the type of
intervention, the timing of the intervention and who should deliver the intervention.
Type of intervention
The participants were very clear that any intervention should be easily accessible. This was both in terms of
being carried out locally, as they had observed a reluctance or inability in many patients to travel, and in
terms of having clear and simple referral criteria so that clinicians would not be burdened by having to
remember complex rules. Some participants reported difficulties remembering what treatment options
and facilities were available for the multiple conditions that they managed; this could be a barrier to
effective treatment.
The need for multiple treatment options was also stressed. This was so that options could be matched with
the varying needs identified in individual CHD patients; because the participants recognised the importance
of patient choice in improving adherence to treatment; and because clinicians value the opportunity to use
their clinical judgement. Interventions that improve adherence to treatment were considered especially
important as most of the clinicians considered that this was poor in CHD patients. However, although
clinical judgement was valued, several nurses said they would favour the development of a protocol to
guide their management decisions. This appeared to arise from their reported uncertainty as to what
management options are available and appropriate for CHD depression.
Any new intervention should be evidence and theory based. Having goals and social support are known to
be important to well-being.64 Although no participant specifically mentioned goals, several noted that the
causes of depression are specific to individuals and that to be effective, management plans should be
patient driven. Evidence-based interventions that involve patients deciding which areas of their lives to
address, such as problem-solving therapy, motivational interviewing or the technique of ‘SMART goals’,
where individuals identify an area to change that is Specific, Measurable, Appropriate, Realistic and Timely,
may therefore be useful in CHD depression and would most likely be accepted by GPs and PNs.
All participants mentioned the importance of social support. Some raised the role of the family in directing
patients to care and helping with self-management. Most participants stressed the importance of
combating isolation, which they felt is a determinant of depression in many CHD patients. This issue was
considered to be especially relevant to housebound CHD patients, for whom, in many practices, no specific
system of care had been devised. Identification by the patient of an individual who can support them in
their self-management is a commonly used and effective strategy in several health-care interventions, for
example weight loss and health training.64 This type of intervention may be appropriate for many CHD
patients and would be supported by GPs and PNs.
Cognitive habits are known to influence depression and, as such, CBT is now an established treatment for
depression.65 Similarly, in chronic disease, the ways in which individuals think about their illness and
approach its management are known to influence outcome.66,67 Given the strength of this evidence, it is
surprising that cognitive factors were not discussed in detail or by all participants. It appears that some of
the clinicians considered physical and mental health separately and were more focused on the former.
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Some participants, however, did mention the importance of cognitions such as illness perceptions and
motivation or commitment to change in improving mood or health in general. Some participants said they
or a colleague within the practice had had training in brief cognitive interventions such as ‘10-minute
CBT’68 or problem-solving therapy.69 It appears that GPs and PNs vary in their understanding of and
willingness to address cognitions when managing CHD depression. A new CHD depression intervention
is likely to be most effective if it involves some level of cognitive change in the patient. Increasing
self-efficacy, motivation, readiness and commitment to change, and changing illness perceptions have all
been shown to improve outcomes in a range of chronic illness, including heart disease.67 Some GPs and
PNs may need education to accept such interventions.
Timing of the intervention
The participants were divided into whether an intervention for CHD depression would be most effective if
delivered immediately following a cardiac event or several months later. The rationale for early intervention
was to prevent the distress that they believed is commonly experienced following a CHD diagnosis or
cardiac event from developing into a lasting depression. An early intervention should, therefore, focus on
helping the patient come to terms with the feelings, observed by the clinicians, of shock and vulnerability
and help them to adjust to changes in role or functioning. However, several clinicians felt that the majority
of people recover without intervention. Previous research has shown that the medical condition and
depression status of individuals within 6 months of MI fluctuate.5 It has been suggested by an expert panel
on depression and CHD5 that a population whose depression is likely to remit spontaneously may not be
the best group in whom to test the hypothesis that reducing depression will reduce the risk of CHD-related
mortality and morbidity.
However, the panel also point out that early treatment with antidepressants, as opposed to depression
symptom interventions, may be appropriate, to the extent that the former may have direct cardiovascular
benefit. A further argument for early intervention concerns the role of illness perceptions in disease
progression, which is well documented.67 This issue was raised by two participants who felt that patients
could be disabled more by their perceptions than by their actual CHD severity. There is some trial evidence
to suggest that early modification of illness perceptions may lead to improved outcomes. In a small RCT,70
inpatients who received a brief intervention designed to alter their perceptions about their MI had
improved functional outcomes and reduced angina symptoms compared with controls at 3 months
post discharge.
The participants’ rationale for a later intervention, that is, some months after an event or initial diagnosis,
was that if spontaneous recovery had not occurred, CHD-associated distress would have become chronic
and therefore could be described as depression that needed treatment. Patients had, therefore, not
adapted to having CHD or to its effects. Effects, such as loss of function or role due to CHD, and
symptoms, such as erectile dysfunction (which may occur any time in CHD and up to 5 years prior to
diagnosis,71 were identified as particular predictors of depression. These may need to be addressed at this
time. It was also suggested that after a few months, when their medical condition has stabilised, the
support available to CHD patients, such as CR and outpatient appointments is reduced. This may increase
patients’ risk of depression.
A complicating factor when deciding on the timing of a new intervention is that many participants were
aware that their CHD patients were depressed prior to their diagnosis or cardiac event. This was explained
in terms of the difficult social lives that many patients in south London lead; CHD was just another
problem that added to their depression. An intervention that addressed multiple problems would therefore
be necessary for such patients. This could be delivered at any time following diagnosis.
Findings from this study and from previous research therefore indicate that it is likely that different types of
intervention may be more or less effective at different times following diagnosis or a cardiac event.
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Who should deliver the intervention?
The participants of this study varied in their opinions as to who should deliver or manage a new CHD
depression intervention, although no one suggested that a GP should lead. There was a majority opinion,
however, that there is currently no suitable person within primary care, at least, not without training. It
was felt important that the person delivering the intervention should be knowledgeable about and have
experience of managing both CHD and depression.
The PNs were all experienced in managing the physical aspects of CHD, but their confidence and interest in
dealing with psychological problems varied widely. This could be addressed through training. Nurse-led
psychosocial interventions have been shown to be effective, including in heart disease.72,73 However, many
nurses complained of a lack of time. A previous study41 has shown that it is possible to have a flexible
attitude to time management in primary care in order to manage depression effectively. This was supported
by data from GPs and a PN in one practice where the policy was to be flexible with time in order to address
their patients’ psychosocial needs. The observation from this study that PNs with 30-minute, as opposed to
the more usual 15-minute, appointments often tended to be more willing to provide informal counselling to
depressed CHD patients also supports this. If the new CHD depression intervention is to be delivered by PNs,
it could be made attractive to them if it could be shown that it would save them time. This may be achieved
by pointing out reports by PNs, gathered during this study, that they currently spend a lot of time delivering
informal counselling despite being unsure that it is effective.
Finally, this study has identified that some primary care clinicians may be reluctant to raise the subject of
depression with their CHD patients. In addition, several of the clinicians perceived that their patients were
also unwilling to do this or to accept treatment. This may explain findings that depressed patients with
comorbidity, including CHD, were less likely to be treated for depression.74 In this study, one reason cited
for this reluctance to discuss mood was fear of stigma, both in patients, who did not want to be
stigmatised, and doctors, who did not want to create stigma. Stigma around mental health is well
documented.75 Some participants suggested that the use of screening questionnaires helped them to raise
mental health issues in a non-threatening manner. This is supported by recent findings that patients liked
their GPs using questionnaires as they saw them as an efficient and structured supplement to medical
judgement and as evidence that the doctor was taking their problem seriously.60
Other reasons for not addressing mood were lack of confidence or interest in treating mental health
problems, prioritisation of physical health problems and a belief that ‘nothing could be done’ about the
depression, which occurred mainly when depression was perceived to stem from social difficulties. These
views suggest that, although they are very aware of the social difficulties experienced by their patients,
some clinicians are still working with a biomedical model of health, where mental health and physical
health problems are viewed as separate entities. This is despite the widespread acceptance of the
biopsychosocial model76 as a more useful explanatory model of health.77
Adoption of the biopsychosocial model may empower clinicians to manage mental health problems that
they see as social in origin. Care systems built around an understanding that physical and mental health
are interlinked and occur in a social context may lead clinicians to explore management options other than
those that are traditional within primary care, for instance local clubs to combat isolation and advice
agencies. Some of our participants were aware that such facilities may be useful, but there did not appear
to be any system for identifying local facilities or for matching them to their patients’ needs. For this to
work, such facilities must be available and accessible. This study shows that provision does vary within the
limited geographical area of south London, but also that many clinicians are not fully aware of all the local
facilities that are available to them. Any new intervention should aim to optimise use of existing facilities.
Therefore, as well as aiming to improve patient health, any new intervention for CHD depression should aim
to increase clinicians’ awareness of the inter-relationship between physical and psychological health, and the
social context in which it occurs. It should also be aimed at increasing primary care clinicians’ feelings of
self-efficacy in managing complex psychological needs that may appear to be social in original.
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Conclusions
The study suggests that for many GPs and PNs, only depression that is severe and chronic is considered to
need treatment in CHD. QOF screening questions are valued in detecting depression, but use of these is
not routinely followed up with a more detailed questionnaire, such as the PHQ-9, which may be more
accurate. Routine use of more detailed questionnaires, especially by PNs, many of who currently do not
have access to these, may increase identification of CHD depression.
The GPs and PNs in this study felt that managing depression in CHD was worthwhile. To be accepted by
clinicians and patients, a new intervention should have clear referral criteria and be local to the practice.
The participants valued their clinical judgement and recognised the importance of patient choice in
successful management; a new intervention should offer a range of treatment options that clinicians and
patients can select together. These should include options for problems identified as exacerbating or
causing depression in CHD, such as erectile dysfunction and being housebound. This study suggests
that housebound patients currently may not receive adequate psychological care. Many clinicians felt
that exercise is useful in managing CHD depression; there may be potential to develop this as a
management option.
Depression in CHD may be exacerbated by, or may exacerbate, distress or depression associated with social
problems. Potential exists, in CHD depression management, for greater use of existing local resources to
combat problems common in CHD, such as social clubs for loneliness or agencies for financial or housing
advice. However, clinicians vary in their perceived responsibility and ability to manage such problems.
Some may need to be supported and empowered to manage problems that they consider social in origin.
Similarly, despite good evidence that cognitions are important predictors of response to chronic disease
and that changing cognitions may improve health outcomes, GPs and PNs appear to vary in their
understanding of this. A new CHD depression intervention should include education for clinicians
concerning the role of cognitions such as illness perceptions, self-efficacy and motivation in chronic
disease management.
Factors associated with depression in CHD may vary according to the time elapsed following receipt of a
diagnosis or a cardiac event. Distress or depression immediately following diagnosis or an event may
resolve spontaneously in many patients. An early intervention to manage unhelpful illness perceptions may
reduce the number of patients whose distress or depression does not resolve. In patients whose depression
is persistent, a more complex intervention may be needed to address adjustment problems or social issues
which are exacerbating the mood problems.
Finally, this study suggests that there is currently no suitable professional within primary care to deliver a
CHD depression intervention, at least not without training. Some nurses say that they would be willing
to be trained to do this, but others would need persuasion owing to a lack of interest in or perceived
responsibility to manage mental health problems. Given their current heavy workload, all PNs would need
to be convinced that any new CHD depression intervention was effective and would have timesaving
benefits. Time may be saved by reducing the time spent in informal counselling, which the PNs report to
be time-consuming and of uncertain benefit.
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Summary: what we learned from reviewing existing literature and
conducting our own qualitative study
The findings of our metasynthesis of studies of primary care management of depression in general and our
qualitative study of primary care management of depression comorbid with CHD were complementary. On
balance, GPs and PNs expressed uncertainty in the management of depression, citing lack of time, training
and available management options that are acceptable to patients. That these findings were similar for our
metasynthesis and this qualitative study indicates that GPs and PNs have similar struggles when managing
depression whether or not it is comorbid with CHD. Social problems, in both studies, were seen as
important contributing factors, which should be addressed; our qualitative study indicated that these might
be especially important in CHD patients who often come from low socioeconomic groups. However,
GPs and PNs are uncertain in their role in and responsibility for addressing social problems and existing
resources are underused; a finding from both our review and this qualitative study which highlights the
need for a new intervention to help address this. Nurses’ attitudes towards and confidence in managing
depression varied enormously. This was a finding of both our review and qualitative study, and, as primary
care patients with CHD commonly receive most of their care through nurse-led clinics, suggests that the
development of interventions for depression in these patients should include sensitive consideration of
nurses’ views.
By asking clinicians, in our qualitative study, to consider depression comorbid with CHD, we not only
confirmed that the findings of our review were relevant when managing people with CHD, but also
identified issues that may be particularly important to people living with CHD. For instance, erectile
dysfunction is a common problem that is not addressed routinely despite clinician awareness that this can
contribute to depression and that if people with CHD become housebound, they are unlikely to receive
any help for depression.
Strengths and limitations
Through the inclusion of only recent studies conducted in the UK, we ensured that our metasynthesis
produced findings relevant to current practice within the NHS; findings may be less relevant to those
wishing to develop interventions in other health-care systems. The aim of our review was to identify broad
themes concerning depression management in order to inform our qualitative study focusing on managing
depression when it is comorbid with CHD and hence we excluded studies focusing on specific aspects of
the management of major depression such as antidepressant use. These more specific aspects of
management were, however, addressed in our qualitative study focusing on their relevance to people with
comorbid CHD. As is the case with all metasyntheses, we had to make decisions concerning which studies
to include; we have detailed our methods clearly but others conducting the same review may have
selected different studies. The findings of our review and qualitative study were, however, concordant,
indicating that our choices were appropriate and that we produced robust findings to inform
our intervention.
The findings of our metasynthesis were extremely useful in ensuring that our qualitative interviews were
focused on known barriers and facilitators to managing depression in the UK; this information was
essential in ensuring that our intervention would be feasible to deliver in primary care. However, we
also used an iterative process of data collection and analysis so that new topics could be explored in
subsequent interviews. For instance, the idea that depression in some people with CHD may be
compounded by erectile dysfunction or by being housebound had not been identified in our review. Such
findings emphasised the need for a future intervention to be personalised in order to address the varying
needs of individuals. A potential weakness is that our participants were all practising within south-east
London; however, we were careful to recruit from areas of contrasting deprivation and affluence in order
to elicit a range of experiences.
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It should also be noted that, as in the case of all qualitative research, it is possible that our positionality
influenced our final findings. For instance, the UPBEAT-UK programme was funded to consider the
‘problem’ of depression comorbid with CHD and this informed our methodology. Had we conducted a
study about the impact of illness on well-being and health as a resource for daily living, our findings may
have been different.
Finally, since we conducted our study, guidelines for the management of depression with a chronic
physical health problem have been issued;18 these may impact on attitudes and practice in the future.
Conclusion
Our systematic review of existing literature describing GPs’ and PNs’ experience of managing depression in
UK primary care identified a range of barriers and facilitators to delivering care that need to be considered
when designing future interventions for depression. We were then able to determine whether or not
similar barriers and facilitators were experienced by GPs and PNs when managing depression in patients
who also have CHD by conducting our own qualitative study. This work addressed a gap in the literature
highlighted by our review and helped us to determine GPs’ and PNs’ views concerning what an
intervention for people with sCHD and comorbid depression should consist of. By seeking clinicians’ views
directly, we were able to identify elements (such as the need for a flexible, personalised intervention which
allowed clinicians to use both their clinical judgement and existing tools and resources) of a future
intervention, which would make it not only effective (in terms of addressing care needs identified as
unaddressed in these patients) but, importantly, feasible to deliver in current practice.
The following chapter describes how we also sought the views of patients with CHD and comorbid
depression to inform our intervention. How this work was synthesised to develop an intervention to test is
then detailed in Chapter 4.
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Chapter 3 Perceptions of distress and depression
in patients with symptomatic coronary heart disease:
a qualitative study (work package 1)
Introduction
In the introductory chapter, we described how CHD and depression are both common health problems
worldwide and are predicted to be the two top causes of global health burden and disability by 2020.
We have described how depression has previously been associated with worse cardiac prognosis and an
increased cardiac mortality. We described a need to better understand the relationship between the two
disorders and a pressing global public health need to improve integrated primary care for people with
both disorders.
Although the prevalence of depression in patients with CHD is high, little is known about how people with
CHD and comorbid depression perceive these conditions and the relationship between them. Treatment
trials for patients with CHD and depression have included antidepressant medication with some success in
reducing mortality.78,79 However, it is currently unclear whether or not patients with CHD would opt for
other interventions recommended by NICE for depression, such as supervised exercise, guided self-help,
problem-solving, group or individual CBT or interpersonal therapy. It is also unclear whether or not NICE
guidelines for depression need modification for patients with concurrent CHD and depression.
Before designing a new primary care-based intervention by nurses for patients with CHD and concurrent
depression we undertook qualitative research to explore patients’ perceptions of their depression in the
context of CHD, their health-care preferences and own self-help strategies for coping with depression.
In this chapter we report on qualitative findings from a pilot study of five unstructured interviews with
UPBEAT-UK cohort study patients with sCHD (chiefly chest pain) and symptoms of depression, as well as
qualitative findings from a semistructured interview study with 30 UPBEAT-UK cohort study patients
presenting with sCHD and symptoms of depression.
Aims
The study aimed to explore (1) primary care patients’ perceptions of links between their physical condition
and mental health; (2) their experiences of living with depression and CHD; and (3) their own self-help
strategies and attitudes to current personalised care (PC) interventions for depression.
Methods
The sampling frame was the UPBEAT-UK cohort study database of primary care patients with CHD.
At the time of recruitment (November 2008–January 2009) this numbered 376. On recruitment to the
cohort, study participants were given the option of being interviewed in depth about their experiences of
CHD and how this affected them emotionally. From participants who agreed to be contacted, we
purposively sampled for positive scores on the PHQ-9,80 which indicates symptoms of depression. We also
sampled for maximum variation on sociodemographic factors: age, sex, ethnicity and occupational status.
At the time of sampling, 42 patients screened positive for symptoms of depression and of these, five were
included in the pilot interview study. Of the remaining 37, one patient declined and three could not be
contacted or had died. Of the remaining 33 patients, 30 were interviewed, at which point interviewing
was stopped as data saturation had been reached.
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We conducted five individual unstructured pilot interviews and 30 semistructured interviews. Topic guides
were informed by the aims of the research, review of the literature, discussion with coauthors and findings
from the pilot interview study. We audio-recorded all interviews and transcribed them verbatim following
written informed consent. Transcribed interviews were entered into NVivo 8 qualitative software for
analysis and data management.
All transcripts were analysed using a thematic approach81 involving a process of constant comparison
between cases.82 Analysis began alongside data collection, with ideas from early analysis informing later
data collection in an iterative process. Analysis of individual transcripts commenced with open coding
grounded in the data. This generated an initial coding framework, which was added to and refined, with
material regrouped and recoded as new data were gathered. Codes were gradually built into broader
categories through comparison across transcripts and higher-level recurring themes were developed. Data
were scrutinised for disconfirming and confirming views across the range of participants. Discrepancies
were resolved by discussion at regular UPBEAT-UK research meetings to ensure consistency.
Pilot interview study
Study results
Participants
Participant characteristics are recorded in Table 3.
Participants were given pseudonyms to protect their anonymity.
Seven key themes were identified:
1. taking control and individual coping strategies
2. the significance of having heart problems
3. ambivalent attitudes to accessing PC mental health services
4. services participants would like for heart disease and depression
5. future orientation (having achievable hopes and dreams for the future)
6. the positives
7. contributory or causative factors for distress/depression.
TABLE 3 Participant characteristics
Age Sex Ethnicity Occupational status
57–59 years Two male Three white British One full-time employment
One Afro-Caribbean One disabled
Two female One South Asian Three retired
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Taking control and individual coping strategies
Analysis of pilot interviews revealed the ways in which patients tried to gain control of their health and
emotional well-being and the individual coping strategies they used. These included:
l devising own fitness regime
l going to the gym
l studying health issues and alternative or complementary medicine
l meditating
l praying and being an active member of a religious community
l learning specific relaxation techniques based on yoga and Buddhist philosophy
l fishing and being in the natural environment (described as a yoga-like experience)
l being able to drive
l setting goals for exercise and pacing performance
l getting an allotment and growing vegetables
l volunteering at a hospital.
The following are illustrations of strategies used by participants: devising own fitness regime, going fishing
and going to the gym. These examples not only illustrate the most cited strategies used but also individual
differences in participant preferences for individual or group approaches to self-help.
Geoff described his fitness regime; he has a mini-gym in his sitting room and also goes fishing.
He explained:
I’ve got equipment where I train, I’ve got the balls, I’ve got the weights, I’ve got a track that I run on,
and I got legs . . . because of this operation, because I have got arthritis I got to strengthen my legs . . .
and I got a thing to do my upper body. Yeah I train at least once per week.
When exercising and out walking, Geoff also wears a heart rate watch and he finds this source of
‘biofeedback’ helps him to pace and monitor his exercise, particularly when climbing hills. Geoff finds that
being by the river, fishing and enjoying the natural environment a therapeutic experience in itself, he said:
Yeah, yeah, it’s like a yoga, you can go into your own trance can’t you, you can sit by the river and
just imagine you’re doing anything, it’s like yoga.
Geoff had worked as a porter in the various Covent Garden markets for most of his life but since retiring
he had built up a sizeable collection of books on alternative and complementary approaches to health.
Geoff may have symptoms of depression, as detected by his PHQ score, but he is actively taking control of
his health.
Another participant, June, talked about the ‘psychosocial’ benefits she gained from her regular trips to a
gym where there was a special programme for heart disease patients:
. . . there is a group there [at the gym] and nine times out of ten we spend most of our time laughing!
This participant clearly enjoyed the fun she had with other people who had similar health problems and
were trying to cope with the gym equipment and exercises through laughter.
The significance of having heart problems
For all five participants, having heart problems was not the health condition that concerned them the
most. Three out of the five participants suffered from arthritis and this condition appeared to be causing
more problems than heart disease owing to chronic pain and impaired mobility. One participant, June, was
unable to work because of arthritis in her shoulder, arms, legs and ankles. She had already undergone five
operations for arthritis.
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Out of the five participants, Gurch seemed the most depressed or unhappy. Gentle probing about his
heart problems (bypass surgery and a number of heart attacks) and how this had affected his feelings
almost immediately led onto the topic that dominated the interview: his unhappy marriage and home life
and his abuse of alcohol. The following exchange illustrates the problems Gurch had experienced:
Researcher: But how did it [heart bypass surgery] affect you emotionally, what did you think and what
did you feel?
Gurch: At that time there are family problems.
Researcher: Did you have family problems?
Gurch: Yes family problems you know then I just take so much whisky you know drank you know.
Researcher: All right so I understand that you were saying that you had family problems and that was
why you were drinking a lot.
Gurch: It was one of the causes you know, the family problem you know I don’t know (. . .) my wife is
but I do not know at that time you know, what are right what are wrong, anyhow it were due to my
family quarrelling.
A little later in the interview he reflected that at the time of his heart bypass surgery, nearly 23 years ago,
he was ‘totally unhappy, just spending my time you know just passing my time’.
Like Gurch, four out of the five participants had experienced problems in their marital relationships that
seemed to have affected them over a long period of time and caused them unhappiness, anxiety and
depression. In comparison with their relationship issues, participants seemed almost blasé about their
heart problems.
Ambivalence about accessing mental health services
The next theme explored participants’ ambivalence about accessing mental health services through their
GP and these included:
l cultural perceptions of depression can act as barrier to accessing help, for example in South Asian and
Sikh communities
l not knowing the meaning of ‘depression’
l suffering seen as Karmic – in the hands of God
l cannot talk to anyone in community (stigma?)
l fearing negative perceptions of GPs as always ‘moaning and groaning’ (this idea is reinforced when
doctor praises client for not moaning)
l discomfort in talking about emotional issues
l low self-esteem and a sense that their problems are not worthy of attention
l the perception that their health is relatively good and that there are people in far worse situations
l some people do not want to go down that path because it frightens them.
Excerpts from interviews with June and Ivy illustrated how health stoicism and fear of being viewed
negatively by their GP acted as an inhibitor to accessing primary care health services. Although June
suffered from asthma, arthritis, heart disease and possible depression she seemed reluctant to visit her GP
other than for her regular 2-monthly check-ups. June explained ‘. . . there are some times when you are
thinking to yourself that there are people a lot worse off than you!’.
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Ivy had also adopted this approach – even though she was 79 years old and had heart disease, arthritis,
balance problems and symptoms of depression. She explained:
Ivy: To be honest, I hardly go near them [GP surgeries] . . . I mean they have got enough to do when
they have got a whole lot of patients who are worse off than I am.
Researcher: OK so do you think of yourself as being in quite good health?
Ivy: Yeah.
Researcher: You think ‘I’m OK I’m much better off than some people’?
Ivy: Yeah, yeah.
Researcher: And does that make you feel better?
Ivy: Sometimes it does.
Although the strategies of stoicism and ‘counting your blessings’ that Ivy used can have some positive
benefits (putting problems into perspective to combat feelings of anxiety about health) it can also act as an
inhibiter to accessing health care.
June was concerned that her GP might perceive her negatively by making more frequent visits to the
surgery. June explained:
June: I don’t want to come in too often!
Researcher: Too often?
June: Even though they say they don’t get fed up, you don’t want them to get fed up, you know?
In relation to depression, a study by Priest et al.83 found that stigma was still associated with depression,
and patients felt ambivalent about consulting a family doctor. Some feared the GP would make negative
evaluations of them or would be irritated or annoyed. With this in mind, June might be similarly reluctant
to disclose her feelings of depression to her GP.
Services participants would like for heart disease and depression
In relation to the services participants would like for heart disease and depression, participants seemed
more interested and comfortable in talking about services they would like for heart disease. The following
suggestions were made:
l more frequent (physical) check-ups at the GP surgery with specialist nurse and improved feedback
l being able to request a check-up when needed
l access to a gym with specialist cardiac trainer for attention, guidance and reassurance
l the promotion of wrist heart rate monitors
l some people were interested in having counselling
l one participant had counselling and found it helpful.
Three out of the five participants had used a gym as part of their aftercare but only one participant, June,
seemed to have attended sessions that were designed for people with heart problems. The other
participants attended general fitness centres where they were assessed by a trainer and then given a set of
exercises and left to get on with these on their own. These three participants all felt that a dedicated
session would be preferable, particularly in the period immediately after their coronary incident when they
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needed the most reassurance about symptoms and safety while exercising. June’s experience of going to a
dedicated gym session was an enjoyable one because there were a group of people ‘in the same boat’ and
they had a good laugh. She also felt safe and reassured by the trainer when she had some cardiac
symptoms. Even though this kind of CR might not be considered a psychological intervention, in the
strictest sense, it may have some positive outcomes for patients suffering from mild depression and may
also help to prevent a ‘cardiac invalid’ mind set.
Only two out of the five participants had received help for depression from their GP. None of the
participants had received antidepressant medication, June had received information and Ivy had attended
counselling sessions. Geoff had been offered group therapy but did not want to attend. Generally
participants seemed cautiously positive about the idea of receiving one-to-one counselling while less
positive about group therapy.
Future orientation (having achievable hopes and dreams for the future)
When asked if there was anything the participants enjoyed or were looking forward to doing with their
lives, the following topics were discussed:
l planning for a holiday with a friend
l gaining skills needed for a new way of life
l planning to retire and live abroad
l wanting to learn how to use a laptop
l volunteering at a hospital.
In a critical literature review of the relevance of hope in the trajectory of heart failure illness, Davidson
et al.84 explained:
. . . hope . . . defend[s] against despair by focusing on the future. Expectations can be directed toward
relief from a difficult situation. To achieve this relief, people must have a sense of control over their
environment and feel that they are capable of making decisions that alter their life circumstances.
In relation to hope, four out of the five participants gave examples of achievable personal goals. When
talking about their personal dreams, participants looked relaxed and animated, and their body language
changed. Even the unhappiest participant, Gurch, seemed a different person when talking about his
activities as a volunteer with Parkinson disease patients at a London hospital. Besides a lot of other
benefits, being a volunteer had given Gurch some future orientation. Gurch explains how this has affected
him as follows:
Gurch: It makes me feel good, when I help a person and I can see that they are suffering like that you
know and I help ladies and gentlemen who are suffering from this disease how to do step by step.
Researcher: You are looking a lot happier while you are talking to me about doing the volunteering
you look quite happy.
Gurch: Yes I am happy.
Another participant, James, talked about his hopes and dreams for the future as follows:
. . . we’ve got friends in Portugal that are living in a very beautiful kind of place and it is very nice to
go and visit them and I think ‘this will do me fine’ nothing grand, just something with a bit of land.
Errrh, yeah and this is why I am doing the allotment because I need to know that I can do it,
if I want to.
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James was close to retirement age and was seriously considering starting a new life abroad. He was taking
some practical steps in preparation for his goal of having some land of his own to cultivate.
Similarly, June talked about her wish to go travelling as follows:
June: What I want to do at the moment is to go travelling and I can’t at the moment, I want to go
away for a holiday but I will have to wait. That is what I want; I really, really want to go away.
June and a friend were hoping to go to Jamaica in a year’s time, health permitting.
Maintaining hope and encouraging a future orientation may be important factors to consider in devising
interventions for patients with CHD and depression. Patients with CHD may need some help in either
finding a future goal or in taking practical steps to achieve something they want to do.
The positives
Although all five participants had positive scores for the PHQ-280 and had suffered from periods of
‘unhappiness’ over the course of their lives, participants spoke about the positive aspects of their lives,
their friendships, interests, hopes and dreams or about how they had successfully tackled personal
problems, such as alcohol abuse. Of the five participants:
l four had a close friend, group of friends and contact with family members
l four mentioned things that they enjoyed doing
l one participant had used his experience of heart disease as an opportunity for personal growth and
improved care of self
l the unhappiest participant was trying to improve his situation by volunteering and by trying to
understand his unhappy relationship
l two participants with alcohol problems had managed to either abstain or moderate their
drinking behaviour.
One participant, James, thought that his heart disease had given him the opportunity for change and
personal growth. James explained as follows:
I started the yoga and the Buddhism and a couple of the meditation techniques. It did change me
quite a lot and I was quite happy about that change . . . I used to be somebody I didn’t like very much
and now I am somebody who is OK, as far as I’m concerned. I used to treat people very badly and
I used to argue about anything and would drink a lot and I have stopped doing a lot of those
things really.
In the excerpt above James explained how having a heart attack had been a catalyst for change in his life.
He had also changed his diet and lost 5 stone in weight.
Participants’ perceptions of what caused or contributed to feelings of
distress and depression
Participants talked about the issues that they felt had contributed to or caused their depression and these
included fear of dying, boredom, unhappy relationships, chronic pain and disability, low self-confidence,
alcohol abuse, being bullied and being bereaved.
In the interview with Geoff, dying and fear of dying was a topic touched on in different ways. Geoff was
understandably scared when he realised he was about to undergo open-heart surgery. Geoff also referred
to his sense of frustration with other heart disease sufferers who were becoming ‘cardiac invalids’ because
of their fear of dying and he gave examples of friends who had suddenly died from a heart attack,
reminding him of his own mortality.
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The following extract describes Geoff’s reaction when he first realised he was going to have a
heart operation.
Geoff: So I went up the hospital earlier about me stomach he looked at me diagrams and me sheets
and all that and he said ‘do you want us to do this one first’ and I thought ‘what one is that?’ He said
sort out yer valves in your artery and so I said Oh . . . !
Researcher: So that was news to you was it?
Geoff: Scary and all. So I said ‘OK then’ he said ‘do you want to know what the chances are of
dying?’ and he said ‘six to one′ so I said ‘all right then.’ So he said it will be a little while before we
get a spare bed so I come home here and then I got a phone call to say could you come in. So that’s
when the scary part went in!
Geoff’s interview provided examples of how the reality of dying had affected and distressed him. Indeed,
since his operation some years ago he had become very interested in health matters and had devised his
own fitness regime that involved monitoring his heart rate, using a wrist monitor. One could speculate
that Geoff’s anxieties had been channelled into monitoring his heart rate, as the following extracts
might suggest:
Researcher: You go fishing yeah and what does going fishing do for you? Why do you prefer going
fishing to group therapy?
Geoff: Because I can train. I got a hill like that (tilts hand) and I go up the hill but I don’t do that
straight away but that’s a little bit of training that is getting me heart pumping I do it and when
I reach the 120 heart murmurs I stop because I have to watch . . . that’s a good idea if you can get
them free, a heart watch so if people are training and have just had open heart surgery and the
doctor said ‘if you want your heart rate to be 120 you should look at your watch and if it says 120
and then I stop, stop going up the hill work it to about 112 and then I will carry on back up the hill,
don’t forget I’ve got all me fishing gear with me and a barra [barrow].
And later in the interview he continued . . .
So when I go fishing there is a hill and it is a hill, but I want to work me heart so going up this hill is
errh when I get to 120 . . . I done 130 actually and then I did stop. I wasn’t out of breath but I just
thought ‘well that’s too much for me’ so I went and I looked at me clock and it was 130 and
I thought ‘that’s quite good’, it went down to 112 and when it goes down to 112 the heart is
(makes pumping sounds) just nicely beating . . .
Although Geoff was doing something positive about his health, his need for reassurance through
biofeedback could be a manifestation of the anxiety he was experiencing. Geoff was not interested in
attending group therapy sessions because he felt that listening to everyone’s symptoms of heart disease
would make him worried for them (or perhaps remind him of his own health issues).
Discussion
The themes explored in this pilot study have revealed more similarities than differences among five
participants who were purposively sampled for contrasting demographic backgrounds.
The participants did not want to be perceived as ‘moaning and groaning’ in relation to accessing health
care and were mostly uncomfortable in talking about their feelings and ambivalent about accessing mental
health services.
PERCEPTIONS OF DISTRESS AND DEPRESSION IN PATIENTS WITH SYMPTOMATIC CORONARY HEART DISEASE
NIHR Journals Library www.journalslibrary.nihr.ac.uk
32
Although all of the participants had experienced unhappiness in their lives (mainly owing to relationship
problems) they were all still trying to do the best they could and seemed to prefer taking their own courses
of action to improve their lives, thereby preserving a sense of agency, control and future orientation.
For all of the participants, having heart disease and the symptoms of heart disease did not seem to be their
main health concern. In contrast, chronic pain and impaired mobility caused by conditions such as arthritis
seemed to affect participants the most.
Most participants would like to be able to attend dedicated gym sessions for people with heart problems
so that they feel safe and supported. As dedicated sessions provide an opportunity for social interaction
with other people with heart problems there is also an opportunity to make these fun and enjoyable
and thereby emotionally therapeutic.
The main difference between the responses of the participants was evident with one participant, James,
who seemed more comfortable about introspecting and talking about his feelings. James occupied the
highest occupational status of the five participants and this difference in socioeconomic status/social class
might indicate that he has access to and is familiar with psychological discourses, whereas the other four
participants appeared to refer to ideas of stoicism in preference to introspection. There may well be issues
of social class influencing the importance patients place on their feelings and whether or not these are
appropriate and safe topics to discuss, either with a researcher or a health-care professional.
How the pilot study informed the main interview study
For the pilot study, an unfocused interview approach was adopted to allow participants to raise issues that
were salient to them around the topic of CHD and depression. Findings from the pilot interviews and
UPBEAT-UK literature reviews were used to inform the topic guide for the main interview study. This
approach allowed us to balance topics identified in academic literature with patient-centred perspectives.
The researcher commenced the interviews by asking the following question: ‘So, if you wouldn’t mind
just starting by telling me about when you first knew that you had some problems with your heart.’
Participants responded to this request by recounting personal accounts of their lives in the context of CHD
and depression. This narrative approach worked well in the pilot study; it provided an opportunity to assess
how participants perceived the connections between their physical, social and emotional worlds, in the
context of illness. For this reason a narrative-based topic guide was developed for use in the main
interview study.
Main interview study
Study results
RS interviewed 30 patients with CHD and symptoms of depression. The main findings from this study have
been published in an open access journal paper by Simmonds et al.85
The interviews were conducted using a narrative approach guided by topics informed by findings from the
pilot interview study.
While recounting their stories of CHD and depression the following topics were explored:
1. participants’ perceptions of the relationship between their physical and mental health
2. participants’ experiences of living with depression
3. participants’ own self-help strategies for coping with depression
4. participants’ views and experiences of primary care interventions for depression
5. participants’ ideas for primary care-based interventions for depression that they would like to be
made available.
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Summary of results
Loss was a theme that underpinned all of the interviews in this study, as seen in Figure 2. Losses included
interpersonal and health factors.85
In relation to health, participants experienced a sense of loss that also impacted on feelings of agency and
being in control of their lives. Loss of good health through CHD had impacted on employment status and
financial security for some participants. Participants also communicated a loss of control in relation to their
bodies, sense of gender identity and the ageing processes in general. Some participants tried to reclaim
and exercise control by resisting the ‘medicalisation’ of their lives, particularly in relation to treatment
interventions for depression, such as antidepressants. Participants also exercised control by developing their
own self-help strategies in relation to depression. The kind of self-help activities participants preferred fell
roughly into two types: (1) social and interpersonal, typically involving group activities and (2) lone
activities, such as fishing or meditation.
Participants varied in the extent to which they attributed feelings of depression to their physical condition.
Three levels of association between mental states and CHD were identified: (1) direct links made between
CHD and depression; (2) indirect links between CHD and depression; and (3) weak links between CHD and
depression. The three levels of association are summarised as follows.
Emasculated by
sCHD/loss of
perceived gender
role ‘breadwinner’
Loss of sexual
intimacy and
self-worth
Loneliness
Bereavement/
grief
Relationship
breakdown: partner
and children
The ageing
body/fears for
the future
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interventions for
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Patient’s own self-help
strategies involving control
and individual (lone) approaches
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Being a carer/
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Control
FIGURE 2 Interpretative diagram of themes relating to participants’ perceptions of sCHD and distress/depression.
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Direct links made between coronary heart disease and depression
Of the 30 participants interviewed, 63% (19 participants) were male. Nearly half of these male participants
(30% of the sample) reported feeling depressed, very depressed or suicidal after having a heart attack and
explicitly stated a link between feeling depressed and having CHD.
The way men described their feelings was closely connected to the loss of perceived manliness
(emasculation) and gender roles, which included loss of ability to work, erectile dysfunction and generally
feeling ‘useless’.
Indirect links made between coronary heart disease and depression
Fewer direct links were made between CHD and depression by participants who reported a history of
negative life events.
Factors contributing to or causing depression in this category were underpinned by feelings of
interpersonal loss. The main issues that participants reported as ‘getting them down the most’ were:
l marriage and partnership breakdown/unhappiness, problems with access to children after marital
breakdown, loss of home/homelessness
l bereavement issues through the death of a child, partner, parents and friends
l being a full-time carer for wife, not having any support or respite and not being able to visit children
in America.
Although partnership breakdown was reported as being a major, long-term, stressful experience by male
and female participants alike, more male participants talked about the added stress of either losing touch
or being denied access to their children. Destructive family politics were mentioned by a number of
participants, both male and female, and these corrosive situations had caused a great deal of stress.
For participants who had talked about marital or relationship breakdown the breakdown had preceded
CHD and participants partly attributed their feelings of distress or depression to this experience and partly
to their physical condition. Experiencing stressful life events was seen more as a factor that caused
participants’ heart disease rather than heart disease causing them to feel depressed.86
Participants experienced bereavement as a severe loss and the source of ongoing distress. Some
participants believed that there was a causal link between experiencing grief and heart disease. Parkes
et al.87 argued that the association between heart disease and bereavement is one that cuts across social
class difference. Patients with CHD may need particular help in the case of bereavement.
One participant was a full-time carer for his wife, who was incapacitated through rheumatoid arthritis.
Although this participant was in his eighties and had suffered a heart attack, he did all the housework,
washing, cooking, shopping and personal care for this wife.
This participant reported feeling depressed about being trapped in the daily grind of being a carer and
not being able to visit his children in America. His wife refused any respite care and her family were
unsupportive. The loss that this participant was experiencing centred round a loss of freedom, which
included the freedom to visit his children in America.
Weak links made between coronary heart disease and depression
A number of participants were coping with CHD and comorbid conditions including: asthma, psoriasis,
chronic obstructive pulmonary disease (COPD), arthritis, diabetes, thrombosis, sarcoidosis, stroke, hearing
loss, poor eyesight, diabetic blindness, memory loss, prostate problems, kidney problems, paroxysmal
positional vertigo, morbid obesity, underactive thyroid and restless leg syndrome. Chronic painful
conditions limited mobility and interfered with the daily activities of participants.
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Conditions that caused pain, such as arthritis, seemed to distress participants the most. As there are no
‘cures’ for some health conditions participants were faced with a seemingly never-ending illness trajectory.
These factors, coupled with the realities of ageing, made the future seem bleak for some participants.
Links made between depression and CHD were weaker in participants coping with other painful health
conditions. Participants with comorbidities seemed more depressed and attributed low mood to physical
conditions that were painful and disabling, such as arthritis.
NHS interventions and services participants found helpful or unhelpful
Talking therapies
Participants seemed to prefer NHS services for CHD and depression that included either or both of the
following: interpersonal talking approaches and the opportunity for social interaction and support. Services
that had been offered to patients and were considered helpful included: CR, information and self-help,
counselling, referral to a psychiatrist or therapist and supervised exercise.
Although a few participants had received a counselling therapy for depression, there appeared to be some
lack of provision for counselling services in primary care. Other problematic issues raised in connection with
counselling were: continuity of care/therapeutic alliance, service availability, effective signposting, crisis
prevention and waiting lists.
Psychiatric services
One male participant who had been severely depressed post cardiac surgery was very appreciative of the
help that he received from two psychiatrists. However, it was the talking part of the psychiatric support
that he found most helpful, particularly in expressing his feelings and in communicating these to his wife.
This participant felt that his marriage had become stronger because of this therapeutic approach.
A number of participants had attended a 6-week CR programme post MI. Everyone who attended CR
found it a helpful and positive experience. Participants found CR programmes to be useful and enjoyable
for the following reasons:
l Mastery: patients taught to monitor their pulse rates, improve diet and lifestyles, and take back control
of their bodies.
l Confidence: supervised exercise programme built confidence – patients felt safe and reassured about
any physical sensations they were experiencing.
l Social support: patients enjoyed a group approach and supported each other.
As found in the pilot interview study, most participants in this study reported wanting to attend a similar
supervised programme of exercise for patients with CHD rather than attending a normal fitness centre,
where there may be a lack of supervision or group support.
Participants’ own coping strategies
Most participants had developed coping and self-management strategies to help themselves when they
were ‘having a down day’ and these included:
l Self-talk and thinking strategies: counsels self, counting one’s blessings, setting mini-goals and pacing
progress, visualisation techniques (taught by therapist).
l Meditation and yoga: a number of participants used meditation and yoga techniques for relaxation, to
calm the mind and alleviate physical symptoms.
l Religious practices/spiritual beliefs: provides social support, calming effect of praying and being in place
of worship.
l Exercise and hobbies: swimming, walking, fishing, lawn bowling, going to gym, Tai Chi.
l Creative expression: writing poetry, listening to music.
l Displacement activities: keeping busy, finding something to do.
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Some of these strategies, such as goal-setting, self-talk/thinking strategies, and meditation and yoga could
be developed in a primary care approach to treating concurrent CHD and depression.
Exercise
Exercise was a strategy used by participants to improve physical fitness, elevate mood and provide
opportunities for social interaction. The kinds of physical activities mentioned were walking, swimming,
Tai Chi, grass bowling, fishing and going to a gym. For some participants exercising also offered the
opportunity to socialise with a friend and share experiences with family members.
Engaging in physical activities, hobbies and sports could be encouraged in primary care by identifying and
addressing any barriers to access and through helping the patient to set goals, pace themselves and by
monitoring and encouraging their progress.
NHS services for depression that participants did not find helpful
Antidepressants
Overall, participants were not enthusiastic about antidepressant medication for the following reasons: did
not want antidepressants on medical record (stigmatising), incompatibility issues with other medications
and unpleasant side effects.
Discussion
Most participants in this study had suffered heart attack(s) and other health/personal traumas that had
impacted on every area of their lives. The losses experienced by participants were complex and multiple.
For this reason the association participants made between CHD and depression varied substantially.
Male participants in the study made the strongest links between their physical state and mental health.
Charmaz88 (p. 268) observed ‘illness can reduce a man’s status in masculine hierarchies, shift his power
relations with women and raise his self-doubt about masculinity’. These observations were reflected in our
study of men who felt emasculated by CHD. Men who suffer serious cardiac disease may need specific
therapeutic support to help them find new ‘scripts’ through which they can perform positive
masculine identities.
Participants who had suffered losses in their personal relationships through divorce and bereavement made
weaker causal links between CHD and depression. These participants attributed depression mainly to the
unhappiness and upheaval they had experienced in their lives. Together with patients who had multiple
health conditions, these participants felt that they needed someone to talk to, who would get to know
them, rather than take antidepressant medications. Patients who have lost a partner through death or
divorce might find the experience of ageing and ill health a lonely process. These participants do not want
to ‘burden’ their children with their concerns and they are reluctant to talk to their GP because they
generally do not want to be perceived as ‘moaning and groaning’. Older CHD patients, living alone,
may be more susceptible to depression if they lack an intimate confidante and someone they can share
age-related anxieties with.
The theme of resistance underpinning reasons participants gave for not wanting to take antidepressants
may be reflecting one way in which patients can reclaim some control. These patients may have been
demonstrating resistance to the medicalisation of their lives and perhaps the resulting feelings of
disempowerment this engendered. As a number of participants felt that their lives were already dominated
by ‘taking pills’ perhaps they felt they could say ‘no’ to antidepressants, in contrast to the rest of their
medication, which was probably essential to the functioning of their hearts. A diagnosis for depression as
a ‘mental illness’ is a culturally powerful label that can have serious implications for how a person is
perceived. Resisting antidepressants could be a way of resisting the meaning given to ‘depression’ via
medical records and biomedical discourse.89–92
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Barriers to accessing care provided by GPs, such as an overly bureaucratic GP appointment system, a lack
of patient privacy when upset and a lack of continuity of care can affect the quality of care for patients
with mild to moderate depression.93 Continuity of care, that allows the patient to develop a relationship
over time with one GP, might also have the benefit of improving facilitation of conversations about
emotions and feelings for patients who are distressed or depressed. Privacy and continuity of care may be
important elements to consider when designing a primary care intervention for CHD and depression.
From care currently provided by the NHS for patients with CHD, CR courses and appropriately supervised
exercise were rated highly by participants. However, the fact that participants enjoyed CR may not equate
with a significant improvement in their depressive symptoms. A longitudinal study on the effect of CR on
depressive symptomatology94 concluded that exercise itself is not effective in alleviating depression and
that CR programmes should provide specific screening and treatment for depression. Doing something
enjoyable or useful is important to most people and perhaps this should be seen as just one important
ingredient in a holistic approach to improving mental health rather than a treatment for depression per se.
Although a theme of ‘loss’ underpins participants’ accounts of CHD and depression, this does not mean
that participants’ lives were totally devoid of happiness and pleasure. Participants talked about enjoying
rewarding relationships with grandchildren, going on holidays and day trips, doing voluntary work and in
self-development. Despite having symptoms of distress/depression, most participants had hopes and
dreams for the future, some of which could be achieved through support in goal-setting and realistic
pacing. A primary care intervention that includes a mentoring approach, as part of a stepped care model
for treating depression, could help patients identify and achieve some of their goals while enhancing a
sense of self-determination and control over their lives. Table 4 summarises participants’ ideas and
preferences for interventions that could be delivered in primary care.
TABLE 4 Summary table of participant ideas/preferences for primary care interventions for CHD and depression
Type of activity
Translation to a primary care
intervention Similar approaches that can be adapted
Group-based exercise Ongoing supervised exercise for people
with sCHD: to achieve a sense of mastery,
increased confidence and an opportunity
for social support
Similar to CR programmes but ongoing
Individual approaches to
exercise and other lone
activities/interests of patient’s
choice
One to one with a PN to identify realistic
goals
Support in pacing and achieving goals
Empowering patients
Improving sense of control and
self-confidence
Mentoring approach
Having someone to talk to
who knows them – when they
need it (within reason) – over
an extended period of time
PN with CBT training
Clinician continuity important
Dealing with issues of loneliness by
helping patient to make supportive social
links in the community
Similar to CBT or solution-based
approaches to counselling, but less formal/
medicalised and with more flexible time
frames. Privacy is also important
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How findings from the interview studies informed the pilot intervention
A clear finding from the patient interview studies was that (1) participants were experiencing a range of
social, physical and gender identity (erectile dysfunction) losses; (2) some participants preferred to do
things on their own, whereas others preferred group activities; (3) most participants had hopes and dreams
for the future or enjoyed some aspect of their lives; (4) participants felt disempowered by ill health and the
medicalisation of their lives; (5) participants preferred therapeutic treatment approaches for depression;
(6) participants were not enthusiastic about antidepressant medication; and (7) loneliness was a problem
for a number of participants.
Given the diverse needs of the sample (older people with chronic health conditions who feel lonely, men
who felt emasculated and/or want to work again and participants who had experienced a number of
adverse life events) an intervention for patients with CHD and depression may need to adopt an individual
approach that can accommodate the specific sociocultural and personal needs of patients. A holistic, case
management/mentoring approach to depression in CHD could help patients to feel more empowered and
in control of their lives, especially if they are supported to achieve personal and health goals.
While conducting the patient interview study, interim findings, participant suggestions and final
conclusions were discussed iteratively with the UPBEAT-UK team. The final design of a primary care,
nurse-led complex intervention was informed by both the GP and PN (see Chapter 2), and patient
qualitative studies together with the UPBEAT-UK literature reviews.
Plans for the content and structure of a nurse-led complex intervention were discussed in-depth with
patients (suffering from sCHD and depression) during a series of two focus groups. Adjustments to the
design and content of the intervention were made according to recommendations from the focus groups.
Ethical approval
Bexley and Greenwich Ethics Committee gave ethical permission for the study (reference 07/H0809/38),
and approval was obtained from NHS trust research governance offices in south-east and south-west
London. The researcher (RS) consented the participants.
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Chapter 4 Development and testing of an
intervention for primary care patients with
symptomatic coronary heart disease and depressive
symptoms (work package 2)
Plan
The previous chapters detail how we gathered the views of patients, GPs and PNs as well as findings from
published studies concerning requirements and preferences for a future intervention for people with sCHD
and comorbid depressive symptoms. In this work package of the UPBEAT-UK programme, our aim was to
develop and evaluate an intervention that would be feasible to deliver in UK primary care.
We conducted an iterative evidence review and synthesised data from previous work packages to develop
the intervention, which we then modified informed by findings of a focus group study with people with
sCHD and depressive symptoms and further literature review.
We then conducted an exploratory randomised controlled study to examine the acceptability, feasibility
and potential costs of the new intervention, and to test the methods for a definitive trial.
Developing the intervention
Barley et al.2 published a full account of the process that we used to develop the intervention in an open
access journal in 2012. The key steps of the process, which followed MRC guidelines for developing
complex interventions,30 are summarised here. This process is also depicted in Figure 3.
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Systematic review
Qualitative interviews
(patients)
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Qualitative interviews
(PNs and GPs)
Focus group study
Adaptation of intervention
Iterative evidence review
Identifying the evidence and developing theory
Feasibility and piloting
Evaluation
Implementation
FIGURE 3 The UPBEAT-UK study intervention development stages. Reproduced from Barley et al.2 © 2012 Barley
et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
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Phase 1: gathering evidence
This phase included the qualitative studies of patients and primary care clinicians, and the metasynthesis of
published literature detailed in Chapters 2 and 3. Essentially, all three studies led to the conclusion that the
needs of patients with CHD and depression are diverse and include psychosocial problems involving
interpersonal and health/control losses that primary care staff are uncertain how to manage.
Phase 2: synthesis of findings from previous work packages and iterative
literature review
Multidisciplinary team discussions involving GPs, psychiatrists, psychologists, nurses and a cardiologist,
of our earlier studies led to agreement that the UPBEAT-UK intervention should:
l improve depression, quality of life and cardiac outcomes in patients with CHD
l help patients and clinicians to manage an individualised range of problems, including social problems
l be nurse-led and feasible for delivery in primary care.
These conclusions were used to guide literature searches focused on identifying high-quality systematic
reviews and evidence-based guidelines: we searched the Cochrane Database of Systematic Reviews, the
Database of Abstracts of Reviews of Effectiveness and the NICE website. We also looked for evidence
published subsequently to the reviews and guidelines using MEDLINE, EMBASE and PsycINFO. Findings
from the evidence reviews were discussed and used to support choices for the intervention content. This is
detailed in Table 5 (first published in our RCT development paper).2
We discussed the meaning of these findings in the context of UK primary care, where an established
component of chronic disease management is the provision of self-management support; this means
enabling patients to take better care of themselves, for instance by providing information and helping
them to change unhealthy behaviours.
Two important factors for behaviour change are known to be belief in the importance of an outcome and
belief in capacity to succeed (self-efficacy).105 This suggested to us that instead of focusing on generic CHD
or depression risk factors, the new intervention should enable patients to specify their own goals, for
instance stopping smoking or increasing social contact, so that work is directed towards outcomes
important to patients.
Informed by our evidence review a ‘toolkit’ of behaviour change skills and existing local resources was
developed to facilitate nurses, acting as case managers, to help the patient to increase their self-efficacy
and achieve their desired outcomes.
The intervention we developed therefore was a PN-led PC intervention. It comprises the following:
Personalised care planning: the nurse acting as case manager conducts a standardised biopsychosocial
assessment (including physical and mental health, difficulties with current treatment regimens, problems
with daily activities and social problems) face to face with the patient either at the patient’s GP surgery or
at their home, according to patient preference. Patients are helped to identify up to three problems that
they consider contribute to their depression and which they most want to address. The nurse case
managers, as applicable, provide information, signpost patients to existing resources (e.g. leisure centres,
social clubs, IAPT services) and use evidence-based behaviour change techniques to help patients set and
achieve goals. The underlying intention of the intervention is to increase the patient’s self-efficacy to
achieve their desired goals (as opposed to goals determined by others such as symptom management or
reduction of cardiac risk factors, a primary aim of many previous collaborative care projects). Details of the
assessment and action plan are recorded in a ‘personalised health plan’, which the patient holds.
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Follow-up care: follow-up interviews to determine progress and/or set new goals are conducted via
telephone to conserve nurse time. This is initially weekly and then the frequency of contact is agreed
between the patient and nurse case manager. Calls are planned to last 15 minutes.
The intervention process is detailed in Figures 4 and 5 (first published in our RCT development paper).2
TABLE 5 Iterative evidence review to guide development of an empirically based intervention to improve mood
and cardiac outcomes in patients with CHD
Intervention should Findings Conclusions in relation to new intervention
Improve depression, quality
of life and cardiac outcomes
in patients with CHD
NICE guidelines18 for depression with a
chronic physical health problem
recommend a stepped care model
involving psychological therapy and/or
pharmacotherapy
Two Cochrane reviews95,96 identify a
range of psychological and
pharmacological interventions; there is
insufficient evidence to determine which
elements are beneficial. No effect found
on cardiac outcomes
A well-conducted trial in the USA12
found that collaborative care improved
depression and disease control in
patients with CHD and/or diabetes
Collaborative care is intensive; our empirical
work suggested only a minimal intervention
would be feasible
A key ingredient of collaborative care is ‘case
management’ (CM):97 a health worker follows
up patients, assesses adherence, monitors
progress, takes action when treatment is
unsuccessful and delivers psychological support
as part of a stepped care approach.25 This is a
central aspect of the UK long-term conditions
strategy98 so it is familiar to PNs
CM allows PC but the processes by which
change is expected to occur should be specified
Help patients and clinicians
to manage an individualised
range of problems,
including social problems
The CHD and depression association is
likely to be explained largely by
behaviour.99,100 Behaviour change
interventions for risk behaviours for CHD
and depression have been delivered in
primary care and shown benefit for
smoking101 and alcohol intake.102 Not
known if they are helpful for patients
with CHD and depression
Current UK policy103 promotes liaison
between professionals and utilisation of
existing resources to tackle depression
and adverse health behaviours
Training in specific behaviour change
techniques and identification of existing local
resources, such as social clubs, advice agencies
and therapy services, would provide PNs with
a ‘toolkit’ of resources that they could tailor
according to patient need and preference
Specification of interventions used will inform
implementation and evaluation of the
intervention
Be nurse-led and feasible
for primary care
Case managers are often nurses, but
studies lack details concerning
implementation and process104
Evidence-based behaviour change
interventions, such as goal-setting and
action-planning, have been identified
for use in primary care64
Pilot work should be undertaken to understand
which aspects of case management are
effective in CHD patients with depression and
which outcomes should be targeted
Source: reproduced from Barley et al.2 © 2012 Barley et al.; licensee BioMed Central Ltd. This is an open access article
distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),
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1. Introduction
    • Introduce yourself and explain the principles of case management
Materials: patient information leaflet
2. Conducting the assessment
    • Assess how the patient’s health is impacting on their life using the standardised 
       assessment form
Materials: patient assessment document (for case manager)
3. Devising the personal health plan
    • Record problems, professionals currently involved, actions to take
    • Agree and set review date for each problem
Materials: personalised health plan
4. Goal-setting (if required by the patient)
    • Help the patient to identify a problem to address. Use goal-setting to help them 
       ‘break down’ the problem into manageable parts
    • Introduce personalised health plan; patient to record up to three goals
Materials: personalised health plan, goal-setting information leaflet
4. Action-planning (if required by the patient)
    • Help the patient to plan how to achieve each goal
    • Patient to record; what they will do, how they will do it, where they will do it,
       when they will do it and with whom they will do it
Materials: personalised health plan
5. Providing information
    • Provide individualised self-management resources
Materials: Lists of self-management resources
6. Building self-efficacy
    • Ensure patient feels confident that they can achieve their goals
    • Discuss barriers to success and ways to overcome. Patient to record reasons to 
       expect success
7. Deciding a review date
    • Record preferred contact details and date for review
8. Encouraging self monitoring
    • Patient to record successes and difficulties in pursuing goals
9. Confirming confidentiality
    • Increase trust by signing the confidentiality agreement
FIGURE 4 Personalised care planning. The UPBEAT-UK intervention assessment stage and initial care planning.
Reproduced from Barley et al.2 © 2012 Barley et al.; licensee BioMed Central Ltd. This is an open access article
distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
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Phase 3: modelling
Having developed the intervention, and following MRC guidance,30 we now wanted to explore its
acceptability among people with sCHD and depressive symptoms. Using maximum variation sampling to
select patients varying by sex, age, ethnicity and borough of residence, we invited participants of the
UPBEAT-UK cohort study to attend two focus groups.
In a short presentation, two researchers (RS and Zoe Fortune) explained the proposed intervention and the
intervention materials (patient information leaflet, assessment form, personalised health plan) were
provided. All participants gave informed consent and ethical approval was granted, along with that for the
other qualitative studies, by Bexley and Greenwich Research Ethics Committee (07/H0809/38).
Sixteen patients agreed to take part. Thirteen actually participated; five out of six came for the first group
and eight out of 10 came for the second group. Reasons for not attending were not elicited. Those who
participated (53% male) were aged between 48 and 86 years (mean 71 years). All but two, who were
African Caribbean, described themselves as white British.
Telephone
• Contact patient at agreed data and time
• Check whether or not each health plan 
   action is complete
If yes
• Assess whether or not future 
   action required
• Record future actions and review
   date
• Type up new health plan and
   send to patient
If successful
• Congratulate
• Discuss reasons for success
• Ask if they want to continue with
   current goals or set new goals
If successful
• Take join responsibility for setting
   a goal which was too difficult
• Discuss difficulties
• Praise small successes
Review
• Continue with process
• Review weekly increasing time between contacts
   as needed
If no
• Discuss reasons and obstacles
• Agree and record future actions
• Agree and record review date
• Type up new health plan and send 
   to patient
If patient has goals/action plan
• Enquire about progress
Continue with current goal/plan
• Set date and time for review
Set new goal/s
• Continue with case management
   from goal-setting
FIGURE 5 Follow-up care. The UPBEAT-UK intervention follow-up care stage. Reproduced from Barley et al.2
© 2012 Barley et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
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Discussions were tape-recorded and transcribed by RS. Transcripts were entered into NVivo 8 qualitative
software. Coding was informed by the aims of the study. The coding frame and themes were discussed
within the research team; we used notes of key discussion points (verified by participants) to guide
our analysis.
Key findings of the discussion and modifications to the intervention
The participants were very focused on their need for someone to confide in and felt that a case manager
would help with this.
The concept of self-management, in which the case manager would help them to solve their own
problems, did not seem to be well understood. We planned to examine this in our exploratory study.
Participants agreed that PNs were the correct people to act as case managers because of their
understanding of heart disease and its associated problems. Nurses should also be able to provide the
continuity of care that participants emphasised as important.
Some participants disliked the planned use of goal-setting. Rather, participants were focused on wanting
case managers to be a source of social contact. Based on our work with PNs, who complained of lack
of time to manage these patients, this did not seem feasible. Instead, we felt that goal-setting and
action-planning could be used to help patients obtain social contact. Furthermore, our literature searches
identified good evidence for the feasibility of goal-setting in primary care.106 This highlighted to us the
importance, when designing interventions, of utilising multiple sources of evidence. We planned to explore
the acceptability of goal-setting further in our exploratory study.
Finally, a minor point was that some of the wording used on the assessment form was not clear. We had
developed our care plan format from the framework proposed by the Department of Health as the
standard assessment for adults;107,108 this grouped health-related domains such as ‘activities of daily living
and mobility’ under headings such as ‘improved personal dignity and autonomy’. These higher-level
headings appeared to confuse patients, so they were removed from intervention documents.
Discussion
Informed by the MRC framework for the design of complex interventions,30 we conducted empirical
studies and iterative literature searching to identify evidence and theory to develop and model a new
PN-led PC intervention to improve mood and cardiac outcomes in sCHD patients with depressive symptoms.
Our approach is only one possible approach to developing a complex intervention using the MRC
framework.30 For instance, others109 have drafted an intervention around a specific psychological theory
and have tested theory-related hypotheses. However, we feel that a strength of our approach is that the
intervention development was driven by the patients who will receive it and by the clinicians who will
deliver it, with theory (i.e. self-efficacy theory and behaviour change theory) and evidence used to support
choices concerning its content. The fact that all the studies reported here were funded by a single
programme grant facilitated access to patients and allowed subsequent work to build on earlier findings in
a timely fashion.
Furthermore, our approach led us to change our initial plans, which, as we have explained in Chapter 1,
were to develop a nurse-led stepped care intervention. Our intervention development work clearly
demonstrated a need for an intervention that could be tailored to the differing needs of individual
patients; this could be included within a stepped care approach. It was also clear from this work that some
PNs will need support to deliver an intervention for depression and that, since their workload is already
very high, they would need convincing that any new intervention is feasible for them to deliver as well as
effective for patients. Hence, with so much uncertainty around the feasibility of PN-led interventions for
depression, we changed our plan to conduct a definitive RCT and decided to conduct an exploratory study
which would provide this evidence and inform the best methods of a future definitive RCT.
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The exploratory randomised controlled trial
In our exploratory study, two nurse researchers, independent of the participating practices, acted as case
managers; one was a general and mental health nurse with experience of working in primary care, and the
other was a general nurse who had subsequently qualified as a health psychologist. We also knew, from
our cohort study, that CHD patients have high levels of comorbidity and that for some any cardiac event
would have been several years ago; we therefore recruited only those patients with sCHD (i.e. reporting
current chest pain) in order to ensure that they would understand the intervention in terms of their CHD.
The study explored the acceptability, feasibility and potential costs of PN-led PC for primary care CHD
patients who have depressive symptoms and current chest pain with the overarching aim to test the
methods for a definitive trial. The full details of this study have been published in a peer reviewed paper by
Barley et al.110 Here we summarise our methods and findings and report additional exploratory analyses.
Aims and objectives
1. To examine the rate of participant recruitment and reasons for non-participation.
2. To examine research procedures such as consent, randomisation/blinding and data collection.
3. To explore possible differences between primary outcome measurements and explore the most
appropriate secondary outcome measures in relation to patients’ reported problems.
4. To identify any trends between the groups in changes in self-efficacy and the impact of this on
depression outcomes.
5. To determine the acceptability and feasibility of the intervention to practices and participants.
6. To explore whether or not the intervention can be standardised and whether or not therapist effects are
likely to be important.
7. To explore potential costs of the intervention.
Methods
Design
The design was a patient-randomised pilot study with a control condition. We compared PN-led PC plus
TAU for 6 months with TAU alone. The protocol for the study has been published;111 deviations from the
protocol are explained in the published report of this study.110 The study was reviewed and approved by
the south-east London Research Ethics Committee (reference 10/H0808/5) and is registered with Current
Controlled Trials International Standard Randomised Controlled Trial Number 21615909. The UPBEAT-UK
Programme Grant Steering Committee, who decided that a data monitoring committee would not be
necessary, oversaw the study.
Study setting
Practices in south London were recruited via the Greater London Primary Care Research Network
(PCRN-GL). To be included, the practice had to keep a register of patients with CHD for the QOF112 and
be willing to liaise over patients in the PC arm when necessary.
Participant eligibility and recruitment
Inclusion criteria were sCHD (registered on GP CHD QOF register and reporting chest pain), reporting
depression symptoms. All patients on practice case registers for CHD were asked by their GP for consent
to contact from a researcher. Those consenting were contacted by a researcher and assessed for depressive
symptoms using the PHQ-280 and for symptoms of current chest pain using the modified Rose angina
questionnaire.113 Patients scoring ≥ 3 on the PHQ-2, and who reported currently experiencing chest pain
(using the modified Rose angina questionnaire) were assessed further using the HADS.114 If they scored ≥ 8
on the depression scale of HADS (HADS-D) they were eligible to participate. Those consenting to participate
were then randomised to either the intervention (PN-led PC and general practice TAU) or control (general
practice TAU). Patients who were temporary registrants or currently hospitalised, or who a GP from the
practice deemed actively suicidal, suffering from psychotic depression or non-English speaking were excluded.
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As estimation of an effect size was not the focus of this pilot study, we used only a preliminary sample size
calculation. An end-of-study mean difference between intervention and control score of ≥ 3 on the
HADS-D, assuming a pooled SD around mean scores of 3.5, would require 30 participants per group for
90% power at the 5% significance level. To allow for loss to follow-up, estimated at 25%, our plan was
to recruit 80 participants (40 per arm) into the study. The target figure of 3 was based on consensus
discussion among clinicians at planning meetings and the assumed SD of 3.5 was obtained from the
baseline cohort study. The estimate of attrition of 25% was considered reasonably conservative; it was felt
that higher levels would have indicated lack of feasibility for implementing and testing the intervention.
We estimated from the results of the UPBEAT-UK cohort study1 that 10–15 practices each with around
10,000 patients would be needed to recruit 40 persons per arm.
Randomisation and blinding
Randomisation at patient level was conducted independently by the Mental Health and Neurosciences
Clinical Trials Unit at King’s College London. A random permuted block design was used to balance the
numbers between groups. PC group participants were randomly allocated to one of two nurse researchers
acting as case managers.
To ensure that those responsible for outcome data collection were blind to participants’ allocation status,
participants were asked at the beginning of each follow-up interview not to mention if they had been in
contact with other study staff. The statistician was also kept uninformed of allocation status.
Outcome data collection
Research assistants who were blind to allocation collected data at baseline and at 1, 6 and 12 months post
randomisation. Data were collected face to face at baseline and at follow-up via telephone.
The intervention: personalised care
This was delivered over 6 months, as detailed above.
Usual care
All patients received primary care TAU from their GP and/or PN; this may or may not include specific
depression intervention such as antidepressant prescription or referral to talking therapy. The nature of
TAU may vary between practices; we assumed that important differences in care delivery between the
participating practices would be randomised between the groups.
Outcomes
Baseline demographic variables
All participants provided baseline demographic data including sex, age, ethnicity, socioeconomic status,115
employment and relationship status, living arrangement and lifestyle factors (e.g. smoking status, alcohol
consumption, body mass index).
Aim 1: to examine participant recruitment
We made detailed records of recruitment rates. The number of participants at each stage of the study was
documented and reasons for attrition were recorded.
Aim 2: to examine the study procedures
We recorded the number of randomisation errors [e.g. numbers of participants randomised despite being
ineligible or who were randomised to the intervention (PC) but who did not receive it], and recorded rates
and reasons for attrition and missing data for outcome measure at each time point.
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Aim 3: to explore outcome measures
The preliminary primary outcome was the HADS-D. We observed depression status (response defined as ≥ 50%
decrease in score from baseline at follow-up and remission defined as a score of < 8 at follow-up) and severity
(continuous score). We also explored the PHQ-9116 as an alternative measure of depression severity and extracted
the number of GP/PN consultations for depression, antidepressant prescriptions and referrals to talking therapy
during the 12-month study period from participants’ medical records for both groups.
Our cohort study found that self-reported chest pain (measured using the modified Rose angina
questionnaire) is associated with mood and social problems, so was also explored as a potential primary
outcome for a future trial. The number of GP/PN consultations for heart-related problems during the
12-month study period was also extracted from participants’ medical records as a proxy measure of
participants’ cardiac status in both groups.
Potential secondary outcomes explored were: anxiety [HADS – anxiety subscale (HADS-A)],114 well-being
(Warwick–Edinburgh Mental Well-being Scale),117 quality of life [Short Form questionnaire-12 items (SF-12)],118
functional status (specific activity schedule),119 number of reported social problems120 and adherence to
antidepressant medication (if relevant – adapted version of Morisky Adherence Index121). To try to capture
between-patient variety in reported problems and needs, we used a validated patient-generated measure of
problems, function and well-being – the Psychological Outcome Profiles Questionnaire.122
To reflect on how these outcome measures relate to the problems that patients consider important or
feasible to change, we explored the types of needs and problems identified by intervention patients in
collaboration with their case manager. This information was extracted from the notes made by nurse case
managers during consultations. The Brief Illness Perceptions Questionnaire (BIPQ)123 asks participants to
‘Please list in rank-order the three most important factors that you believe caused your illness’ – we also
explored these responses.
Aim 4: to explore changes in self-efficacy
We used the General Self Efficacy Scale;124 the scale has 12 items designed to assess perceived self-efficacy
in order to predict coping with daily hassles and adaption after life events, with a high score indicating
greater self-efficacy (range 10–40). We also used the BIPQ123 to assess changes in perceptions about illness
along the following dimensions: consequences, timeline (anticipated duration of illness), personal control,
treatment control, identity (symptoms associated with the illness), illness concern, illness coherence
(understanding of CHD) and emotional representations (emotional impact of CHD). Each of these eight
items is scored 1–10. We examined General Self Efficacy Scale and BIPQ total scores as mediating factors
for depression symptom reduction, remission and response.
Aim 5: to determine the acceptability and feasibility of the intervention
We recorded the time taken for assessment and the number and duration of follow-up telephone calls per
patient, and explored participant satisfaction using an 11-item questionnaire devised for the study that was
posted to the intervention patients after their 12-month follow-up.
Aim 6: to explore whether or not the intervention can be standardised and whether or
not therapist effects are likely to be important
We developed a manual for the intervention, examined differences in patient outcomes between the two
nurse researchers delivering the intervention and recorded nurse actions during the intervention.
Aim 7: to explore potential costs of the intervention
We calculated quality-adjusted life-year (QALY) gain using the European Quality of Life-5 Dimensions
(EQ-5D).125 The EQ-5D consists of five domains (mobility, self-care, usual activities, pain/discomfort and
anxiety/depression) and each is rated 1 (no problem), 2 (moderate problems) or 3 (major problems). UK
values were applied to the distinct health states derived from the EQ-5D to estimate the utility value for
each patient at each time point and area-under-the-curve methods were used to calculate the QALYs.126
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Economic costs were calculated from a societal perspective. PC costs included the time spent by PNs with
patients in face-to-face assessments and subsequent telephone reviews. A unit cost of £36 per hour was
attached to the average intervention duration for each patient. Other service use was recorded using the
Client Service Receipt Inventory127 for the 6-month period preceding baseline, 6- and 12-month follow-ups.
Health services included hospital inpatient and outpatient visits, GPs, psychiatrists, psychologists,
physiotherapists, counsellors, nurses and other therapists. Unit costs were applied to service-use data using
the NHS reference costs in 2009–10 prices128 and the 2010 Unit Costs of Health and Social Care.129 In
addition, data were collected on the weekly number of hours of help (i.e. personal or child care, help in/
around and outside the house) received from friends and relatives of the patient. The unit cost of a home
care worker was used as a proxy for costing informal care.
Medication use was recorded and costs were calculated based on the 2010 prices from the British National
Formulary130 and the Prescription Cost Analysis.131 The basic types of medication included psychological,
cardiovascular (most common type), gastrointestinal, respiratory, eye, ear, nose and oropharynx drugs.
Indirect costs of productivity loss because of CHD and comorbid depression were calculated using the
human capital approach. For employed patients, productivity loss was the product of the days missed from
work caused by sickness and the national mean daily wage in the UK,132 adjusted for full- or part-time
working. However, only resource-use costs were considered in the cost-effectiveness analysis, as data on
medication and sickness absence were self-reported and available for the baseline only (regarding the past
6 months).
Analysis
We conducted exploratory analyses using Stata version 11.2 (StataCorp LP, College Station, TX, USA). The
intention-to-treat principle was used for all analyses. Owing to the exploratory nature of the analysis, p-values
are reported for the preliminary primary outcome (HADS-D) only. We were fortunate to have a National Institute
for Health Research-funded statistical fellow attached to our programme and were therefore able to conduct
detailed exploratory analyses; these are explained fully in the published report of this study.110 Essentially, we
developed a single statistical model to estimate the difference in mean scores between participants randomised
to PC and TAU across the three follow-up points (1, 6 and 12 months). Other exploratory analyses compared
the median number of responders (≥ 50% decrease in score from baseline at follow-up) and remitters (score of
< 8 at follow-up) according to the HADS-D score between groups and explored changes in self-efficacy,
the effect of nurse contact time and therapist effects using t-tests and chi-squared tests.
A health economics analysis used multiple regression, incremental cost-effectiveness ratios and the net
benefit approach to estimate mean differences in costs and QALYs. Non-parametric bootstrap analyses
were conducted to account for the highly skewed distribution of the cost data; results were plotted on a
cost-effectiveness plane and used to estimate cost-effectiveness acceptability curves.
Results
Aim 1: examining recruitment
Seventeen practices were approached by the PCRN-GL and agreed to participate. Practices were recruited
between October 2010 and June 2011; practice recruitment was therefore completed in considerably
less than the 12 months planned in the study proposal, indicating that recruitment of practices for a
definitive trial would be feasible.
We have published patient recruitment details in a paper by Tylee et al.111 We summarise it briefly here.
Of the 3325 people on the 17 GP CHD registers, 1001 consented to be contacted by returning a letter to
their GP. A brief screen by telephone found that 126 were eligible for assessment (PHQ-9 score of ≥ 3 and
reporting current chest pain on the modified Rose angina questionnaire). Of the 126 who were eligible, 40
had a HADS score of < 8, two had experienced hallucinations, two had no current chest pain and one did
not have sufficient English, therefore, 81 were found to be eligible. These were consented and randomised
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(41 to intervention, 40 to control). The screening process involved minimal effort (return of a letter and a
brief telephone screen). Target recruitment was achieved within 8 months, which was considerably faster
than expected (we had planned a 12-month recruitment period based on experience of other studies);
recruitment of patients for a definitive RCT, therefore, seems promising.
Baseline demographic and lifestyle data are reported elsewhere.110 There were 27 (66%) males in the PC
group and 25 (63%) in the TAU group; mean age was 64.2 years (SD 13.0 years) in the PC group and
64.9 years (SD 8.5 years) in the TAU group. Any differences between the groups on the recorded
demographic, lifestyle and outcome variables appeared small and the randomisation process appears to
have produced balanced groups.
Past depression
Forty-eight participants reported having ever been diagnosed with depression (21/41= 51% PC;
27/40= 67% TAU). Of these, 12 had had one episode, seven had had two episodes, four had had three
episodes and 23 reported having had four or more episodes (data on number of episodes were missing for
two participants). Forty-six participants had previously received treatment for depression; of these, 41 had
taken antidepressants and 29 had had talking therapy. Eighteen reported having received other treatment
such as ‘anger management’, seeing a psychiatrist, electroconvulsive therapy, inpatient psychiatric care and
relaxation and assertiveness courses. Our participants therefore represent a chronic and severe group.
Current depression
Twenty-four participants reported that they were currently receiving treatment for depression (9 in PC, 22%;
15 in TAU, 38%). According to the medical notes data, 13 in PC (32%) and 17 in TAU (43%) were taking
some form of antidepressant medication at baseline. Despite being prescribed antidepressants, these
participants were still reporting depressive symptoms. Nineteen participants reported their current episode had
lasted > 12 months, two said it had lasted between 6 and 12 months, and three said it had lasted < 6 months.
Mean HADS-D scores [PC 11.6 (SD 3.3); TAU 11.4 (SD 3.0)] indicated moderate depression and mean
PHQ-9 scores [PC 16.0 (SD 5.3); TAU 15.4 (SD 5.5)] indicated moderately severe depression in both
groups. At baseline, according to the HADS-D, 21 (51.2%) participants in the PC group could be
considered mild, 14 (34.2%) moderate and six (14.6%) severe. In the TAU group there were 19 (47.5%)
mild, 15 (37.5%) moderate and six (15.0%) severe. For the PHQ-9, three (7.3%) were mild, 10 (24.4%)
were moderate, 14 (34.2%) were moderately severe and 12 (29.3%) were severe in the PC group. In the
TAU group, there were eight (20.0%) mild, eight (20.0%) moderate, 14 (35.0%) moderately severe and
nine (22.5%) severe. The correlation between baseline HADS-D and PHQ-9 was r= 0.48 (p< 0.0001).
Coronary heart disease status
Patients were recruited if they reported current chest pain. Overall, 19 were current smokers and 53 were
overweight or obese (see Table 8). Participants were also asked if they had high blood pressure and
cholesterol, and diabetes; 56 out of 76 who responded (74%) said yes to high blood pressure (29/37 in
PC; 27/39 in TAU), 42 out of 72 who responded (58%) said yes to high cholesterol (21/34 in PC; 21/38 in
TAU) and 22 out of 80 who responded (28%%) said yes to diabetes (12/40 in PC; 10/40 in TAU).
Aim 2: examining study procedures
Randomisation
Three patients who were ineligible owing to no current chest pain were randomised in error (two in the
intervention arm); reasons for this are unclear. Based on the intention-to-treat principle these were
included in all analyses, however, we conducted a sensitivity analysis and found that there were no
differences in our conclusions when these patients were omitted from the analyses.
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Blinding
Over the course of the study, there were many staff changes, especially among the research assistants
responsible for outcome data collection. It was therefore not possible to test formally whether or not those
collecting data remained blinded to the patients’ allocation status. However, it was noted that some
participants had reported contact with the case manager. Following the conduct of the main analyses, the
statistician reported becoming unblinded; this was as a result of hearing that an additional participant had
been randomised to PC.
Attrition
The Consolidated Standards of Reporting Trials diagram for the study is shown in Figure 6 and has been
published.110 By 12 months, six people in the intervention group had dropped out (two because they found
participation upsetting, two because they felt too physically unwell to continue and two gave no reason)
and one from the control group had dropped out (because they found participation upsetting). Two
intervention group participants received baseline assessment but no intervention, as the nurses were unable
to contact them. Overall, attrition was low (7/81= 9%), with data collected at one or more follow-up points
for 79 people (98%).
Across the study period, completion was better for the TAU group than the PC group (Table 6).
Completion was better among non-drinkers and those that drank the most (> 11 units per week), as well
as those who were retired compared with being in paid employment across time points. Characteristics of
completers are described in Table 7, which lists the demographics of those who completed follow-up and
those who did not. HADS-D scores (Table 8) were marginally lower at 1 and 6 months among non-
completers; however, they evened out by 12 months. We compared the models from our analyses with an
additional model that controlled for any variables that were associated with missing follow-ups; these
analyses did not give us any reason to alter any of our conclusions.
Data collection
The maximum number of observations available was 81 at baseline, 77 at 1 month, 74 at 6 months and
69 at 12 months. Table 9 shows the number of (and percentage of available) missing scores for each
questionnaire at each assessment point. Note: missing data for the Social Problems Questionnaire (SPQ)
are not recorded because of confusion concerning whether items were missing or left out because they
were not applicable (for analysis purposes no response was considered to mean ‘not applicable’ and
therefore no problem in this area). Two of our outcome measures had no missing scores at any point: the
modified Rose angina questionnaire and the specific activity schedule. The second question of the BIPQ
(BIPQ2) had the most missing scores, with 14% missing at 6 months. For the other measures, between 5%
and 10% of scores were missing at one or more assessment points for the General Self Efficacy Scale, the
BIPQ (questions 3 and 4) and the Warwick–Edinburgh Mental Well-Being Scale; and < 5% of scores were
missing for HADS-D, PHQ-9, BIPQ (questions 1, 5, 6, 7, 8), HADS-A and the SF-12 (mental and physical
components). Therefore, our selected outcome measures appeared to be acceptable to the participants
and would be feasible to use in definitive trial within a similar population.
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Enrolment
Allocated to PC (n = 41)
• Received allocated intervention, n = 41
• Did not receive allocated intervention,
   n = 2 (uncontactable)
Allocated to TAU (n = 40)
• Received allocated intervention, n = 40
• Did not receive allocated intervention,
   n = 0
Lost to follow-up (n = 4)
• Uncontactable, n = 3
• Withdrawn (participation upsetting), n = 1
Excluded (n = 45)
• HADS score of < 8, n = 40
• Psychosis, n = 2
• No chest pain, n = 2
• Poor English, n = 1
Lost to follow-up (n = 0)
Lost to follow-up (n = 5)
• Uncontactable, n = 3
• Withdrawn, n = 2 (upset, n = 1, 
   no reason, n = 1)
Lost to follow-up (n = 1)
• Uncontactable, n = 1
Lost to follow-up (n = 5)
• Uncontactable, n = 3
• Withdrawn, n = 2 (physical illness, n = 2)
Lost to follow-up (n = 3)
• Uncontactable, n = 2
• Withdrawn, n = 1
Analysed (n = 37)
Excluded from analysis (n = 4)
Analysed (n = 40)
Analysed (n = 35)
Excluded from analysis (n = 6)
Analysed (n = 39)
Analysed (n = 32)
Excluded from analysis (n = 9)
Analysed (n = 37)
Excluded from analysis (n = 3)
Assessed for eligibility (n = 126)
Randomised (n = 81)
Allocation
1 month
Analysis
6 months
Analysis
Analysis
12 months
FIGURE 6 The UPBEAT-UK pilot study Consolidated Standards of Reporting Trials diagram. Uncontactable means
lost to follow-up. Reproduced from Barley et al.111 © 2014 Barley et al. This is an open access article distributed
under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original author and source are credited.
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TABLE 6 Demographics of those who complete follow-up and those who do not
Measure
1-month follow-up
completed, n (%)
6-month follow-up
completed, n (%)
12-month follow-up
completed, n (%)
Randomisation
PC 37 (90) 35 (85) 32 (78)
TAU 40 (100) 39 (98) 37 (93)
Sex
Male 48 (92) 46 (88) 44 (85)
Female 29 (100) 28 (97) 25 (86)
Ethnicity
White 64 (96) 61 (91) 57 (85)
Black 3 (100) 3 (100) 3 (100)
Asian 5 (100) 4 (80) 4 (80)
Other 5 (83) 6 (100) 5 (83)
BMI
Underweight 3 (100) 3 (100) 2 (67)
Normal 19 (100) 17 (90) 15 (79)
Overweight 22 (96) 21 (91) 21 (91)
Obese 27 (90) 28 (93) 25 (83)
Smoke
Never 20 (91) 20 (91) 18 (82)
Ex-smoker 39 (98) 37 (93) 35 (88)
Current 18 (95) 17 (89) 16 (84)
Units of alcohol
Does not drink 38 (97) 37 (95) 35 (90)
1–10 26 (90) 24 (83) 21 (72)
≥ 11 13 (100) 13 (100) 13 (100)
Employment status
Paid employment 10 (83) 10 (83) 10 (83)
Retired 55 (100) 52 (95) 49 (89)
Housewife/husband 4 (100) 3 (75) 3 (75)
Unemployed/student 6 (86) 7 (100) 5 (71)
Relationship status
Married 38 (95) 37 (93) 37 (93)
Cohabiting 6 (75) 7 (88) 5 (63)
Widowed 12 (100) 12 (100) 10 (83)
Separated 4 (100) 4 (100) 4 (100)
Divorced 11 (100) 8 (73) 8 (73)
Single/non-cohabiting partner 6 (100) 6 (100) 5 (83)
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TABLE 6 Demographics of those who complete follow-up and those who do not (continued )
Measure
1-month follow-up
completed, n (%)
6-month follow-up
completed, n (%)
12-month follow-up
completed, n (%)
Live with
Spouse 26 (93) 27 (96) 25 (89)
Spouse and children 14 (88) 13 (81) 13 (81)
Children 7 (100) 7 (100) 6 (86)
Alone 28 (100) 25 (89) 23 (82)
Other 2 (100) 2 (100) 2 (100)
Place of residence
Owner occupied house/flat 32 (97) 32 (97) 29 (88)
Privately rented house/flat 8 (100) 8 (100) 7 (88)
House/flat rented from local authority 32 (91) 30 (86) 29 (83)
Sheltered housing/warden control 4 (100) 3 (75) 3 (75)
Other 1 (100) 1 (100) 1 (100)
BMI, body mass index.
TABLE 7 Continuous demographics of those who complete follow-up and those who do not
Measure
Completed Not completed
n Mean SD n Mean SD
1-month follow-up
Age (years) 77 65.1 10.8 4 53.8 7.1
IMD score 77 26 13.9 4 26.6 10.2
BMI (kg/m2) 71 29.5 7.1 4 32.3 5.3
Years in education 74 12.7 8.4 4 14.3 5.3
6-month follow-up
Age (years) 74 65.4 10.5 7 55.1 11.6
IMD score 74 26.1 14 7 25.6 10.8
BMI (kg/m2) 69 29.8 7.2 6 28 3.8
Years in education 72 12.0 4 6 11.8 3.1
12-month follow-up
Age (years) 69 64.9 10.4 12 62.4 13.9
IMD score 69 26.3 14.4 12 24.2 8.6
BMI (kg/m2) 63 30 7 12 27.7 6.6
Years in education 67 12 4 11 11.7 3.2
BMI, body mass index; IMD, Index of Multiple Deprivation.
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TABLE 9 Completeness of outcome measure data collection
Measure
Baseline missing,
n (%)a
1 month missing,
n (%)a
6 months missing,
n (%)a
12 months missing,
n (%)a
HADS-D 0 0 1 (1.4) 0
PHQ-9 1 (1.2) 2 (2.6) 1 (1.4) 0
General Self Efficacy Scale 8 (9.9) 5 (6.5) 6 (8.1) 2 (2.9)
BIPQ1 0 2 (2.6) 3 (4.1) 0
BIPQ2 4 (4.9) 5 (6.5) 10 (13.5) 5 (7.2)
BIPQ3 2 (2.5) 3 (3.9) 5 (6.8) 1 (1.5)
BIPQ4 5 (6.2) 6 (7.8) 5 (6.8) 0
BIPQ5 0 3 (3.9) 3 (4.1) 0
BIPQ6 0 3 (3.9) 3 (4.1) 0
BIPQ7 0 2 (2.6) 3 (4.1) 0
BIPQ8 0 2 (2.6) 3 (4.1) 0
HADS-A 0 0 1 (1.4) 0
WEMWBS 2 (2.5) 5 (6.5) 4 (5.4) 3 (4.4)
SF-12 physical 2 (2.5) 1 (1.3) 1 (1.4) 1 (1.5)
SF-12 mental 2 (2.5) 1 (1.3) 1 (1.4) 1 (1.5)
Modified Rose angina
questionnaire
0 0 0 0
Specific activity schedule 0 0 0 0
WEMWBS, Warwick–Edinburgh Mental Well-Being Scale.
a Percentage of the number of participants available at baseline= 81, 1 month= 77, 6 months= 74, 12 months= 69.
Missing refers to questionnaire score missing owing to insufficient items completed to allow a score to be calculated or
owing to participants not completing a particular questionnaire.
TABLE 8 Comparison of psychiatric baseline scores between completers and non-completers of follow-ups
Measure
Completed Not completed
n Mean SD n Mean SD
1-month follow-up
HADS-D score 77 11.6 3.2 4 10.0 2.3
HADS-A score 77 12.4 5 4 15.5 1.3
PHQ-9 score 76 15.7 5.4 4 16.3 5.2
6-month follow-up
HADS-D score 74 11.7 3.2 7 10.3 2.4
HADS-A score 74 12.5 4.9 7 13.3 4.5
PHQ-9 score 73 15.9 5.4 7 13.6 5.1
12-month follow-up
HADS-D score 69 11.5 3.1 12 11.6 3.4
HADS-A score 69 12.3 4.8 12 14.4 5.4
PHQ-9 score 68 15.8 5.2 12 15.4 6.6
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Depression
Depression outcomes are shown in Table 10. Both groups showed some improvement in depression
symptoms (HADS-D score) at all time points, with the mean score in both groups moving from indicating
moderate depression severity at baseline to mild severity at 12 months. We saw a similar pattern using the
PHQ-9, with mean scores in both groups indicating moderately severe depression at baseline reducing to
moderate depression at 12 months.
TABLE 10 Depression outcomes
Outcomes PC TAU Mixed-effects model
HADS-D severity, mean (SD)
Baseline 11.6 (3.3) 11.4 (3) Mean difference –0.73 (95% CI –2.08 to 0.62; p= 0.29)a
1 month 11.0 (3.4) 10.0 (4.5)
6 months 10.3 (3.8) 9.2 (4.6)
12 months 9.5 (4.6) 8.8 (4.8)
HADS-D remission,b % (number of patients/total number)
Baseline N/A N/A OR 2.67 (95% CI 0.71 to 10.4; p= 0.15)c
1 month 14 (5/37) 30 (12/40)
6 months 24 (8/34) 36 (14/39)
12 months 34 (11/32) 41 (15/37)
HADS-D response,d % (number of patients/total number)
Baseline N/A N/A OR 1.33 (95% CI 0.38 to 4.61; p= 0.65)d
1 month 3 (1/37) 10 (4/40)
6 months 15 (5/34) 21 (8/37)
12 months 28 (9/323) 24 (9/37)
PHQ-9 severity (PHQ-9 scores)
Baseline 16.0 (5.3) 15.4 (5.5) Mean difference –0.63 (95% CI –2.60 to 1.35; p= 0.54)b
1 month 14.8 (6.4) 13.0 (6.8)
6 months 13.4 (7.0) 11.7 (6.5)
12 months 12.6 (7.1) 12.0 (6.9)
CI, confidence interval; N/A, not applicable; OR, odds ratio.
a PC – TAU, based on 1 month, 6 month and 12 month combined; adjusted for time and baseline measure of outcome.
b HADS-D score of < 8, odds of remission in the TAU compared with the PC group.
c PC – TAU, based on 1 month, 6 month and 12 month combined; adjusted for time.
d Decrease ≥ 50% in HADS-D score from baseline and odds of response in the TAU compared with the PC group.
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According to the HADS-D, there was a greater percentage of remitters in the TAU group compared with
the PC group at 6 and 12 months; there was also a greater percentage of responders at 6 months in the
TAU compared with the PC group, but by 12 months more PC group participants had responded.
However, the mixed-effects models showed no significant differences between groups over time for any
measure of depression and CIs were wide so an effect in favour of either group cannot be ruled out.
From the medical notes, across the 12-month study period, in the PC group, 31 participants (76%) saw
their GP or PN regarding their mental health (total of 101 consultations recorded); in the TAU group,
29 participants (73%) made a mental health consultation (total of 102 mental health consultations
recorded). Of those participants who were not treated for depression at baseline (i.e. no record of
antidepressant prescription or talking therapy referral), three PC participants had received a prescription
for an antidepressant [Citalopram (Cipramil®, Lundbeck), n= 2; Mirtazepine (Mirtazepine®, Merck Sharp &
Dohme, Corp.), n= 1; one of these participants was also referred for ‘counselling’] and one additional PC
group participant had been referred to a ‘psychiatric clinic’ by 12 months; no participants in the TAU
group had a new referral for depression treatment or a new prescription for an antidepressant at the end
of the study.
Chest pain
The most notable difference between the PC and TAU groups was in self-reported chest pain (modified
Rose angina questionnaire). At 6 months the proportion of patients who no longer reported chest pain
was 37% in the PC group versus 18% in the TAU group and at 12 months it was 31% in the PC group
versus 19% in the TAU group. From the medical notes across the 12-month study period, in the PC group,
34 participants (83%) saw their GP or PN regarding their CHD (total of 158 consultations recorded); in the
TAU group, 29 participants (73%) made a CHD consultation (total of 170 consultations recorded). It is not
clear from the notes whether these were routine or emergency visits, so we examined recorded accident
and emergency (A&E) visits.
In the PC group, 10 participants (six for heart problems, two for other state reasons, two no reason recorded)
visited A&E (total 13 visits: nine heart problems, two other stated reasons, two no reason recorded). In the
TAU group, 15 participants (four for heart problems, five for other state reasons, six no reason recorded)
visited A&E (total 26 visits: seven heart problems, six other stated reasons, 13 no reason recorded). PC
participants therefore made fewer A&E visits (24% in PC vs. 38% in TAU), although missing data concerning
the reason for these visits makes this information difficult to interpret.
Preliminary secondary outcomes
At 6 and 12 months both groups improved on all outcomes (Table 11); these data have been published.111
There was no evidence for an interaction between time point and study arm for any outcome, so a
differential effect over time appears unlikely.
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Aim 3: validity of outcome measures in comparison with
participant-reported problems
Using the BIPQ, participants were asked to list the three most important problems that caused their illness
(CHD). Sixty-one participants gave at least one reason (these data are published online as an appendix110).
The most common reason given was ‘genetics or heredity’, followed by lifestyle factors such as smoking,
poor diet and lack of exercise. Mood problems, especially stress and work-related stress were also
mentioned, and comorbid or past health problems were also blamed. Four patients mentioned relationship
problems and one mentioned financial problems.
Participants in the PC group (n= 41) identified 21 types of problem as contributing to their depression and
which were addressed during the intervention (up to three problems per patient); most common were pain
(chest and other pain, e.g. arthritis) (n= 18), lack of exercise (n= 17), difficulty sleeping (n= 13), anxiety
(n= 11) and being overweight (n= 11). Reported problems and whether or not they were addressed
during the intervention are published online as an appendix.110
Participants therefore explained both their CHD and their depression in terms of wide-ranging problems
that appeared similar for the two conditions; lifestyle problems in particular were associated with both.
Within our study, mood outcomes were assessed using the HADS (depression and anxiety) and the PHQ-9
(depression); however, we had no measure of change in lifestyle-related outcomes. The PC intervention
was aimed at tackling the problems that each participant felt were important rather than addressing
specific cardiac risk factors; however, in view of our current finding that patients do consider lifestyle
factors known to be associated with CHD as contributing to their depression, inclusion of a measure of
change in cardiac risk factors should be considered for a definitive trial of PC. It will be important to select
a measure that captures the variation between participants in terms of which risk factors they want to
address; a validated measure of goal attainment may therefore be appropriate.
Aim 4: exploring changes in self-efficacy
Self-efficacy improved over the course of the study (see Table 11). At 12 months, the PC group had a
mean increase of 2.5 points versus 0.9 points in the TAU group, suggesting a greater increase in
self-efficacy in the PC group; however, the mixed-effects model indicated no difference between groups
over time (adjusting for baseline self-efficacy): mean difference –0.58 (95% CI –3.05 to 1.89).
At 6 and 12 months the overall illness perceptions score and most measured dimensions showed
improvement in both groups, though differences between groups were small (Table 12). The mean
improvement in overall score from baseline to 12 months was greater in the PC group than in the TAU
group: 7.8 points versus 2.5 points. As expected, the biggest difference in mean improvement between
the PC and TAU groups in dimension scores was in personal control (mean change in BIPQ from
baseline= 1.5 for PC group vs. 1.1 for TAU at 6 months; and 1.1 for PC vs. 0.1 for TAU at 12 months);
however, the mixed-effects model suggested no difference between groups over time (adjusting for
baseline total BIPQ score): mean difference –0.42 (95% CI –4.57 to 3.72).
Controlling for changes in self-efficacy or overall illness perceptions had little effect on change in
depression over time, whether or not considering depression severity, remission or response (Table 13).
Since CIs were wide, change in favour of either PC or TAU cannot be ruled out.
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TABLE 12 Brief Illness Perception Questionnaire scores
BIPQ sections
PC TAU Mean difference
n Mean (SD) n Mean (SD) PC – TAU 95% CIa
Consequences (BIPQ1)
Baseline 41 5.4 (3.1) 40 6.1 (3.2) –0.6 –2.0 to 0.8
1 month 35 5.9 (3.0) 40 5.8 (3.0) 0.1 –1.3 to 1.5
6 months 32 5.8 (2.9) 39 5.3 (3.2) 0.5 –1.0 to 1.9
12 months 32 5.6 (3.6) 37 5.0 (3.2) 0.6 –1.0 to 2.2
Timeline (BIPQ2)
Baseline 39 9.3 (2.1) 38 9.2 (2.5) 0.1 –0.9 to 1.2
1 month 34 9.1 (2.0) 38 9.2 (2.1) 0.0 –1.0 to 0.9
6 months 29 9.2 (2.0) 35 9.3 (2.0) –0.1 –1.1 to 0.9
12 months 30 9.5 (1.5) 34 9.2 (2.2) 0.3 –0.7 to 1.2
Personal controlb (BIPQ3)
Baseline 39 3.5 (3.3) 40 3.5 (3.3) 0.0 –1.4 to 1.5
1 month 35 4.6 (3.1) 39 3.5 (3.5) 1.1 –0.4 to 2.6
6 months 32 5.0 (3.5) 37 4.6 (3.5) 0.4 –1.3 to 2.1
12 months 32 4.6 (3.7) 36 3.6 (3.6) 0.9 –0.9 to 2.7
Treatment controlb (BIPQ4)
Baseline 40 7.0 (2.9) 36 6.9 (2.9) 0.0 –0.3 to 1.3
1 month 35 7.4 (2.6) 36 6.4 (3.8) 1.0 –0.6 to 2.5
6 months 31 7.7 (2.3) 38 6.6 (3.5) 1.1 –0.4 to 2.5
12 months 32 7.5 (3.1) 37 7.0 (3.6) 0.4 –1.2 to 2.1
Identity (BIPQ5)
Baseline 41 5.1 (8.1) 40 5.5 (3.2) –0.4 –1.7 to 1.0
1 month 34 4.7 (2.9) 40 5.4 (3.3) –0.7 –2.1 to 0.8
6 months 32 4.9 (3.2) 39 4.7 (2.9) 0.2 –1.3 to 1.6
12 months 32 5.1 (9.7) 37 4.9 (3.2) 0.1 –1.4 to 1.6
Illness concern (BIPQ6)
Baseline 41 6.4 (3.7) 40 6.1 (3.9) 0.3 –1.4 to 2.0
1 month 34 6.3 (3.8) 40 5.4 (3.9) 0.9 –0.9 to 2.7
6 months 32 6.4 (3.7) 39 4.5 (3.6) 2.0 0.2 to 3.7
12 months 32 4.7 (3.8) 37 4.8 (4.0) 0.0 –1.9 to 1.8
Illness coherenceb (BIPQ7)
Baseline 41 6.0 (4.1) 40 5.7 (3.6) 0.4 –1.3 to 2.1
1 month 35 6.0 (3.7) 40 6.3 (3.4) –0.3 –1.9 to 1.3
6 months 32 6.4 (3.7) 39 6.0 (3.9) 0.4 –1.4 to 2.2
12 months 32 7.7 (3.2) 37 6.8 (3.7) 0.9 –0.8 to 2.6
continued
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Post-hoc analyses
As anxiety symptoms were high at baseline, we also explored HADS-A score as mediator for improvement
in depression. Controlling for anxiety slightly reduced the difference in depression symptoms between the
groups over time: mean difference –0.43 (95% CI –1.48 to 0.63; p= 0.43). Controlling for anxiety
considerably reduced the odds of remission in the TAU group versus PC group in favour of the PC group:
odds ratio (OR) remission in TAU versus PC group 0.42, 95% CI 0.10 to 1.68; p= 0.22, which suggests
that changes in anxiety symptoms may be a mediator for depression remission. The odds of depression
response in the TAU group compared with the PC group were also slightly reduced when anxiety scores
were controlled, although the odds were still in favour of TAU (OR 1.12, 95% CI 0.32 to 3.94; p= 0.86).
None of these analyses showed a statistically significant effect; all changes in effect were small and CIs
were wide so we cannot rule out benefit for PC or TAU.
Aim 5: exploring acceptability and feasibility of personalised care
Nurse time used for intervention
Intervention patients (n= 41) received a mean of 203 minutes (SD 100 minutes) of nurse time [78 minutes
(SD 19 minutes) for assessment, 125 minutes (SD 91 minutes) in telephone follow-up calls over 6 months].
TABLE 12 Brief Illness Perception Questionnaire scores (continued )
BIPQ sections
PC TAU Mean difference
n Mean (SD) n Mean (SD) PC – TAU 95% CIa
Emotional representations (BIPQ8)
Baseline 41 6.7 (3.4) 40 6.1 (3.5) 0.6 –0.9 to 2.2
1 month 35 5.8 (3.4) 40 6.2 (3.1) –0.4 –1.9 to 1.1
6 months 32 5.4 (3.5) 39 4.6 (3.4) 0.7 –0.9 to 2.4
Total scorec
Baseline 36 47.8 (13.5) 35 45.5 (14.1) 2.3 –4.3 to 8.8
1 month 30 42.8 (13.3) 35 44.4 (13.3) –1.5 –8.2 to 5.1
6 months 28 43.0 (13.3) 34 40.9 (11.5) 2.1 –4.2 to 8.4
12 months 30 40.0 (14.8) 33 43.0 (13.1) –3.0 –10.0 to 4.0
a t-test.
b A high score is good.
c A higher score reflects a more threatening view of the illness.
TABLE 13 Effect of controlling for changes in self-efficacy and illness perceptions on depression outcomes over the
study period
Depression
Mixed-effects modelsa (95% CI; p-value)
Time point Self-efficacyb Illness beliefsc
Severity (mean difference) –0.73 (–2.08 to 0.62; 0.29) –0.88 (–2.11 to 0.36; 0.16) –0.57 (–1.90 to 0.77; 0.40)
Remission (odds ratio) 2.67 (0.71 to 10.05; 0.15) 3.15 (0.64 to 15.50; 0.16) 3.26 (0.94 to 11.24; 0.07)
Response (odds ratio) 1.33 (0.38 to 4.61; 0.65) 1.02 (0.26 to 3.95; 0.98) 1.27 (0.34 to 4.66; 0.72)
a Examining difference in HADS-D score and depression remission and response in TAU vs. PC groups controlling for
HADS-D baseline score, treatment arm and time.
b Is also controlling for change in General Self Efficacy Scale score across the study period.
c Is also controlling for change in total BIPQ score across the study period.
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The mean number of follow-up calls was nine (SD five); the mean duration of calls was 14 minutes
(SD 4 minutes). The nurses arranged a time to call the patient, but sometimes patients did not respond;
there was considerable variation between patients in the number of failed follow-up contact attempts by
nurses over the 6-month intervention period (range 0–32), but on average nurses made 2.8 calls for every
successful contact.
Effect of intervention intensity
The amount of time spent talking to the nurse varied considerably between patients (range 74–406
minutes), so we used the median duration (167 minutes) to divide the participants into high (n= 20) and
low (n= 19) ‘dose’ groups. There were no significant differences (p> 0.05) between the groups at baseline
in depression [HADS-D mean: low-dose group 11.0 (SD 3); high-dose group 12 (SD 3.7)]. The magnitude
of improvement in depression over time was greater for the high- compared with the low-dose group and
fewer high-dose patients had chest pain at 6 and 12 months, although the mixed-effects models indicated
little difference between the groups: depression mean difference –0.72, 95% CI –3.03 to 1.60; chest pain
OR 0.34, 95% CI 0.01 to 7.53.
Patient satisfaction with personalised care
Of the 41 PC participants, 21 completed and returned the satisfaction questionnaire. The questionnaire
and responses are shown in Table 14. On the whole, patients reported finding the different elements of
TABLE 14 Patient satisfaction with the PC intervention
Question
Number of responses
Yes No
I found the assessment meeting with nursea helpful 18 1
My care plan has been helpful 16 1
My telephone conversations with nursea were helpful 15 2
My contact with nursea helped in consultations with
my GP, PN or other health professional
12 4
About right Too little Too much
My level of contact with nursea was . . . 11 5 2
Strongly
Agree Agree Neutral Disagree
Strongly
Disagree N/A
Nursea answered any questions I may have had about
my heart problem
4 9 2 0 0 1
Nursea answered any questions I may have had about
my low mood
3 10 1 1 0 2
Nursea answered any questions I may have had about
other health issues
4 9 1 1 0 2
Nursea provided and explained information in an
understandable way
7 6 2 1 1 0
Nursea provided support and encouragement 8 6 1 1 1 0
Nursea had a courteous personal manner 12 3 1 0 1 0
Yes No
Would you like your GP practice to provide a service
such as this?
15 0
N/A, not applicable.
a The name of the nurse with whom the patient had been working was inserted.
DOI: 10.3310/pgfar04080 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 8
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Tylee et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
63
the intervention (assessment, care plan and follow-up calls) helpful. They also found that the intervention
helped them communicate with other health professionals such as their GP. Most respondents agreed or
strongly agreed that the nurse was able to answer their questions about their mood, heart or other health
problems and that they could understand the information given, and that the nurse provided support
and encouragement and had a courteous manner. Of the 15 patients who responded to this question,
all said that they would like their GP to offer a similar service.
The patients were also asked which aspect of working with their nurse they had liked best and least.
Seventeen patients responded regarding what they liked best: two patients liked ‘everything’ or ‘all’;
several comments referred to the patient’s pleasure in having someone pleasant to talk to:
it’s just good to talk to somebody.
sympathetic helpful and friendly approach.
[Nurse] is a nice person and very pleasant.
Other comments were more specific and referred to the nurse’s ability to treat them as an individual when
offering advice and understanding:
Their personal interest in me as a patient and not just a number, like you feel in hospital sometimes.
Their interest in my problems and how they could help me with my problems and difficulties and
trying to help, in getting me to understand my problems and difficulties and that there was a light at
the end of the tunnel and they has been so good to me in that area and I’m hoping I can do their
help worthy.
They always had a nice manner (sic). Listens very well and after what I’ve been through they had a
good answer and good advice. Please thank [nurse] for their time.
their advice about routine – listening to radio and when you believe somebody care about you – here
I am alone, no family (except my children), no friend. We need such as this service.
Regarding what they liked least: 10 patients responded ‘none’ or ‘N/A’ [not applicable]; one patient
responded ‘forms’; another, who had been positive about the intervention, appeared to indicate that they
had found participation difficult:
Knowing the value of time it was so difficult to convince myself that I was not wasting both
(the Nurse’s) and my time operating this plan. I fought hard against this feeling.
This patient’s comment in the ‘liked best’ section seemed to suggest that they nevertheless valued the
intervention, so their earlier comment may be reflective of their depressed state:
Honestly I didn’t really like any of it. I feared that I was too set in my regimes to open my soul and
shortcomings. However I understood that it was important for me to proceed and tried to give it my
full attention. But it wasn’t likeable.
Aim 6: exploring standardisation and therapist effects
Intervention fidelity
As planned, the nurse case managers used a range of nursing and behaviour change techniques to help
patients address their problems. Classifiable behaviour change techniques reported by nurses were:
general encouragement, information linking health and behaviour, goal-setting and action-planning,
barrier identification and focus on past success. Other nurse-reported actions included lifestyle advice,
AN INTERVENTION FOR SYMPTOMATIC CORONARY HEART DISEASE AND DEPRESSIVE SYMPTOMS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
64
signposting (e.g. to relevant local resources such as leisure or day centres), promoting adherence to
therapy and supportive counselling.
There was also some evidence of collaborative care. The nurse case manager contacted the patient’s GP
(10 patients), the patient’s PN (four patients), social services (one patient) or another professional, for
example IAPT worker or other therapist, occupational therapist, community mental health nurse,
physiotherapist, housing or benefits officer (17 patients). With the patient’s permission, the nurse case
managers consulted a family member of four patients.
Therapist effects
The patients of Nurse 1 had a higher mean baseline HADS-D score (12.4 vs. 10.9, Wilcoxon rank-sum test;
p= 0.07). However, the random-effects model (combining data from 1, 6 and 12 months) indicated little
difference in the average therapist effect on the HADS-D score across the time points (adjusting for
baseline HADS depression score): mean difference –0.86 (95% CI –2.81 to 1.10).
Regarding self-reported chest pain, of Nurse 1’s (registered general nurse and health psychologist) patients,
44% continued to report chest pain at 6 months, compared with 79% of Nurse 2’s (registered general
and mental health nurse) patients (p= 0.03). In the random-effects model, the odds of reporting chest
pain across the study period were higher for Nurse 2 than for Nurse 1 (OR 7.80, 95% CI 0.88 to 69.40).
Aim 7: examine the potential cost of personalised care
The average EQ-5D utility scores at baseline were slightly higher for the PC group (see Figure 7, which is
also published elsewhere110), although the difference between groups was not statistically significant
(95% CI –0.98 to 0.25; p= 0.40). By the 1-month follow-up, the TAU group had a higher utility score,
and this difference was maintained up to the 12-month follow-up [95% CI –0.26 to 0.11; p= 0.422
(at 6-month follow-up: 95% CI –0.27 to 0.11, p= 0.408)]. In terms of QALYs, the TAU group showed an
incremental QALY gain of 0.038 compared with PC over the 12-month treatment period. In Figure 7 the
area between the two curves represents the QALY gain for the control group.
Service use and costs
Service use was fairly similar between the intervention and the control groups during the study period
(Table 15, which is also published online as an appendix to our paper110). Hospital services were used more
intensively by the TAU group than the PC group at all time points, with inpatient and outpatient care
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being the most frequently used services. The TAU group incurred higher inpatient costs than the PC group
at each time point (particularly at baseline and at the 12-month follow-up). Few patients used day hospital
services, but the costs incurred were high for both groups. The majority of patients received care from GPs
and the costs of this were similar between the groups. Informal care was used slightly more among
patients in the PC group than in the TAU group. Average total costs at each time point were lower for the
PC group than for the TAU group. However, the differences were not statistically significant. For the PC
group, the intervention itself accounted for only 6.7% of total costs.
Cost–utility analysis
Of the total 81 participants, cost and QALY data at each time point were available for 68 patients (84%).
Cost–utility results yielded an incremental cost-effectiveness ratio of £29,921 per additional QALY.
Cost-effectiveness plane and cost-effectiveness acceptability curves were produced from bootstrapped
resamples. The distribution of the cost-effectiveness point estimates on the cost-effectiveness plane
(Figure 8, which can also be found in Barley et al.110) indicated a strong likelihood of cost savings for the
PC group compared with the TAU group. The point estimate of the incremental cost-effectiveness ratio
falls in the south-western quadrant, representing the situation where the PC group has reduced costs and
worse outcomes. The second most likely result is that PC results in lower costs and better outcomes
(south-east quadrant).
The cost-effectiveness acceptability curves (Figure 9) for the PC group compared with the TAU group was
downward sloping. There is a greater likelihood of PC being the most cost-effective option up to a QALY
threshold of £3035.
Discussion
We developed a PN-led PC intervention, which was designed to be easily implemented within practice in
order to improve current primary care. In this patient-randomised pilot trial we explored the acceptability,
feasibility and potential costs of the intervention for primary care CHD patients who have probable
concurrent depression and current chest pain. We also explored the feasibility of the trial protocol to
inform the methods of a definitive trial.
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FIGURE 8 Distribution of the cost-effectiveness point estimates on the cost-effectiveness plane. NE, north-east;
NW, north-west; SE, south-east; SW, south-west. Source: reproduced from Barley et al.110 © 2014 Barley et al. This is
an open access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source
are credited.
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Feasibility and acceptability of personalised care
The PC intervention appeared to be feasible and acceptable for use in current primary care: a short
amount of nurse time was needed, engagement with the nurse case managers was high and most of the
PC group participants who returned our questionnaire reported satisfaction with all aspects. To further
understand participants’ experience of the intervention, we have interviewed a subsample of 12 PC group
participants. We used purposive sampling to select participants by age [>/≤ 60 years], sex, nurse case
manager, depression (HADS-D >/≤ 10) and nurse case manager impression of depression response. Owing
to research assistants leaving the programme for positions with longer-term prospects, these data are yet
to be analysed.
As expected, this exploratory study confirmed the findings of our earlier qualitative work that patients with
CHD and depression symptoms report a wide range of problems that they consider contribute to their low
mood. The PC intervention enabled patients to identify and address these problems with the nurse case
managers. This is an improvement on current care for these patients since management of depression
and/or psychosocial problems is not routinely addressed in this population,31,59 despite recent routine
depression screening under the QOF.112 Compared with the widespread organisational change that would
be needed for collaborative care interventions as trialled in the USA,12 our PC intervention appears to offer
an enhanced form of TAU which could be implemented easily in current primary care practice. Evidence
from the UK-based proactive care by PNs for people with depression and anxiety (ProCEED) trial133,134
that care reviews delivered by PNs acting as case managers were acceptable to patients with long-term
depression supports this.134
We explored a wide range of outcomes focusing on depression, as measured by the HADS-D as a
potential primary outcome. Findings tended to show slight benefit for TAU compared with PC for
depression symptoms, remission and response, except that at 12 months more PC participants had
responded. However, differences between groups were very small and wide CIs mean that improvement
with either PC or TAU cannot be ruled out. Our mixed-effects model indicated that PC would be unlikely
to do much harm compared with TAU (mean difference –0.73), but could improve symptoms up to 2.1
points on the HADS-D (95% CI –2.08 to 0.62). We see little reason to change to a different outcome.
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FIGURE 9 Cost-effectiveness acceptability curves. c-e, cost-effective; p, probability. Source: reproduced from Barley
et al.110 © 2014 barley et al. This is an open access article distributed under the terms of the Creative Commons
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Accepted health psychology models agree on two factors important for behaviour change: belief in the
importance of an outcome and belief in capacity to succeed (self-efficacy). Our intervention facilitated
participants to work on outcomes important to them, and we used techniques such as action-planning to
increase self-efficacy. Our data indicated that self-efficacy and illness perceptions, especially personal
control, which is closely related to self-efficacy, were increased in those receiving PC but the difference
from the increase in TAU group participants was not great.
Although both groups improved on all our measured outcomes, there were no large differences between
groups, except in self-reported chest pain, which was also an inclusion criterion for the study. Our cohort study
indicated that chest pain has a range of negative impacts and is therefore an important outcome to study.
Potential costs of personalised care
There were no great differences in service use and costs between PC and TAU, with the exception of
inpatient care, which also accounted for a substantial proportion of total costs. Overall, it appears that PC
reduced costs compared with TAU, but produced slightly lower benefits in terms of QALYs. This may
appear counterintuitive given the other findings, but the utility scores underlying the QALY calculations
were fairly similar and did not change much over time. Costs may have been underestimated owing to
reliance on patient self-report in service use, the lack of medication and sick-leave data at all time points
and the approach used to quantify informal care. Informal care constitutes a major cost driver in
chronically ill populations. In this analysis, the ‘proxy good method’135 and the unit cost of home care
worker was used to calculate informal care. However, in a future trial, an alternative cost, such as the
national minimum wage, could be used to quantify informal care in the context of a sensitivity analysis.
A future trial should also test whether or not a longer time horizon is needed for this particular patient
group to benefit from an intervention of this kind. It may be considered unusual to include a full economic
analysis in a feasibility study and, therefore, these results should be seen as exploratory.
Implications of clinical findings for a future trial of personalised care
An implication of the lack of difference between PC and TAU and the small degree of change in
depression symptoms detected is that, if depression symptoms are to be used as a primary outcome in a
definitive trial, a large sample size would be required to replicate difference of the order found here
[e.g. using the HADS-D mean and SD (PC: mean 10.3, SD 4.6; TAU: mean 9.2, SD 4.6) at 6 months an
achieved sample size of 368 per group would be required for 90% power at a 5% significance level
(two-sided)]. This would be increased considerably if a cluster design were employed, which would be
necessary to reduce contamination if PC were tested using PNs based in practice, and would also need to
be increased to take account of attrition. On the other hand, a clinically significant effect of 3 on HADS-D,
as originally proposed, would require fewer. The main implications for planning are the somewhat higher
SD than that originally assumed (4.6 compared with 3.5), and the lower attrition rate (13% compared with
25%). The recruitment of practices to achieve these figures is another factor to be considered in planning.
The fact that only a small improvement in depression symptoms was found over the entire sample is
consistent with systematic review evidence indicating that even intensive evidence-based psychological
treatments, such as CBT, problem-solving and pharmacological intervention with selective serotonin
reuptake inhibitors, have only a small effect on depression in people with CHD.96,136
Furthermore, our sample appears to represent a hard-to-treat group: the level of depression symptoms was
high, more than half reported recurrent depression and more than one-quarter reported that they were
receiving depression treatment at baseline and yet still reported depression symptoms. In addition, a large
longitudinal cohort study (n= 1209)137 has found that pain, mediated by baseline severity of mood
symptoms, was predictive of a worse course of depressive and anxiety disorders; all of our participants
reported current chest pain, which was an inclusion criterion. A 3-point change in HADS-D score (which a
trial of this size could have detected) after 6 months of relatively low-intensity intervention may therefore
be an unrealistic expectation and a more intensive intervention for depression with engagement over a
longer period may be needed for patients such as these. Our data, which suggest that receipt of more
nurse time is associated with greater improvement in depression and self-reported chest pain, support this.
AN INTERVENTION FOR SYMPTOMATIC CORONARY HEART DISEASE AND DEPRESSIVE SYMPTOMS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
70
As well as chest pain, anxiety comorbid with depression is predictive of a worse depression outcome;138
our participants reported high anxiety levels and we found some evidence of anxiety as a mediator for
depression improvement. In a future trial, more active treatment of anxiety should be tested, particularly
when associated with chest pain.
The potential to detect differences between PC and TAU in our trial may have been reduced because TAU
is itself an active intervention: at baseline 43% of the TAU group versus 32% of the PC group were
prescribed antidepressants (according to their medical notes), and we were unable to control for this
difference in our analyses. It is also possible that TAU may have been intensified during the trial: during
our qualitative work GPs and PNs reported greater awareness of the problem of comorbid depression and
CHD as a result of participation in our cohort study, the same may apply to participation in our RCT.
This may have led to more than usual intervention in the TAU group, although from the medical notes it
appeared that the number of mental health consultations were similar for both groups. In a future trial,
changes in TAU during the trial should be recorded systematically.
We hypothesised that the intervention would increase self-efficacy to achieve desired outcomes which
would lead to improved depression outcomes. However, the small recorded changes in self-efficacy and
related illness perceptions had little effect on depression outcomes. This may have been expected: a
difference between our intervention and that of others that have not found improved self-efficacy139
following self-management intervention is that our participants chose the outcomes on which to work on,
that is, they identified the factors that they felt contributed to their low mood, rather than being required
to work directly on their depression. A better examination of the theory behind our PC intervention would
be to explore the effect of changes in self-efficacy on a measure of goal attainment, then test the effects
of goal attainment on depression over the long term, although this would require a complex trial. Fewer
PC compared with TAU participants visited A&E (24% vs. 38%), which may indicate increased self-efficacy
in self-management in the PC group, though in a future trial a more robust measure than self-report of
A&E attendance should be used to examine this, for instance Hospital Episode Statistics.140
The possibility that our PC intervention may impact on reported chest pain requires further investigation.
We are unable to determine whether or not self-reported chest pain in our trial participants was of cardiac
origin. It is estimated that in half of all patients presenting with chest pain, the pain is of non-cardiac
origin.141 A high-quality review of psychological interventions for chest pain in patients with normal
coronary anatomy (15 studies, 803 participants),142 suggests a modest to moderate benefit, especially for
CBT and possibly hypnotherapy. Our trial indicates that non-pharmacological intervention may also be
effective for chest pain in patients with CHD. Given the impact of chest pain on patients’ quality of life,
mood and on the health service, self-reported chest pain may be an important primary outcome for a
future trial. However, since determination of the causes of self-reported chest pain is complex, this should
be supported by a more objective measure of cardiac status, such as heart rate variability, which is a
predictor of a range of cardiac outcomes and associated with a number of psychological risk factors
for CHD.143
Lessons learnt concerning delivery of personalised care
The PC intervention was designed, informed by the findings from our qualitative work, to facilitate both
patient choice and clinical judgement, so variation in intervention delivery was expected. However, we
produced a manual for the intervention and the nurse case managers reported using its key elements of
behaviour change interventions, signposting and liaison with other professionals. In weekly study group
meetings, the multidisciplinary clinical team was satisfied that the PC was delivered as planned. Exploratory
investigation of therapist effects indicated no difference in depression outcomes between the patients of
the two nurse case managers, but that the patients of the nurse case manager with more health
psychology experience may have had a greater reduction in self-reported chest pain. There was a very
small sample size for this analysis, so this finding should be interpreted with caution, but it suggests that
training in the behaviour change aspects of the intervention is important for case managers. However,
other studies have shown that even nurses and GPs trained in behaviour change techniques may have
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difficulty applying them.144,145 Further research into how best to train, or whether or not non-psychologists
can be trained, to work more psychologically to increase the effectiveness of care is needed. A future trial
of PC could test it as delivered by IAPT psychological well-being practitioners (PWPs).
An alternative approach would be to make greater effort to ensure that depressed patients managed using
PC receive guideline-informed treatment. Multidisciplinary collaboration to ensure receipt of available,
effective depression treatment has been a key element in a number of successful trials of complex
interventions for depression in primary care patients.12,146,147 In this trial, four participants in the PC group,
compared with none in the TAU group, received new depression treatment (antidepressant treatment or
psychological treatment) by the end of the trial. The nurse case managers often contacted other
professionals involved in the care of the majority of PC group participants. However, the nurses reported
difficulty in accessing some of the participants’ GPs and PNs (e.g. several telephone attempts needed,
lack of response to e-mails); this limitation may be overcome by using case managers based within the GP
surgery. However, even when contact was made, patients may not have received guideline-informed
depression treatment (e.g. one GP was reluctant to prescribe antidepressants to a severely depressed
patient despite advice from the nurse case manager because of expressed anxiety concerning
multipharmacy and because IAPT services were unavailable in some areas). This suggests that in a
future definitive trial, nurse case managers should be embedded within study practices to increase
multidisciplinary collaboration (e.g. by planned times for discussion of cases with GPs and PNs, as is often
the case in collaborative care) and means of ensuring that patients can access guideline-informed
depression treatment should be predetermined.
Lessons learnt concerning the study protocol
Overall, the findings suggest that the trial protocol was feasible, with high levels of compliance and
acceptability. For instance, attrition was < 10% and rates of missing data for most outcomes were low,
despite the large number of measures. The PCRN-GL was responsible for practice recruitment, which was
achieved well within our predicted time frame. This was helped by their prior knowledge of practices
willing and able to conduct such research. Patient recruitment was also as expected and was in line with
other studies of depression interventions in primary care.146,148,149 Only around one-third of patients invited
to participate by his or her GP provided consent to contact; this was also the case in our cohort study.
Use of this ‘opt-in’ system appears to result in substantial loss of potential participants; however, this is the
usual method of recruitment for studies conducted in UK primary care. All of the patients meeting our
inclusion criteria at baseline agreed to be randomised. Low attrition and high acceptability suggest that
people with CHD, depressive symptoms and chest pain are receptive to additional support.
Conclusions
We have developed an intervention that is acceptable to primary care CHD patients who have probable
concurrent depression and current chest pain, and which is feasible for use in current practice. The PC
intervention could, we think, be delivered by PNs, although training in behaviour change techniques will
be necessary. IAPT PWPs may also be potential case managers, but they would need training in long-term
condition management.
Depression symptoms in CHD patients who report chest pain appear difficult to treat, as evidenced by this
trial and by previous work.96 Our data suggest that more nurse time was associated with improved
outcomes, so more intensive follow-up should be included in future use of the PC intervention.
In this trial, collaborative working to ensure that patients received guideline-informed depression
intervention was not optimal; this may be improved by using case managers based within trial practices
and having agreed methods for providing access to guideline-informed care. Other trials12,146 suggest that
this will improve depression outcomes.
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It is uncertain which outcomes, other than depression, should be used in a future trial of PC. Our data
suggest that self-reported chest pain may be important, but given the complexities in the relationship
between self-reported chest pain and cardiac outcome, use of this measure should be supplemented with
a more objective measure of cardiac health, for instance heart rate variability.
Our data also suggest that the underlying theory of our PC intervention, that increased self-efficacy to
achieve desired outcomes would lead to improvements in depression, needs further testing. Since
participants chose a wide range of problems on which to work on, it was difficult to determine how many
achieved their goals; a measure of goal attainment should be included in a future trial. However, changes
in self-efficacy were small and more intensive psychological intervention may be needed to achieve greater
improvement. Longer follow-up is likely to be needed to see impact on depression outcomes.
The trial protocol appeared, on the whole, to be successful with high levels of compliance and
acceptability. However, we found, in common with other studies, that large numbers of patients have to
be approached and screened for a sufficient number of CHD patients with both chest pain and depressive
symptoms to be randomised. This makes such trials costly.
In so much as patients were able to address the wide variety of problems that trouble them, the PC
intervention represents enhanced care, which may also be cheaper than TAU. If a fair test of the
differences between this low-intensity, quality improvement intervention and TAU is to be made, in future
trials it will also be important to monitor more closely any changes in TAU over the course of the trial
which may occur owing to increased awareness in participating clinicians of the need to manage
depression in people with CHD.
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Chapter 5 Cohort study (work package 3)
Objectives and methods
In this chapter we describe the relationship between depression and chest pain in primary care patients
recruited into the study from the GP QOF CHD registers. The aims, objectives and methods have been
presented in detail elsewhere1 and will be summarised here.
Objectives
The objectives of the cohort study were to:
1. determine the prevalence, incidence rate and risk factors of depressive disorders in primary care patients
with CHD
2. explore and describe the course and prognosis of physical and depressive symptoms among primary
care patients with CHD over a 3-year period
3. determine the effect of depression on mortality, symptom severity and pain in primary care patients
with CHD.
Service use, service costs and lost employment costs will be described separately.
Methods
The cohort study methods, instruments and analysis plan have been described elsewhere.1 This was a
naturalistic cohort study of primary care patients recruited from QOF CHD registers held by GP practices in
south London. All participants on these registers were eligible for inclusion in the study as long as they
were > 18 years of age and not temporarily registered with their GP. Eligible consenting patients were
assessed at baseline and then followed up at 6-monthly intervals for a period of up to 4 years. We report
on the 3-year follow-up data here. All patients were eligible for 36 months follow-up at the end of the
study. A smaller population was eligible for a 4-year follow-up (and will be analysed in the future).
The measures used at baseline and follow-up are shown in Table 16, previously published as table 1 in
Tylee et al.1 Not all measures have been used in the analyses presented here. For more details on the
instruments used, see Appendix 4.
The reporting of chest pain by cohort members was recorded at each wave of follow-up. Chest pain is the
cardinal symptom of CHD and the key to a clinical diagnosis of angina pectoris. We report here the
prevalence rate of this physical symptom at baseline and the outcome in terms of cardiovascular events
(e.g. MI) or continued exertional chest pain (i.e. patients reporting exertional pain on most occasions).
We have analysed the relative roles of depression, anxiety and quality-of-life scores for these outcomes.
Chest pain assessment
We used the Rose questionnaire113 to assess the severity of the symptomatology (i.e. chest pain) of CHD.
Devised in the 1960s for the purpose of detecting angina pectoris in field studies, it has been widely used
since. The original validation criterion was agreement with CHD diagnosis in GP medical notes but since
then it has been used as a useful predictor of subsequent cardiovascular events in the longer term.157–160
On the other hand, the agreement between a positive response on the Rose and concurrent clinical testing
for evidence of CHD can be poor.161,162 It is used in both a long form in field studies and, as the short form
of the Rose questionnaire has equivalent predictive power, the short form is often preferred. We describe
how both the short form and the long form are rated below. Pain on exertion seems to be the key
symptom to predict subsequent problems.163
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The short form is outlined in Table 17 below and the additional questions for the long form are shown in
Table 18.
To assess cardiac outcomes, all cardiology notes, investigations and interventions were collected from the
GP notes by a medical doctor on the team (JP) and entered into an encrypted Microsoft Access® 2007
database (Microsoft Corporation, Redmond, WA, USA). The dates of each visit to a cardiologist, each
investigation for a cardiac-related problem and each visit to a rapid access chest pain clinic, A&E or hospital
admission for a cardiac investigation or intervention (e.g. bypass graft, angioplasty) were recorded. We also
recorded any GP visit for cardiac-related problems or regular follow-ups. The data to be inputted and the
specific definitions of cardiac investigations were decided before the hard copies were examined, with
exception to the ‘rapid access chest pain clinic’ category. The GP notes were re-examined to gather this
TABLE 16 Measures used at baseline and follow-up assessments
Measure Baseline Follow-up
Modified Rose angina questionnaire (chest pain)113 ✗ ✗
Guy’s Hospital Chest Pain Questionnaire150 ✗ ✗
Specific activity scale119 ✗ ✗
General Health Questionnaire-12 (psychological distress)151 ✗
HADS114 ✗ ✗
Clinical Interview Schedule – Revised (psychiatric symptoms)152 ✗
PHQ-9 (depression)116 ✗ ✗
EQ-5D (quality of life)153 ✗ ✗
SF-12 (quality of life)118 ✗ ✗
List of Threatening Experiences Questionnaire (life events)154 ✗ ✗
SPQ120 ✗ ✗
Client Service Receipt Inventory (health costs)127 ✗ ✗
BIPQ123 ✗ ✗
PSYCHLOPS (patient defined problems)155 ✗ ✗
Rapid Estimate of Adult Literacy in Medicine (health literacy)156 ✗
PSYCHLOPS, Psychological Outcome Profiles Questionnaire.
Source: reproduced from Tylee et al.1 © 2011 Tylee et al.; licensee BioMed Central Ltd. This is an open access article
distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
TABLE 17 Rose items used for scoring the short version: specific wording and order of items given
Rose angina questionnaire item Response required for scoring
1. Do you ever have any pain or discomfort in your chest? (Rose question 1) Yes
2. When you walk at an ordinary pace on the level does this produce the pain? No (grade 1)/yes (grade 2)
3. When you walk uphill or hurry does this produce the pain? Yes
Scoring criteria for the short Rose angina questionnaire: grade 1 angina: chest pain+ pain uphill; grade 2 angina: chest
pain+ pain uphill+ pain on the level. (Experiencing chest pain when walking on the level is classed as more serious than
pain only when walking uphill.)
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extra information and all data were entered into the Access database before any analysis of cardiac
investigation data occurred. Numerous records per individual were condensed into variables that denoted:
(a) the first cardiac investigation to occur within two time points would be recorded per person; and
(b) the most severe cardiac investigation to occur within two time points would be recorded per person.
Thus, a cardiac outcome variable with seven hierarchical categories was created using a combination of the
short form of the Rose angina questionnaire, the GP medical notes and publicly available mortality records:
l no chest pain: score of 0 on the short Rose angina questionnaire
l chest pain: positive response to the Rose angina questionnaire item
l exertional chest pain: positive classification of grade 1 or grade 2 angina as defined by the short form
Rose angina questionnaire
l rapid access: any visit to the rapid access chest pain clinic, or any visit to A&E or emergency hospital
admittance where cardiac-related chest pain was the diagnosis
l bypass graft or angioplasty: intervention reported on GP medical notes or cardiologist/cardiology
service notes
l MI: occurring at any point during the follow-up period
l death: any cardiovascular-related cause of death included (i.e. cardiovascular and cerebrovascular).
For the purpose of the longitudinal analysis, the most severe outcome was assigned to the time point at
the end of the period where the outcome occurred. MIs and deaths had to be combined for some
analyses, when there were insufficient numbers to fit full models. When linking cardiac investigation and
mortality data with interview data at specific time points, deaths and cardiac investigations were coded
into time points at the end of the 6-month window between interviews. If a participant had a recorded
cardiac investigation within the 6 months before baseline, this was recorded in the baseline time point.
All cardiac investigation data as described, with dates of the investigations, were merged into the cohort
data set. The aim of this time assignment was to produce data where mental health status could be clearly
identified in its temporal relation to cardiac outcomes (the actual date of death was, however, used for a
more detailed and specific study of mortality).
Mortality data was gathered from a number of sources, including case notes and publicly available records.
The deaths of the cohort participants were tracked in the first instance via the practice manager
at the different GP surgeries, where we asked for date and cause of death. In those cases in which the
participant had moved away from the surgery, we contacted the primary care support services within
the specific boroughs. Further to this, we purchased death certificates through the health authorities
relating to the specific boroughs. Where consent had been withdrawn we recorded the fact of death if
known but not the reason. The censoring date was the date of death, the final interview date or the date
TABLE 18 Rose angina questionnaire items used for scoring the long version: specific wording and order of
items given
Rose angina questionnaire item Response required for scoring
4. When you get any pain or discomfort in your chest on walking,
what do you do?
Stop or slow down
5. Does the pain or discomfort in your chest go away if you stand still? Yes
6. How long does it take to go away? ≤ 10 minutes
7. Diagram
7.1 Diagram cross section Upper centre chest pain
7.2 Diagram cross section Middle centre chest pain
7.3 Diagram cross section Upper left chest pain and middle left chest pain
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when the interview would have taken place for those who were lost to follow-up. For the latter group,
deaths were monitored using public sources up to their censoring date. If the reason for loss to follow-up
was withdrawal of consent, the reasons for death were not sought unless available as part of the public
record. An intermediate censoring date was also created, based on the 36-month interview date.
Only deaths that occurred before that date were used when analysing the 36-month data.
A sample size of at least 800 participants was calculated to be adequate to allow modelling of associations
between physical and mental illness.1
Analyses
Descriptive statistics were used to summarise the cohort at baseline and logistic regression was used to
estimate associations between outcome and predictor variables.164
The incidence of depression was described from the raw data and separately by depression at baseline.
The incidence rates are minimum rates, as missing time points (non-response) were coded as
non-depression incident. Mechanisms of missingness were explored and the analyses were adjusted
for variables associated with missing time points (age, ethnicity and cancer). The analysis was conducted
under the assumption that data were missing at random.
Data were set up for a discrete-time survival analysis as per Singer and Willett.165 Discrete-time survival
analysis was chosen as the appropriate model to estimate the odds of an event and the time to an event
occurring. Discrete-time (as opposed to the more common continuous time) survival analysis was chosen to
reflect the sampling design of 6-monthly time intervals. For more information on discrete-time survival
analyses please refer to Singer and Willett.165
The baseline hazard was first modelled as unstructured, thereby allowing the odds of depression incidence
to vary freely among time points; however, we chose to adopt a growth curve modelling framework
for the odds of becoming depressed over time. This was estimated using Mplus version 7 (Muthén &
Muthén, Los Angeles, CA, USA) and in a latent variable framework using robust maximum likelihood.
For more information please see Muthén and Masyn.166 This approach allows for both time-invariant and
time-variant predictors to affect both the intercept and the change in odds with time (linear and quadratic
terms). The assumption of proportional odds was tested by including time-varying effects of predictors
and comparing nested models using the Satorra-Bentler scaled chi-squared difference test.167 Model
development started with an unconstrained ‘full’ model, with a number of variables included on a
theoretical basis and inspired by our baseline paper (see List of variables tested). Parameters were tested
using chi-squared difference testing and assessment of model fit statistics (Akaike information criterion
and Bayesian information criterion), and the model presented is our best fitting constrained model.
List of variables tested
Depression at baseline, history of depression, sex, age, employment status, relationship status, alcohol
intake, smoking status, EQ-5D items (problems with mobility/pain, self-care, usual activities,
pain/discomfort), SPQ items covering a range of social problems, diabetes, Rose angina questionnaire,
cardiac events during the cohort (including MI) and cardiac operations (bypass graft or angioplasty).
Standardised mortality ratios for those aged > 45 years were calculated in relation to the 2011 Office for
National Statistics figures for heart disease (International Classification of Diseases, 10th edition), by age
and sex.168 Time at risk was assigned to 10-year age bands with a ‘lexis’ expansion using the stsplit
command in Stata. Incident rates of mortality were analysed separately using Poisson regression modelling
which took into account the time at risk. Covariates were selected to be the same as those considered
in the primary analysis of cardiac outcome. An analysis was also performed using the outcome of
‘non-cardiovascular deaths’ with the same covariates to explore trends for other causes of death.
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Results
Recruitment and retention of the study population
Recruitment
Recruitment into the cohort study is shown in Figure 10. Sixteen general practices from south London
participated in the research programme, and from these practices 803 participants were recruited into the
cohort study from the practice-held CHD registers. The study population represented 27% of those eligible
to be included in the cohort study.164
Retention of study population
The average follow-up time for 803 participants (561 men and 242 women) from 16 practices was
2.64 years and the median was 2.94 years; 141 (17.9%) were lost to (complete) follow-up or declined to
be interviewed at some point during the 36-month follow-up period. A further 22 (2.8%) died of cardiac
causes, 22 (2.8%) from vascular disease and a further 28 (3.64%) died from other causes. Table 19 shows
the reasons for leaving the study prematurely.
Total population on CHD register
(n = 2938)
Invited by post to participate
(n = 2878)
Excluded by GP
(n = 60)
Contact established
(n = 917)
Recruited
(n = 803)
Baseline interview completed
(n = 803)
• Declined, n = 57
• Uncontactable, n = 22
• Dead, n = 1
• Ineligible, n = 34
• No response, n = 1847
Total excluded
(n = 1961)
Sampling frame
People on the CHD registers of 16 participating 
general practices (total practice population 142,648)
FIGURE 10 Recruitment profile of the UPBEAT-UK cohort study.
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Baseline characteristics of the study population
The baseline characteristics of the cohort population have been published in detail.164 Tables 20–22 show
the demographic, social and clinical characteristics of participants. Essentially, this was an older population
(average age 71 years), predominantly male (70%), with 87.3% classifying themselves as ‘white’. Black
and ethnic minorities made up 13% of participants. As would be expected, the majority were retired
(77%). The average length of time since a diagnosis of CHD was made in the GP records was 10 years,
and 44% reported ongoing chest pain. Social problems were common, with relationship problems being
the most common reported social problem (38%). Levels of disability were also high in this population,
with 53% reporting problems with pain or discomfort and 49% with mobility problems.
Table 23 shows that our cohort study population contains approximately equal proportions of those with a
completed MI and a current GP diagnosis of ischaemic heart disease with no history of MI. Similarly, equal
proportions have and have not received some kind of surgical intervention.
Cardiac status at baseline is shown in Table 24.
Using the short Rose angina questionnaire, just over one-quarter of the cohort report exertional pain,
which could indicate angina. Using the more stringent full Rose angina questionnaire criteria, 13.9% are
likely to have a clinical diagnosis of angina (grade 1 or 2).
TABLE 19 Reasons for leaving the study prematurely
Reasons n (%)a
Declined
Poor health 22 (2.79)
No longer interested 46 (5.84)
Other 27 (3.43)
Died
Cardiac 22 (2.79)
Stroke/vascular disease 22 (2.79)
Cancer 16 (2.03)
Other 8 (1.02)
Unobtainable 4 (0.51)
Lost to follow-up 46 (5.84)
Total 213 (27.04)
a N is 788 because of missing values.
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TABLE 20 Physical health status at baseline (N= 803)
Physical health status n (%)
Patient reports suffering chest pains 356 (44.3)
Primary diagnosis according to GP recordsa
Documented MI 336 (41.8)
Ischaemic heart disease 374 (46.6)
Angina 57 (7.1)
Heart failure 3 (0.4)
Chest pain not otherwise specified 10 (1.2)
Arrhythmias 6 (0.8)
Other vascular causes or no diagnosis given 14 (1.7)
Length of time since first recorded diagnosis of CHD and entry into study (years) 10.36 (8.0)b
Comorbidc
Diabetes mellitus 200 (24.9)
Osteoarthritis 134 (16.7)
COPD 91 (11.3)
Chronic renal disease 152 (18.9)
Asthma 65 (8.1)
Hypertension 445 (55.4)
Cancer 96 (12.0)
Total number of comorbid medical illnessesd
None 296 (36.9)
One 301 (37.5)
Two 145 (18.1)
More than two 61 (7.6)
BMI classificatione
Normal 180 (22.4)
Overweight 343 (42.7)
Obese 251 (31.3)
Missing data 28 (3.5)
BMI, body mass index.
a Classified hierarchically.
b Mean (SD).
c As recorded in GP medical records.
d Diabetes mellitus, osteoarthritis, COPD, chronic renal disease, asthma, cancer.
e Classified as BMI < 18.5 kg/m2= underweight; 18.5–24.99 kg/m2= normal; 25–29.99 kg/m2= overweight;
≥ 30 kg/m2= obese.
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TABLE 21 Sociodemographic characteristics of the cohort at baseline
Characteristics n (%)
Age (years) 71.1 (10.9)a
Sex
Male 561 (69.9)
Ethnicity
White 701 (87.3)
Black 33 (4.1)
Asian 47 (5.9)
Other 22 (2.7)
Employment status
Paid employment 148 (18.4)
Retired 617 (76.8)
Housewife/husband 2 (0.3)
Unemployed 30 (3.7)
Relationship status
Married/cohabiting 508 (63.2)
Spouse/partner deceased 150 (18.7)
Separated/divorced 65 (8.1)
Single 77 (9.59)
Usually live with
Spouse/partner 488 (60.8)
Children 33 (4.1)
Alone 236 (29.4)
Other 43 (5.4)
Usual residence
Owner occupier 526 (65.5)
Private rental 53 (6.0)
Housing association rental 174 (21.7)
Sheltered housing 18 (2.2)
Other 23 (2.9)
Index of Multiple Deprivation score 20.3 (14.0)a
a Mean (SD).
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TABLE 22 Social problems and disability at baseline
n (%)a
Social problemsb
Housing problems 43 (5.4)
Work problems 73 (9.0)
Financial problems 70 (8.7)
Social contact problems 106 (13.2)
Problems with relatives 89 (11.1)
Relationship problems 302 (37.6)
Living alone 29 (3.6)
Disabilityc
Mobility problems 391 (48.7)
Self-care problems 101 (12.6)
Problems with usual activities 237 (29.6)
Problems with pain/discomfort 425 (53.0)
Problems with depression or anxiety 196 (24.7)
Number of disability areasd
No disability areas 264 (33.2)
One to two disability areas 285 (35.9)
More than two disability areas 246 (30.9)
a N differs because of missing data.
b As reported on the SPQ.
c From the EQ-5D
d Disability areas from the EQ-5D.
TABLE 23 Cardiac status of the cohort at baseline
Cardiac status n (%)
Report of chest pain (Rose angina questionnaire question 1)
No 447 (55.7)
Yes 356 (44.3)
Primary GP coded CHD diagnosis
MI 339 (42.2)
IHD/angina 431 (53.7)
Other 33 (4.1)
Treatment (stent, angioplasty, CABG, pacemaker, ablation)
No 385 (47.9)
Yes 418 (52.1)
Number of years from first coded coronary event, median (IQR), range 8.5 (4.3–14.7), range: 0.1–46.2
CABG, coronary artery bypass graft; IHD, ischemic heart disease; IQR, interquartile range.
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Discussion
A total of 44% of the sample stated that they currently experience chest pain. If this pain reflected just
current angina pectoris, this figure would be very high, given that angina typically accounts for 4% of GP
consultations and, in community samples of older people in Scotland, rates of angina pectoris using the
Rose angina questionnaire are reported as 2.5% for men and 2.7% for women.169 A meta-analysis of
prevalence rates of angina in community samples in 31 countries showed a weighted mean of 5.7% for
men and 6.7% for women – the highest rates from any of the countries were 14.4% for men and 15.7%
for women.170 Rates of angina following infarction are reported at 19%171 and there should not be any in
the aftermath of successful revascularisation.
In fact, chest pain is commonly reported as a symptom in representative epidemiological studies, along
with other types of pain. In one study, 12% of participants reported chest pain, compared with 41%
reporting backache and 26% reporting headache.172 The most common explanatory physical diagnosis for
chest pain is oesophageal reflux.173,174 There has been one epidemiological study in Australia of those with
non-cardiac chest pain.175 The authors noted that (1) the most common accompanying symptom was
heartburn that suggests oesophageal disorder; (2) many did not seek help for it; and (3) quality of life was
reduced for those reporting it with.175,176 Non-specific chest pain is associated with an increased
mortality rate.177
It has long been recognised that many patients referred for investigation of chest pain have concurrent
anxiety and depression syndromes.173 Chest pain is indeed a recognised symptom for the diagnosis of a
panic attack.178 Case-level anxiety or depression has been stated to be a contraindication to expensive
cardiology investigation, as few patients are found to have coronary disease.179
Most of the work on the association of chest pain with psychiatric disorders has been carried out in
cardiology patients. Our study population is different in that we have recruited our patients from a primary
care-based register of CHD patients, some of whom are under the care of cardiologists. To our knowledge,
there are no previously published studies on this topic based on GP register patients.
We are mainly reporting on the group identified as ‘exertional pain’ from the short Rose angina questionnaire,
as there is adequate indication from published studies that this symptom is the most prognostically important
for future events as described above.163 The distribution of the data when classified by the short Rose angina
questionnaire data also allows greater power in our analyses, and there are fewer missing responses than
when using the long version. Multivariate analyses have been conducted to investigate baseline associations
of short Rose classification.
TABLE 24 Baseline classification of the cohort using short and long versions of the Rose angina questionnaire
Baseline classification n (%)
Short Rose angina questionnaire classification
No chest pain 447 (55.7)
Chest pain only 132 (16.4)
Exertional pain (grade 1 or 2) 214 (26.6)
Unclassifiable 10 (1.3)
Full (long) Rose angina questionnaire classification
No chest pain 447 (55.7)
Chest pain only 171 (21.3)
Grade 1 angina 64 (8.0)
Grade 2 angina (requires pain on the level) 47 (5.9)
Unclassifiable 74 (9.2)
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Exertional pain versus non-exertional pain (risk factors)
The next analysis (Table 25) simultaneously compares those with chest pain with those with non-specific
pain, and with those with exertional chest pain. Each paired analysis takes into account the third group.
The variables entered were those baseline variables describing cohort members set out in the paper on
baseline analyses.164 They concern sociodemographic status, cardiac variables, self-reported cardiac risk
factors, physical disease comorbidity and social problems.
Variables were included in the model if they provided information to an alpha threshold of p< 0.2. Variables
in the model were age, sex, ethnicity, Index of Multiple Deprivation (IMD) score, smoking status, comorbidity
of COPD, depression (positive on the HADS-D scale), anxiety (positive on the HADS-A scale), total number of
SPQ social problems and ‘How much bodily pain’ (i.e. non-specific pain) in the past 4 weeks? (Question 21
on the Short Form Questionnaire 36-items quality-of-life scale.) Only those variables contributing with a
significance threshold of p< 0.05 are reported above.
For continuous variables (age, IMD score and total SPQ social problems): with every one unit increase in
IMD deprivation, the RR of being in the chest pain group compared with the no chest pain group increases
by 3% (RR 1.03; p> 1).
TABLE 25 Multinomial logistic regression of the Rose classification (short Rose angina questionnaire classification)
on sociodemographic and clinical predictors (n= 626). Reference group 1: no chest pain
Sociodemographic and clinical predictors Group 2: chest pain only Group 3: exertional pain
Variable (adjusted risk ratio)
IMD score 1.04*
Depression
No Reference Reference
Yes 3.29* 2.32*
Anxiety
No Reference Reference
Yes 2.96* 2.26*
How much bodily pain? 1.18 1.27*
Comorbidity: COPD
No Reference
Yes 1.86
Primary GP coded CHD diagnosis
MI Reference
IHD/angina 2.34*
Other 0.74
Total SPQ social problems 1.36*
*, p= 0.05.
IHD, ischemic heart disease; IMD, Index of Multiple Deprivation.
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For the categorical variables (sex, ethnicity, depression, COPD and primary GP coded CHD diagnosis): for
those classified by the HADS as having depression compared with those without HADS depression, the RR
of being in the chest pain group was 2.87, and being in the exertional pain group was 2.92, both
compared with the no chest pain group.
The analysis in Table 25 was repeated using the full (long) Rose angina questionnaire classification
variables: no pain (n= 447), pain in chest (n= 171), grade 1 and grade 2 angina (n= 111). The results,
which are not reported here, were very similar.
Discussion
Notable in the results of this analysis is the absence of any of the cardiac variables or cardiac risk factors
that we recorded as associations of chest pain (whether or not the chest pain was exertional) – in
particular whether or not there is a history of a revascularisation procedure. The association with GP
diagnosis of ischemic heart disease and exertional pain is compatible with the validation criteria of the
Rose angina questionnaire. The association with COPD has clinical face validity – sufferers may experience
discomfort when they exert themselves.
Depression, anxiety and social factors are the evident associations. The most potent association is the
number of social problems rather than any individual social problem. For every additional social problem
reported, the risk of exertional pain increases by 36%. Depression and anxiety are both associated with
complaints of non-specific and exertional pain – the RR being higher for the exertional pain. Experience of
panic and bodily pain remain independently associated with chest pain. Increasing report of bodily pain is
associated with increased risk of being in both of the two chest pain categories.
The data from this cohort strongly suggest a psychosocial context for the complaint of chest pain whether
or not it is anginal in type. As this is a cross-sectional analysis, direction of causality cannot be assumed.
It is possible that having chest pain limits life to the extent that multiple social problems result, for example
less social contact.
Chest pain and quality of life
Baseline analysis
The literature suggests that quality of life is impaired many years after MI for those with persisting
symptoms,180 the effect being more marked in younger than older people. The same is reported for those
with non-cardiac chest pain.175 The EQ-5D is used in these analyses as a measure of health-related quality
of life, a score can be obtained by summing the response to the five questions asked or from the
accompanying visual analogue, in which the respondent makes a judgement of their quality of life now.
We have chosen the latter, as one of the five questions asks about anxiety and depression and we wish to
examine quality of life separately from mental state so far as is possible.
Examination of associations of baseline European Quality of Life-5
Dimensions visual analogue scale
Quality of life was thus recorded using the EQ-5D questionnaire visual analogue scale (EQ-5D-VAS). To
examine the factors associated with quality of life, we used a multiple linear regression model and selected
variables from a large pool of sociodemographic and clinical factors. Variables were selected using a
stepwise selection procedure that retained all predictors if evidence for their association with the visual
analogue scale was lower than p= 0.2.
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The outcome, as well as all predictors used in this analysis, was collected by self-report questionnaire and
at the same time point (baseline), and so this analysis can be seen as an examination into the factors
associated with quality of life and, on an exploratory basis, an examination into the potential predictors of
quality of life in our cohort. Owing to the positively skewed distribution of the EQ-5D-VAS, non-parametric
bootstrapping using 200 replications was used in the analyses.
The results of this analysis are shown in Table 26–28.
The data in Table 27 show high correlation between anxiety and depression scores, and between EQ-5D
scores and both. In the latter, high depression anxiety scores (bad) correlate inversely with high EQ-5D sores
(good). Table 28 shows analyses that explore, at baseline, what factors influence the EQ-5D-VAS score in
this cohort.
TABLE 27 Relationship between anxiety, depression and EQ-5D
EQ-5D (summary score) EQ-5D-VAS HADS-D HADS-A
EQ-5D (summary score) 1 – – –
EQ-5D-VAS 0.4801 1 – –
HADS-D –0.5021 –0.4694 1 –
HADS-A –0.4472 –0.3715 0.6504 1
Pearson correlation coefficients with p-values (all 0.000).
TABLE 26 Description of EQ-5D-VAS at baseline
Statistic Score (0–100)
Observations 797
Mean (SD) 69.26 (18.76)
Median (IQR) 70 (55–80)
Range 4–100
IQR, interquartile range.
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Summary of results
The following variables associated with baseline quality of life:
l Ethnicity: white ethnic group had a 4.74 unit higher score (p= 0.024). This is a small standardised
effect size (0.1).
l Current smokers: current smokers scored, on average, lower by 5.19 units (p= 0.022).
l Exertional chest pain: those with exertional chest pain had a lower quality-of-life score by 3.90 units
(p= 0.020), a small effect size (0.09).
l Bodily pain: those reporting bodily pain (an item taken from the SF-12) had, on average, a 3.85-point
lower score on the EQ-5D-VAS (p< 0.001). This was a moderate effect size (0.28).
TABLE 28 Multiple linear regression examining sociodemographic and clinical variables as predictors of EQ-5D-VAS
Sociodemographic and clinical variables Coefficient SE 95% CI (bias corrected) p-value Beta
Ethnicity (other vs. white) –4.74* 2.10 –8.97 to –0.85 0.024 –0.09
BMI class
Underweight/normal – – – – –
Overweight 1.19 1.61 –2.04 to 4.33 0.462 0.03
Obese –3.04 1.81 –6.70 to 0.23 0.093 –0.08
Smoking status
Never – – – – –
Ex-smoker –2.47 1.45 –5.25 to 0.67 0.088 –0.06
Current smoker –5.19* 2.27 –9.36 to –0.96 0.022 –0.09
Rose angina questionnaire score
No chest pain – – – – –
Chest pain only 0.031 1.72 –3.09 to 3.39 0.986 0.001
Angina (grade 1 and 2) –3.90* 1.67 –7.30 to –0.65 0.020 –0.09
How much bodily pain?a –3.85** 0.47 –4.83 to –3.02 0.000 –0.29
Received any past treatment for heart (including
stent, angioplasty, CABG, pacemaker or ablation)?
–2.75* 1.19 –5.23 to –0.58 0.021 –0.07
Physical comorbidities
Chronic kidney disease –2.18 1.61 –5.53 to 0.91 0.176 –0.05
Cancer –5.63* 2.26 –9.87 to –0.74 0.013 –0.10
Psychological
HADS-D (positive) –9.71** 2.36 –13.55 to –4.72 0.000 –0.17
HADS-A (positive) –4.80** 1.63 –7.76 to –1.30 0.003 –0.11
*p< 0.05; **p< 0.01.
BMI, body mass index; CABG, coronary artery bypass graft; SE, standard error.
a Item taken from the SF-12.
Notes
Observations: n= 679.
Adjusted r2= 0.255.
Predictors selected using a stepwise selection procedure and retaining all predictors p< 0.2. Bootstrapping was used to
compute standard errors and CIs owing to the skewed distribution of EQ-5D-VAS. Both bootstrap standard errors and
bias-corrected CIs are reported.
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l Treatment for heart problem: people who had received a treatment for their heart problem in the past
had a lower quality-of-life score by –2.75 units (p= 0.021). This was a small effect size (0.07).
l Cancer: cancer was associated with lower quality of life by 5.63 points (p= 0.013). This was a small
effect size (0.1).
l Depression: HADS-D (scoring ≥ 8 on the HADS-D scale) was associated with a 9.71-unit lower quality
of life (p< 0.001). This was a small effect (0.17).
l Anxiety: HADS-A (score of ≥ 8) was also associated with a lower score on the EQ-5D-VAS scale by
4.8 units (p= 0.003). This was a small effect (0.11).
Depression, anxiety and chest pain all impair quality of life at baseline.
Prevalence, incidence and course of depression
Prevalence of depression
The prevalence of depressive and anxiety disorders and the risk factors associated with a depressive
disorder at baseline have been presented in detail elsewhere31 and will be summarised here. The
prevalence of depressive and anxiety disorders in this population at baseline is shown in Table 29.
The proportion of the population who had depression recorded as an active problem in GP records at
recruitment into the cohort was 7%, whereas 4.6% of the population had an International Classification
of Diseases, 10th edition, diagnosis of a depressive disorder (mild, moderate or severe) as defined by the
Clinical Interview Schedule – Revised (CIS-R). According to the HADS-D scale, 12.8% of the population
suffered from a depressive disorder at baseline (i.e. scored > 7 on the depression subscale).
TABLE 29 Mental health status at baseline (N= 803)
Mental health status n (%)
GP diagnosis of depression 56 (7.0)
GP diagnosis of anxiety 95 (11.8)
Depression and anxiety by CIS-R
No disorder 654 (81.4)
Severe depressive episode 17 (2.1)
Moderate depressive episode 14 (1.7)
Mild depressive episode 23 (2.9)
Panic disorder 4 (0.5)
Generalised anxiety disorder 25 (3.1)
Mixed anxiety and depression 66 (8.2)
HADS scores
Mean depression score (SD) 3.34 (3.5)
Depression score of ≥ 8 103 (12.8)
Mean anxiety score (SD) 4.97 (4.5)
Anxiety score of ≥ 8 199 (24.8)
CIS-R, Clinical Interview Schedule – Revised.
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The statistically significant associations between predictor variables and CIS-R-defined depression at
baseline fell into three domains: living alone, disability and pain, and age (problems with living alone:
adjusted OR for a CIS-R diagnosis of mild, moderate or severe depressive episode 5.49, 95% CI 2.11 to
13.40; p< 0.001; experiencing chest pain: adjusted OR for a CIS-R diagnosis of mild, moderate or severe
depressive episode 3.27, 95% CI 1.58 to 6.76; p= 0.001; being disabled by pain or discomfort: adjusted
OR for a CIS-R diagnosis of mild, moderate or severe depressive episode 3.39, 95% CI 1.42 to 8.10;
p< 0.006; having problems carrying out usual activities: adjusted OR for a CIS-R diagnosis of mild,
moderate or severe depressive episode 3.71, 95% CI 1.93 to 7.14; p< 0.001; and age: adjusted OR per
year for a CIS-R diagnosis of mild, moderate or severe depressive episode 0.95, 95% CI 0.92 to 0.98;
p< 0.001) (see Walters et al.164). Chest pain was significantly associated with depression independently
of other pains and discomfort.
Participants had an increased odds of having a GP-recorded diagnosis of depression if they reported
problems with close relationships (adjusted OR for a GP diagnosis of depression 2.51, 95% CI 1.40 to
4.52; p= 0.002), reported having diabetes mellitus (adjusted OR for a GP diagnosis of depression 2.01,
95% CI 1.11 to 3.63; p= 0.02), were disabled by pain and discomfort (adjusted OR for a GP diagnosis of
depression 1.95, 95% CI 1.04 to 3.68, p= 0.037), or were female (adjusted OR for a GP diagnosis of
depression 1.88, 95% CI 1.04 to 3.37; p= 0.035) (see Walters et al.164).
Incidence of depression and risk factors for incident depression
The incidence risk of developing a depressive disorder (as defined by scoring ≥ 8 on the HADS-D subscale)
is shown in Table 30. The proportion of new cases of depression was similar at each time point for those
TABLE 30 Risk of a new depressive disorder during each 6-month time point
Time point (months)
Not depresseda up to time point,
n (%)
New cases of depression during time point,
n (%)
Not depressed at baseline
0 696 (100) –
6 620 (94) 42 (6)
12 569 (95) 33 (5)
18 510 (95) 29 (5)
24 477 (97) 17 (3)
30 434 (96) 18 (4)
36 383 (94) 25 (6)
Total 164
Depressed at baseline
0 103 (100) –
6 45 (47) 50 (53)
12 31 (70) 13 (30)
18 25 (86) 4 (14)
24 17 (81) 4 (19)
30 10 (71) 4 (29)
36 9 (90) 1 (10)
Total 76
a As defined by a HADS-D subscale score of ≥ 8.
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who were not depressed at baseline. However, the proportion of incident cases of depression decreased
across time points for those who were depressed at baseline. The cohort followed participants for a total
1942.3 years at risk. During this period there were 240 incident cases of depression giving an incident rate
ratio of 123.6 per 1000 person-years at risk.
The risk factors associated with the incidence of depression are shown in Table 31. The strongest predictor
of incident depression was having had a documented MI at some point before the incident depression.
Other predictors of incident depression were: suffering with depression at baseline or having a past history
of depression, self-reported exertional chest pain, problems with disability and living alone.
[Exertional pain was initially considered as a possible type 3 variable. However, in the final model it was
better treated as a time-invariant (baseline only) predictor because of uncertainties in the longitudinal data
recording. It was not always possible to establish the time sequence of the incidence of pain and
depression and there were a large number of missing values, which greatly reduced the sample size.]
The course of depression in cohort participants is described in Table 32.
TABLE 31 Discrete-time survival model for predictors of incident depression (as defined by a HADS-D subscale score
of ≥ 8)
Predictors OR
Logit-hazard
function SE Estimate/SE p-value
Time-invariant predictors with a time invariant effect a
Depression at baseline vs. no depression at baseline 5.39 1.69 0.20 8.57 0.000
History of depression vs. no history of depression 1.91 0.65 0.16 4.06 0.000
Exertional pain vs. no chest pain 3.38 1.21 0.29 4.20 0.000
Problems with mobility/pain vs. no problems with mobility 1.73 0.55 0.19 2.87 0.004
Problems with usual activities vs. no problems with usual
activities
2.14 0.759 0.185 4.09 0.000
Work problems vs. no work problems 3.10 1.13 0.387 2.92 0.004
Problems with living alone vs. no problems living alone 1.79 0.58 0.28 2.05 0.040
Age (centred at 70 years) per year 0.99 –0.001 0.007 –0.16 0.872
Ethnicity (non-white vs. white) 1.27 0.24 0.22 1.11 0.266
Comorbid cancer vs. no comorbid cancer 0.80 –0.22 0.25 –0.86 0.390
Time-invariant predictors with a time varying effect b
Exertional pain vs. no chest pain (effect with time) 0.69 –0.37 0.16 –2.29 0.022
Work problems vs. no work problems (effect with time) 0.75 –0.28 0.10 –2.97 0.003
Time-varying predictors with a time invariant effect c
History of MI preceding depression 11.24 2.42 0.88 2.76 0.006
SE, standard error.
a Time-invariant predictors with a time invariant effect denote predictors that had a constant effect on the incidence of
depression (i.e. proportional).
b Time-invariant predictors with a time varying effect denote variables that had an initial effect of changing the odds of
becoming depression incident but this effect was not proportional and changes with time.
c Time-varying predictors with a time invariant effect denote predictors that change with time (i.e. a person may not
experience a MI until 30 months). The effect of the predictor is said to be time invariant, as whenever the variable
changes (e.g. 6 months or 30 months), it will have the same effect.
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Of the 12.9% of participants depressed at baseline, 42.7% remained depressed throughout the 36-month
follow-up period. Only 35% were not depressed at final follow-up. Of those not depressed at baseline,
23.6% developed depression at some point over the follow-up period.
The incidence and effect of depression and anxiety on cardiac outcomes
and mortality
The incidence of cardiac outcomes is reported in two ways – first, the incidence of cardiac events over the
follow-up period (and the effect of depression and anxiety) and, second, the continuing reporting of chest
pain over that same period.
Table 33 shows the incidence of cardiac events over the 36-month follow-up. There were 44 total deaths
that had a cardiovascular cause. Sixteen patients in the cohort had a MI during the follow-up period.
Table 34 shows the percentage of cardiac outcomes that were related to depression and anxiety. Although
our initial analysis was done with depression, we found that for every cardiac outcome anxiety was more
strongly related, especially in MI and cardiovascular death.
Table 35 shows the predictors of cardiac outcome with ‘no chest pain’ as comparator.
TABLE 32 Patterns of depression from baseline to 36 months
Patterns of depression
No missing values,
n (%)
Missing values during
follow-up, n (%)
Missing at
follow-up, n (%) Total, n (%)
Depression at baseline 54 (10.8) 9 (13.0) 40 (17.4) 103 (12.9)
Always depressed 18 (33.3) 5 (55.6) 21 (52.5) 44 (42.7)
No depression at final follow-up 19 (35.2) 3 (33.3) 14 (35.0) 36 (35)
Improved then depressed at
final follow-up
17 (31.5) 1 (11.1) 5 (12.5) 23 (22.3)
No depression at baseline 446 (80.2) 60 (87.0) 190 (82.6) 696 (87.1)
No depression at any point 338 (75.8) 45 (75.0) 149 (78.4) 532 (76.4)
Developed depression at final
follow-up
51 (11.4) 9 (15.0) 24 (12.6) 84 (12.1)
Developed depression, not at
final follow-up
57 (12.8) 6 (10.0) 17 (8.9) 80 (11.5)
Total 500 (62.6) 69 (8.6) 230 (28.8) 799
TABLE 33 Incidence of cardiac interventions, MI and cardiovascular deaths up to 36-month follow-up
Time point (months) Bypass graft or angioplasty, n (%) MI, n (%) Cardiovascular death, n (%) Any
Baseline 12 (63.2) 7 (36.8) 0 (0.0) 19
6 11 (73.3) 0 (0.0) 4 (26.7) 15
12 11 (52.4) 4 (19.0) 6 (28.6) 21
18 8 (36.4) 3 (13.6) 11 (50.0) 22
24 15 (53.6) 1 (3.6) 12 (42.9) 28
30 10 (76.9) 0 (0.0) 3 (23.1) 13
36 10 (52.6) 1 (5.3) 8 (42.1) 19
Total 77 (56.2) 16 (11.7) 44 (32.1) 137
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TABLE 34 Percentage of cardiac outcomes in which there was a prevalence of depression or anxiety at previous
follow-up
Cardiac outcome Depression (%) Anxiety (%)
No chest pain 7.2 15.5
Chest pain 17.8 34.4
Exertional pain 23.1 41.2
Rapid access 18.3 26.3
Bypass graft/angioplasty 18.4 24.7
MI 6.3 25.0
CV death 6.8 29.5
CV, cardiovascular.
TABLE 35 Full model for predictors of cardiac outcome (relative risk ratio compared with no chest pain)
Outcome Relative risk ratio 95% CI p-value
Chest pain (Rose angina questionnaire category 1 at follow-up)
Time point (year) 0.952 0.896 to 1.012 0.115
Age in years 0.988 0.970 to 1.006 0.193
Sex (female vs. male) 1.763 1.252 to 2.484 0.001
Ethnic group (non-white vs. white) 1.053 0.653 to 1.700 0.831
Rose category 1 vs. no chest pain 2.131 1.407 to 3.228 < 0.001
Rose category 2 vs. no chest pain 3.059 1.802 to 5.192 < 0.001
Baseline depression (score of ≥ 8 on HADS-D) 1.353 0.762 to 2.400 0.302
Baseline anxiety (score of ≥ 8 on HADS-A) 1.938 1.285 to 2.922 0.002
Exertional chest pain (Rose category 2 at follow-up)
Time point (year) 0.993 0.945 to 1.043 0.785
Age in years 0.986 0.972 to 0.999 0.044
Sex (female vs. male) 1.418 1.025 to 1.961 0.035
Ethnic group (non-white vs. white) 1.116 0.729 to 1.709 0.614
Rose category 1 vs. no chest pain 8.797 6.153 to 12.579 < 0.001
Rose category 2 vs. no chest pain 12.610 7.987 to 19.871 < 0.001
Baseline depression (score of ≥ 8 on HADS-D) 1.627 0.992 to 2.668 0.614
Baseline anxiety depression (score of ≥ 8 on HADS-A) 1.807 1.214 to 2.690 0.004
Attendance at a rapid access clinic at follow-up with a cardiac cause
Age in years 0.988 0.965 to 1.012 0.332
Sex (female vs. male) 0.887 0.524 to 1.501 0.655
Ethnic group (non-white vs. white) 1.455 0.965 to 1.012 0.332
Rose category 1 vs. no chest pain 4.439 2.538 to 7.762 < 0.001
Rose category 2 vs. no chest pain 4.003 1.838 to 8.720 < 0.001
Baseline depression (score of ≥ 8 on HADS-D) 1.749 0.837 to 3.656 0.137
Baseline anxiety (score of ≥ 8 on HADS-A) 1.155 0.634 to 2.101 0.638
continued
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Discussion
In terms of predictors of cardiac outcome status, chest pain and exertional chest pain were not associated
with baseline depression status but were statistically significantly associated with baseline anxiety. There
were no associations between attendance at a rapid access cardiac clinic for a cardiac reason and either
baseline depression or anxiety.
There was no evidence of an association between baseline depression and having a MI or dying from a
cardiac cause, but there was a statistically significant association with baseline anxiety and having a MI or
dying from a cardiac cause. Rose angina questionnaire categories for chest pain at baseline were
significantly and strongly associated with subsequent chest pain and exertional chest pain, especially the
latter, and in the direction that would be expected, that is, both were associated with all cardiac outcome
status compared with no chest pain with exertional chest pain having a stronger association with cardiac
status (apart from attendance at a rapid access cardiac clinic) than chest pain. Women have an increased
risk of chest pain and exertional pain (but no evidence for higher risk of other cardiac outcomes). Age was
a significant predictor only of MI/death. The effect of adding covariates to an unadjusted mode, leading to
the full model reported above, is shown in Table 36.
Sensitivity analyses
General practitioner practice was also included in the model as a sensitivity analysis as the practices were
situated in areas with different sociodemographic characteristics and also had varying levels of loss to
follow-up. The results did not differ significantly from the original model, apart from the exertional chest
pain outcome, in which depression and anxiety had similar relative risk ratios (RRRs), both of which were
significant (depression: RRR 1.702, 95% CI 1.025 to 2.827; p= 0.040; anxiety: RRR 1.573, 95% CI 1.027
to 2.411; p= 0.037).
TABLE 35 Full model for predictors of cardiac outcome (relative risk ratio compared with no chest pain) (continued)
Outcome Relative risk ratio 95% CI p-value
Cardiac intervention at follow-up (angioplasty, bypass grafting)
Age in years 0.968 0.949 to 0.988 0.002
Sex (female vs. male) 0.794 0.431 to 1.461 0.458
Ethnic group (non white vs. white) 1.743 0.935 to 3.248 0.080
Rose category 1 vs. no chest pain 6.076 3.369 to 10.956 < 0.001
Rose category 2 vs. no chest pain 7.512 3.736 to 15.104 < 0.001
Baseline depression (score of ≥ 8 on HADS-D) 1.910 0.858 to 4.249 0.113
Baseline anxiety depression (score of ≥ 8 on HADS-A) 0.708 0.348 to 1.439 0.340
MI/death at follow-up
Age in years 1.089 1.037 to 1.143 0.001
Sex (female vs. male) 0.653 0.348 to 1.224 0.184
Ethnic group (non-white vs. white) 0.808 0.248 to 2.636 0.724
Rose category 1 vs. no chest pain 2.150 0.916 to 5.049 0.079
Rose category 2 vs. no chest pain 3.724 1.539 to 9.010 0.004
Baseline depression (score of ≥ 8 on HADS-D) 0.587 0.198 to 1.739 0.336
Baseline anxiety depression (score of ≥ 8 on HADS-A) 3.930 1.954 to 7.904 < 0.001
763 participants, average 5.13 follow-up points per participant.
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The baseline number of comorbid medical illnesses and social problems as measured by the SPQ was
added to the model. Depression was now no longer significant for chest pain (RRR 1.177, 95% CI 0.650
to 2.130; p= 0.591), although anxiety remained significant (RRR 1.730, 95% CI 1.132 to 2.643;
p= 0.011). Total number of social problems was also related to chest pain (p= 0.001), but not the number
of comorbidities. In terms of exertional chest pain, in this model, depression was no longer statistically
significant (RRR 1.424, 95% CI 0.560 to 2.373; p= 0.174) although, again, anxiety remained statistically
significant (RRR 1.600, 95% CI 1.059 to 2.413; p= 0.026). There was no change in associations for rapid
access chest clinic or for cardiac interventions (neither significant), but social problems were significant for
chest pain and exertional chest pain (p= 0.001 for both) and for cardiac interventions (p= 0.005), but not
for other outcomes.
Two alternative definitions of depression were analysed:
1. Depression in the 6 months before the index cardiac event. The results of this analysis were similar to
the main model, except that both depression and anxiety were statistically significantly associated with
exertional chest pain (depression: RRR 1.85, 95% CI 1.291 to 2.663; p= 0.001; anxiety: RRR 1.867,
95% CI 1.349 to 2.585; p< 0.001). For other outcomes, the model could not be fitted owing to small
sample sizes.
2. Cumulative burden of depression using the sum of follow-up periods, occurring before the index
cardiac outcome, in which the patient had been depressed. Chest pain and exertional chest pain were
both associated with depression and anxiety (depression: RRR 1.217, 95% CI 1.000 to 1.482; p= 0.05;
anxiety: RRR 1.239, 95% CI 1.041 to 1.474; p= 0.016). However, other outcomes were similar to the
main model except that cumulative anxiety was associated with attendance at a rapid access chest clinic
(RRR 1.350, 95% CI 1.059 to 1.722; p= 0.015).
Redefining the cardiac outcome with rapid access chest clinic combined with any other interventions did
not show any association with baseline depression or anxiety.
Mortality
There were 72 deaths altogether, of which 22 were from cardiac disease, 22 from vascular disease,
16 from cancer and eight were attributable to other causes; in four cases, the cause of death was not
ascertainable. Of the 22 cardiac deaths, 14 were of men (2.5% of 561) and eight of women (3.3%
of 242). Incidence rates of cardiac death were 12.7 per 1000 person-years for men and 9.3 per
1000 person-years for women. Standardised mortality ratios compared with the general population were
1.13 (95% CI 0.62 to 1.90) and 1.87 (95% CI 0.81 to 3.70), for men and women, respectively.
Table 37 shows a Poisson regression model for the rates of cardiovascular deaths. Only risk ratios for
increasing age and a higher baseline anxiety were significant at p= 0.05. A sensitivity analysis using the
CIS-R definition of depression and anxiety was similar, except that the risk ratio for depression was
TABLE 36 Effect of adjusting for confounders on association between depression and cardiac outcomes
(relative risk ratios compared with no chest pain)
Model
Chest
pain
Exertional
chest pain
Rapid
access Intervention MI/death
(a) Unadjusted 2.557** 3.729** 2.932** 2.907** 1.030
(b) Adjusted for age, sex, ethnic group 2.357** 3.363** 2.688** 2.430** 1.378
(c) As (b) + Rose category at baseline 1.951* 2.231** 1.892* 1.592 1.177
(d) As (c) + anxiety at baseline 1.353 1.627* 1.449 1.910 0.587
*, p= 0.1; **, p= 0.05.
MI/death were combined, as there were too few instances for separate analysis.
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increased to 1.260 (95% CI 0.274 to 5.796; p= 0.766) and that for anxiety decreased (risk ratio 2.001,
95% CI 0.694 to 5.774, p= 0.199) and was no longer significant.
Table 38 shows a Poisson regression model for the rates of non-cardiovascular deaths. Only RRs for
increasing age, male sex and higher baseline total comorbidities were significant at p= 0.05.
The types and course of chest pain, and predictors of chest pain
as an outcome
The effect of depression on continuing chest pain
This next series of analyses use data from the five-wave follow-up. We report on the frequency of cardiac
events, the persistence of chest pain reported by respondents and the predictive power of depression and
other psychosocial factors.
Chest pain type and frequency of report
As shown in Table 39, the amount of chest pain is reported, ranging from 0 to 100%, of the occasions
when patients were interviewed using the Rose angina questionnaire. These proportions became the
outcome variable to contrast with baseline predictors between those with no chest pain and those with
non-exertional pain only.
TABLE 37 Baseline associations with cardiovascular mortality
Adjusted RR 95% CI p-value
Female 0.726 0.357 to 1.473 0.374
Age (years) 1.119 1.076 to 1.164 0.000
Rose category
1: chest pain only 0.768 0.292 to 2.017 0.592
2: angina 1.089 0.402 to 2.957 0.866
BMI class
2: overweight 1.119 0.544 to 2.303 0.760
3: obese 0.959 0.375 to 2.457 0.931
Smoking status
1: ex-smoker 1.123 0.556 to 2.271 0.746
2: current smoker 1.299 0.379 to 4.459 0.677
Units alcohol
1: 0 units 0.881 0.430 to 1.80 0.730
2: 1–10 units 1.012 0.379 to 2.701 0.982
3: 11+ units 0.856 0.236 to 3.109 0.813
SPQ total 1.149 0.847 to 1.559 0.371
Total comorbidities 1.027 0.776 to 1.360 0.852
Baseline depression 0.313 0.069 to 1.431 0.134
Baseline anxiety 2.482 1.125 to 5.48 0.024
BMI, body mass index.
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TABLE 38 Baseline associations with non-cardiovascular mortality
Adjusted RR 95% CI p-value
Female 0.227 0.065 to 0.796 0.021
Age (years) 1.059 1.009 to 1.110 0.020
Rose category
1: chest pain only 1.916 0.750 to 4.893 0.174
2: angina –a
BMI class
1: normal 0.632 0.242 to 1.648 0.805
2: overweight 0.549 0.169 to 1.789 0.320
Smoking status
1: ex-smoker 0.894 0.367 to 2.176 0.805
2: current smoker 0.392 0.042 to 3.055 0.348
Units alcohol
1: 0 units 0.518 0.398 to 1.250 0.143
2: 1–10 units 0.191 0.024 to 1.533 0.119
3: 11+ units 1.099 0.322 to 3.749 0.879
SPQ total 0.952 0.598 to 1.514 0.834
Total comorbidities 1.391 1.015 to 1.907 0.040
Baseline depression 1.122 0.212 to 5.928 0.892
Baseline anxiety 0.415 0.076 to 2.255 0.309
BMI, body mass index.
a Unable to compute owing to limited data.
TABLE 39 Frequency of chest pain (both exertional and non-exertional) reported across the follow-up period
Full sample (N= 803), n (%)
No chest pain 345 (45)
Non-exertional pain only 103 (14)
1–25% 90 (12)
26–50% 98 (13)
51–75% 43 (6)
76–100% 82 (11)
Total 761 (91)
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In contrast to Table 39, which takes into account the whole cohort, subsequent analyses report on those
who remained under follow-up who did not experience any of the events mentioned above. In addition,
only those who had, at most, two missing chest pain responses out of the five possible over the follow-up
period were included. Those with more than two missing responses were excluded. (Sensitivity analysis was
carried out restricting it to one or fewer missing responses, and no differences were found, thus we
selected this analysis, which includes a larger portion of the sample.) These two exclusions reduced the
sample for analysis to n= 568. Baseline depression and anxiety scores were examined separately, and then
quality of life, as measured by the EQ-5D-VAS, was entered into the analysis.
Predictors of non-exertional pain
Females and those with asthma comorbidity were most at risk of reporting non-exertional chest pain
(Tables 40 and 41). Shorter amount of time on the GP CHD register is also predictive. Anxiety and
depression, counterintuitively, do not have an effect. The addition of the quality-of-life measure does
produce a significant finding, with a lower score being predictive of more pain report.
Exertional pain
The situation with exertional pain is quite different (Tables 42 and 43). Exertional pain reported at baseline
had a massive effect in predicting subsequent reports of chest pain, as did, to a lesser extent,
non-exertional pain. Depression and anxiety each had an additional effect on baseline pain. The length of
time on the register was predictive, but in the opposite direction to non-exertional pain, meaning the
longer time spent on the register, the more likely they were to report exertional pain. Older age was a
weak risk factor. Addition of the quality-of-life measure eliminated the effect of depression, and weakened
that of anxiety.
TABLE 40 Effect of anxiety alone on non-exertional chest pain and with inclusion of EQ-5D-VAS in patients with
two or fewer missing time points
Non-exertional chest pain (SD)
Non-exertional chest pain with
inclusion of EQ-5D-VAS (SD)
Chest pain only 7.19** (2.62) 7.34** (2.71)
Sex (female) 2.74** (7.26) 2.80** (7.14)
Asthma 3.34* (1.87) 3.34* (1.88)
Number of years since first coded coronary event 0.95* (0.02) 0.95* (0.02)
HADS-A 1.81 (0.79) 1.33 (0.62)
Age 0.98 (0.02) 0.98 (0.02)
Ethnicity (other vs. white) 1.56 (0.78) 1.49 (0.75)
Cancer 1.79 (0.82) 1.87 (0.88)
EQ-5D-VAS 0.98* (0.01)
*p< 0.05; **p< 0.01.
COHORT STUDY (WORK PACKAGE 3)
NIHR Journals Library www.journalslibrary.nihr.ac.uk
98
TABLE 41 Effect of depression alone on non-exertional chest pain and with inclusion of EQ-5D-VAS in patients
with two or fewer missing time points
Non-exertional chest pain (SD)
Non-exertional chest pain with
inclusion of EQ-5D-VAS (SD)
Chest pain only 7.08** (2.57) 7.45** (2.75)
Sex (female) 2.83** (0.96) 2.67** (0.93)
Asthma 3.41* (1.88) 3.37* (1.88)
Number of years since first coded coronary event 0.96* (0.02) 0.95* (0.02)
HADS-D 1.31 (0.93) 0.77 (0.59)
Age 0.98 (0.02) 0.98 (0.02)
Ethnicity (other vs. white) 1.54 (0.77) 1.47 (0.74)
Cancer 1.84 (0.83) 1.92 (0.89)
EQ-5D-VAS 0.97** (0.01)
*p< 0.05; **p< 0.01.
TABLE 42 Effect of anxiety alone and with inclusion of EQ-5D-VAS, patients with two or fewer missing time points
Anxiety alone (SD)
Anxiety with inclusion of
EQ-5D-VAS (SD)
Chest pain only 4.82** (1.15) 4.64** (1.12)
Exertional chest pain 28.93** (7.26) 28.07** (7.14)
Number of years since first coded coronary event 1.02 (0.01) 1.02 (0.01)
HADS-A 2.01** (0.44) 1.65* (0.38)
Age 0.99 (0.01) 0.99 (0.01)
Ethnicity (other vs. white) 0.96 (0.29) 0.87 (0.27)
Cancer 0.72 (0.24) 0.75 (0.25)
EQ-5D-VAS 0.98** (0.01)
*p< 0.05; **p< 0.01.
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Economic analysis of the UPBEAT-UK programme
Objectives
To:
1. assess the long-term costs of care for a sample of patients with CHD and comorbid (a) baseline, and
(b) subsequent depression compared with those without comorbid depression
2. identify predictors of these costs.
Methods
Health-care utilisation and costs
The primary measures for the economic analysis were health-care utilisation and total health-care and
societal costs. Medical and informal (i.e. family care) resource utilisation was assessed using a
questionnaire, the Client Service Receipt Inventory, developed by members of the Centre for the
Economics of Mental and Physical Health.127 The questionnaire is frequently used in mental and physical
care evaluations. Medical utilisation included the number of contacts with hospital and community services
and (where appropriate) the length of these contacts and the duration of stay for inpatient care. Hospital
service utilisation consisted of outpatient, inpatient, A&E and day hospital visits. Community services mainly
included contacts with GPs, practice and district nurses, other medical professionals (psychiatrist, other
community-based doctor, community mental health nurse, health visitor, other nurse, psychologist,
counsellor, occupational therapist, physiotherapist, ‘alternative’ medicine or therapy, other therapist) and
care professionals (social worker, housing worker, home help/home care worker, care attendant,
community support worker, voluntary worker, day centre/drop-in/social club, any other community-based
service). Informal care involved assistance in daily activities by family members, relatives or friends
(i.e. personal or child care, help in/around and outside the house) and was measured as the average
weekly hours spent with the patient specifically because of their health problems.
Data were collected every 6 months for a period of 3 years between September 2007 and
September 2012.
TABLE 43 Effect of depression alone and with inclusion of EQ-5D-VAS in patients with two or fewer missing
time points
Depression alone (SD)
Depression with inclusion of
EQ-5D-VAS (SD)
Chest pain only 5.14** (1.22) 5.00** (1.20)
Exertional chest pain 29.82** (7.48) 29.18** (7.41)
Number of years since first coded coronary event 1.02* (0.01) 1.02 (0.01)
HADS-D 1.83* (0.50) 1.30 (0.37)
Age 0.99 (0.01) 0.99 (0.01)
Ethnicity (other vs. white) 0.89 (0.27) 0.82 (0.25)
Cancer 0.73 (0.24) 0.75 (0.25)
EQ-5D-VAS 0.98** (0.01)
*p< 0.05; **p< 0.01.
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Total costs were calculated from both a health-care payer’s and a wider societal perspective, by multiplying
the estimated resource use by the corresponding unit cost. Unit costs were applied to service-use data
using the NHS Reference Costs for 2011–12181 and the 2012 Unit Costs of Health and Social Care.129
The unit cost of a home care worker was used as a proxy for costing informal care. Wherever necessary,
costs were inflated to 2012 prices using the inflation indices for hospital and community health services.129
All costs were expressed in pounds sterling (GBP).
Indirect costs of productivity loss due to CHD and comorbid depression were not included in the analysis
because of incomplete data on sickness absence from work, occupation and status or mode of
employment (i.e. full time or part time). However, the average age was 71 years and most participants
were retired. Therefore, productivity loss is not likely to be a major consideration.
Medication use was self-reported and was recorded for baseline only (for the past 6 months).
Missing values
Across the study period (six follow-ups), some data (overall approximately 15% of data items) on
health-care utilisation were missing, mainly representing the missing number and/or duration of contacts.
The approach adopted to handle the missing data was imputation by the mean values of the respective
variables at each time point. Owing to the large sample size and the fact that total outcomes are
presented at a mean level, it was decided to use the mean instead of median imputation. In three
observations where the number and/or duration of contacts were reported but the type of service was
missing, the imputed value was assumed to be the most frequently used service across the study period.
Sample characteristics
Differences in sociodemographic variables between CHD patients with/without comorbid baseline
depression were analysed using a two-sided t-test and chi-squared test. Depression status was measured
by the HADS-D at baseline and at each follow-up point. Patients were classified into depressed and
non-depressed, using a cut-off score of ≥ 8 for possible depression.114 At baseline, 13% of patients
had depression.
Sociodemographic characteristics of the sample are shown in Table 44. Approximately two-thirds were
male in both groups and the average age was 66 years and 71 years for the depressed and the
non-depressed group, respectively. The majority of patients were married and retired, with only a small
proportion (< 5%) cohabiting. In the non-depressed group, 53% received > 11 years of education while a
similar proportion in the depressed group received < 10 years of education. Approximately half of either
group were ex-smokers and consumed, on average, between 0 and 10 units of alcohol per week. The
mean IMD score was 20 and 23, for the non-depressed and depressed group, respectively. The vast
majority of the depressed patients reported chest pain, while most of the non-depressed patients did not
have chest pain. Both groups had an average number of two additional comorbidities, with the most
frequent ones being hypertension and diabetes. Approximately 65% of patients had depression when
assessed by the CIS-R instrument. It is noticeable that approximately 80% of the depressed patients also
had anxiety when measured by the HADS-A. Most of the differences were statistically significant at a 10%
level (see Table 44).
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TABLE 44 Sample characteristics by depression status (HADS-D) at baseline
Baseline characteristics p-value
Non-depressed (N= 696) Depresseda (N= 103)
n (%) Mean (SD) n (%) Mean (SD)
Age (years) < 0.001 696 (87) 71 (11) 103 (13) 66 (12)
Sex 0.382
Male 489 (70) 68 (66)
Female 207 (30) 35 (34)
Ethnicity 0.016
White 617 (89) 80 (78)
Black 26 (4%) 7 (7%)
Asian 37 (5) 10 (10)
Other 16 (2%) 6 (6)
Relationship status < 0.001
Married/civil partner 426 (61) 51 (50)
Cohabiting 27 (4) 3 (3)
Spouse/partner deceased 134 (19) 16 (16)
Separated 9 (1) 17 (17)
Divorced 36 (5) 11 (11)
Single/non-cohabiting partner 64 (9) 13 (13)
Years in education
Average number 0.666 693 (100) 12 (8) 101 (98) 12 (9)
≤ 10 0.504 320 (46) 54 (52)
> 11 368 (53) 46 (45)
Employment status < 0.001
Paid employment 134 (19) 14 (14)
Retired/housewife/househusband 543 (78) 74 (72)
Unemployed/student 16 (2) 13 (13)
Smoking status < 0.001
Never 215 (31) 25 (24)
Ex 405 (58) 52 (50)
Current 76 (11) 26 (25)
Alcohol consumption (average/week) 0.001
Does not drink 181 (26) 42 (41)
0–10 units 343 (49) 40 (39)
11–20 units 99 (14) 6 (6)
> 20 units 71 (10) 15 (15)
BMI (kg/m2) 0.098 680 (98) 28 (6) 97 (94) 29 (7)
IMD score 0.028 696 (100) 20 (14) 103 (100) 23 (13)
Number of CHD factors – 0/6 0.004 696 (100) 3 (1) 103 (100) 3 (1)
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TABLE 44 Sample characteristics by depression status (HADS-D) at baseline (continued )
Baseline characteristics p-value
Non-depressed (N= 696) Depresseda (N= 103)
n (%) Mean (SD) n (%) Mean (SD)
Have chest pain < 0.001
No 419 (60) 27 (26)
Yes 277 (40) 76 (74)
Total number of comorbidities 0.097 696 (100) 2 (1) 103 (100) 2 (1)
Currently active comorbidities
Diabetes 0.045 166 (24) 34 (33)
Arthritis 0.837 116 (17) 18 (17)
COPD 0.142 74 (11) 16 (16)
Cancer 0.655 85 (12) 11 (11)
Osteoporosis 0.295 22 (3) 5 (5)
Stroke 0.247 10 (1) 6 (6)
CKD 0.668 134 (19) 18 (17)
Asthma 0.531 55 (8) 10 (10)
Hypertension 0.688 384 (55) 59 (57)
Parkinson’s disease 7 (1)
Multiple sclerosis 2 (0)
Depression 0.681 38 (5) 17 (17)
Anxiety 0.351 9 (1) 4 (4)
Both depression and anxiety 0.104 8 (1) 5 (5)
Anxiety (HADS) < 0.001 118 (17) 11 (2) 81 (79) 13 (3)
Depression (PHQ-9) < 0.001 62 (9) 72 (70)
Depression (CIS-R score of > 12) < 0.001 73 (10) 66 (64)
BMI, body mass index; CKD, chronic kidney disease.
a HADS-D score of ≥ 8.
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Statistical analyses
Statistical analyses were carried out using Stata version 11. Regression analysis was used to estimate mean
differences in service use and costs between groups. Baseline and follow-up costs were used as the
dependent variables and the group identifier as the independent variable. To estimate whether or not the
difference in costs between depressed and non-depressed patients was present at each time point, the
HADS-D status was also assessed at consecutive follow-up times (Figure 11).
Sociodemographic and clinical baseline variables were tested for significance using simple ordinary least
squares regression models. Each variable was regressed on the cumulative 3-year hospital care costs,
community care costs, informal care costs, total health-care costs and total societal costs. Those variables
with statistical significance at the 10% level (p< 0.10) in at least one of the above mentioned dependent
variables were included in the final multivariate model to identify predictors of costs (Table 45). Certain
other variables that were of interest, although not statistically significant in the first stage, were also
included in the final models. Of the statistically significant variables, those with high numbers of missing
values were excluded from the final models. The remaining variables were checked for correlation and
those that were highly correlated (r≥ 0.7) with each other were removed, one at a time, from the model.
Two models were constructed using the cumulative health-care and societal costs as the dependent
variables. The models included the following baseline covariates: sex, ethnicity, relationship status, age at
referral, health literacy status, years in education, family history of depression or cardiac problems, smoking
status, average units of alcohol per week, the body mass index score, number of CHD risk factors,
depressive disorder assessed by the CIS-R, currently being treated for depression, anxiety status measured
by the HADS, the IMD score, housing, working or financial problems, social contact and relationship
problems, currently active comorbidities such as diabetes, arthritis, cancer, asthma, hypertension, COPD
and chronic kidney disease. The models were also adjusted for informal care costs and total health-care
costs at baseline. Approximately 100 observations had missing data on the health literacy variable. Thus,
two additional models including all the above covariates except the health literacy variable were also run.
To produce a more parsimonious model that aids interpretation, the backward elimination stepwise
method was used. This method involved starting with all independent variables and then sequentially
removing variables with the highest p-values until only those with p-values < 0.1 were included.
3.0
3.2
3.4
3.6
3.8
4.0
0 6 12 18 24 30 36
Time period (months)
D
ep
re
ss
io
n
 (
H
A
D
S-
D
)
FIGURE 11 Mean depression score (HADS-D) across time.
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TABLE 45 Significant covariates at 10% level (p< 0.1) for inclusion in the final model
Label
Missing
values
Hospital
costs
Community
costs
Informal
costs
Total health-care
costs
Total societal
costs
1 Sex 0 * *
2 Ethnicity 0
3 Had chest pain 0 *
4 Smoke 0 * *
5 Diabetic 4 * *
6 Family history of heart
problems
28
7 Family history of
depression
44
8 Received any treatment
for depression
602
9 Taken antidepressants 620
10 Currently being treated
for depression
2
11 Drink alcohol 1
12 Had a major financial
crisis
2
13 Marital status 3 * * *
14 Years in education 6
15 Highest examination level
achieved
4
16 Employment status 3
17 Retired owing to ill health 187
18 Relationship status 2
19 HADS-D score 4 * * * *
20 HADS-A score 1
21 Depression status (PHQ-9) 2 * * * * *
22 EQ-5D summary score 8 * * * *
23 Housing problems 0 * * *
24 Work problems 0 * * *
25 Financial contacts 0 * * * *
26 Social contact problems 0 * * * *
27 Relative problems 0
28 Relationship problems 0 * * * *
29 Health literacy 116 * *
30 Age at referral (years) 0 * *
31 Smoking status 0 *
32 BMI 22 *
33 IMD score 0 * * * * *
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TABLE 45 Significant covariates at 10% level (p< 0.1) for inclusion in the final model (continued )
Label
Missing
values
Hospital
costs
Community
costs
Informal
costs
Total health-care
costs
Total societal
costs
34 Number of CHD factors –
0/6
0 * * * *
35 Number of episodes of
depression
602
36 Average units drink per
week
2
37 Currently active diabetes 0 * * *
38 Currently active arthritis 0 * * *
39 Currently active COPD 0 * * *
40 Currently active cancer 0
41 Currently active
osteoporosis
771
42 Currently active stroke 763 * * * *
43 Currently active CKD 0 * * * *
44 Currently active asthma 0
45 Currently active
hypertension
0
46 Currently active
Parkinson’s disease
796
47 Currently active MS 801
48 Currently active
depression
678
49 Currently active anxiety
with depression
774
50 Currently active anxiety 757
51 Total number of
comorbidities
0 * * * * *
52 Number of comorbidities
(0–1, 2–6)
0 * * * * *
53 Total health-care costs at
baseline
0 * * * * *
54 Total societal costs at
baseline
0 * * * *
55 Depression (CIS-R) at
baseline
0 * * * *
* Significant covariates at 10% level (p< 0.1).
CKD, chronic kidney disease; MS, multiple sclerosis.
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It is commonly known that health-care data often violate the assumptions underlying ordinary least
squares. Therefore, the models were run to test for the assumptions of normality and homoscedasticity of
residuals. Both assumptions were violated and generalised linear models were used. The use of log
transformation is common practice for dealing with skewed data, such as costs. However, log-scale results
are of little interest in decision-making, while actual values (i.e. GBPs) are meaningful. Generalised linear
models overcome the shortcomings of (log) ordinary least squares using the original scale of costs.182 To
use generalised linear models, the distribution of cost data and a function that specifies the relationship
between the mean and the linear specification of the covariates (the so-called link function) must be
specified.182 The appropriate distribution of costs was identified by implementing the modified Park test.183
The gamma distribution, with a log-link function, was applied to the final model. The log-link function
means that the value of the exponentiated coefficients is interpreted as proportional changes of the 3-year
total health-care and societal costs (Tables 46–49).
TABLE 46 Predictors of total health-care costs (cumulative for 3 years) (n= 624)
Independent variables Coefficient Exponentiated coefficient Standard error 95% CI
Ethnicity (reference: white)
Other –0.5991 0.5492 0.1073 0.3745 to 0.8056
Smoking status (reference: never)
Ex-smoker –0.2032 0.816 0.1004 0.641 to 1.0388
Health literacy (reference: adequate)
Inadequate –0.4840 0.6163 0.1144 0.4282 to 0.8869
Housing problems (SPQ) 0.7307 2.0764 0.628 1.1478 to 3.7565
Relationship problems (SPQ) 0.2608 1.2979 0.1656 1.0106 to 1.6669
Currently active comorbidities
Currently active cancer 0.4017 1.4943 0.2805 1.0343 to 2.1588
Depression status (CIS-R) 0.4856 1.6251 0.2896 1.1459 to 2.3046
Total health-care costs (baseline) 0.0001 1.0001 0.0000 1.0000 to 1.0001
TABLE 47 Predictors of total societal costs (cumulative for 3 years) (n= 624)
Independent variables Coefficient Exponentiated coefficient Standard error 95% CI
Ethnicity (reference: white)
Other –0.6530 0.5204 0.1026 0.3536 to 0.7661
Housing problems (SPQ) 0.6914 1.9965 0.6266 1.0792 to 3.6935
Relationship problems (SPQ) 0.2239 1.2508 0.1651 0.9656 to 1.6204
Currently active comorbidities
Currently active cancer 0.4259 1.5309 0.2961 1.0477 to 2.2368
Depression status (CIS-R) 0.4135 1.5121 0.2705 1.0649 to 2.1472
Total health-care costs (baseline) 0.0001 1.0001 0.0000 1.0000 to 1.0001
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Results
Health-care utilisation
Tables 50 and 51 show the cumulative resource use by depression status. Depressed patients utilised more
health-care resources than non-depressed patients during the 3-year study period (87.6 vs. 59 total
health-care contacts; 95% CI 5.4 to 51.8). In particular, 41% of the depressed patients used the A&E
department, compared with 33% of the non-depressed patients, but the average number of attendances
was 0.3 lower in the depressed group than in the non-depressed group. However, the mean number of
attendances was higher for the depressed patients in all periods except the last year. The differences were
not statistically significant.
TABLE 48 Predictors of total health-care costs (cumulative for 3 years and excluding the health literacy status from
the model) (n= 719)
Independent variables Coefficient Exponentiated coefficient Standard error 95% CI
Ethnicity (reference: white)
Other –0.6391 0.5277 0.0983 0.3662 to 0.7604
Housing problems (SPQ) 0.6279 1.8736 0.5443 1.0602 to 3.311
Relationship problems (SPQ) 0.2345 1.2642 0.1604 0.9859 to 1.6212
Had chest pain (Rose angina
questionnaire)
0.2068 1.2297 0.1500 0.9682 to 1.5618
Currently active comorbidities
Currently active CKD 0.3008 1.3509 0.2083 0.9984 to 1.8277
Currently active cancer 0.4785 1.6136 0.2936 1.1296 to 2.3052
Depression status (CIS-R) 0.3959 1.4857 0.2510 1.0668 to 2.069
Total health-care costs (baseline) 0.0001 1.0001 0.0000 1.0000 to 1.0001
CKD, chronic kidney disease.
TABLE 49 Predictors of total societal costs (cumulative for 3 years and excluding the health literacy status from the
model) (n= 719)
Independent variables Coefficient Exponentiated coefficient Standard error 95% CI
Ethnicity (reference: white)
Other –0.6356 0.5296 0.0971 0.3696 to 0.7588
Housing problems (SPQ) 0.6051 1.8314 0.5235 1.0457 to 3.2073
Relationship problems (SPQ) 0.2327 1.2620 0.1578 0.9876 to 1.6126
Had chest pain (Rose angina
questionnaire)
0.2054 1.2280 0.1475 0.9703 to 1.5541
Currently active comorbidities
Currently active CKD 0.2948 1.3428 0.2040 0.997 to 1.8087
Currently active cancer 0.4644 1.5910 0.2850 1.1198 to 2.2604
Depression status (CIS-R) 0.4173 1.5178 0.2525 1.0955 to 2.103
Total health-care costs (baseline) 0.0001 1.0001 0.0000 1.0000 to 1.0001
CKD, chronic kidney disease.
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Patients with depression used inpatient care more and stayed in hospital significantly longer (7.8 days,
95% CI 0 to 15.6 days) than patients without depression. Approximately 5% of the patients were
hospitalised for CHD reasons (1% of those had depressive symptoms). Nearly 80% of patients in both
groups used outpatient care, with the depressed group using it more intensively (17.6 vs. 12 visits, 95%
0.7 to 10.9 visits). Patients in both groups made similar use of primary care, which included contacts with
GPs, practice and district nurses, with the depressed group having a slightly higher frequency of contact.
The mean duration of contacts with GPs and PNs was slightly, but not significantly, higher (1.4 minutes per
patient) for the depressed patients than for the non-depressed patients. Patients with depression tended to
spend approximately 5 minutes more with their GPs than non-depressed patients. Overall, secondary care,
which included hospital care and care provided by other medical and care professionals (e.g. psychiatrists,
psychologists, other community-based doctors, mental health nurses, social workers, housing workers and
care attendants), was used more by the depressed group, with a significant difference of 27.9 contacts
(95% CI 5.8 to 50 contracts) compared with the non-depressed group.
Resource use (by time point)
It was found that informal care was utilised more (54% vs. 30%) and more intensively (19.6 vs. 17.7
average hours per week per patient) by the depressed patients than by the non-depressed ones.
Information on resource use by type of service and by group at each time point, separately, is given in
Tables 52–58.
TABLE 51 Grouped cumulative resource use for service users at 36 months
1–3 years: service users
No depression (N= 696) Depression (N= 103)
Difference, mean
(95% CI)n (%) Mean (SD) n (%) Mean (SD)
Hospital care contacts 162 (23) 7.5 (14.1) 30 (29) 10.0 (21.0) 2.5 (–3.5 to 8.5)
Community care contacts 210 (30) 15.6 (52.3) 32 (31) 44.1 (138.2) 28.5 (2.5 to 54.6)
Primary care contacts (includes contacts to
GPs, practice and district nurses)
655 (94) 20.9 (26.3) 93 (90) 22.2 (21.3) 1.3 (–4.3 to 6.9)
Secondary care contacts (includes hospital
care and contacts to other medical or care
professionals/specialists).
630 (91) 40.0 (95.7) 91 (88) 67.9 (128.5) 27.9 (5.8 to 50.0)
Total health-care contacts 658 (95) 59.0 (102.7) 94 (91) 87.6 (134.5) 28.6 (5.4 to 51.8)
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Costs
The cumulative costs for the 3-year study period are shown in Tables 59 and 60. Costs by type of service
and by patient group at each time point for service users only (i.e. excluding those with zero costs) and for
the whole sample are given in Tables 61–67 and Tables 68–74, respectively. In almost all types of service,
patients with depression incurred higher costs than patients without depression. The difference was
statistically significant for costs of outpatient services and contacts with other medical professionals as well
as for total costs. The aggregated 3-year costs for service users were significantly higher for the depressed
group than for the non-depressed group, by approximately £4000 (see Table 59). The highest costs were
for inpatient care across the study period (Figure 12). At baseline the non-depressed group incurred higher
inpatient care costs per patient than the depressed group (–£1739, 95% CI –£3790 to £312). However,
baseline costs were not included in the calculation of the aggregate costs because the estimates referred
to the 6-month period prior to the study initiation. In all other follow-ups, there was a positive difference
of approximately £3000 in inpatient care costs between patients with and without depression, except in
the 36-month follow-up, in which case the difference remained positive but at a lower level (£1534,
95% CI –£1772 to £4840) (see Tables 61–67).
TABLE 60 Grouped cumulative costs per patient (£, in 2011–12 prices) by group for service users at 36 months
1–3 years: service users
No depression (N= 696) Depression (N= 103)
Difference, mean,
£ (95% CI)n (%) Mean, £ (SD) n (%) Mean, £ (SD)
Hospital care costs 439 (63) 2037 (5202) 49 (48) 2990 (5217) 953 (–587 to 2493)
Community care costs 496 (71) 457 (1423) 60 (58) 931 (2176) 475 (66 to 883)
Primary care costs 493 (71) 239 (654) 60 (58) 257 (315) 18 (–150 to 187)
Secondary care costs 451 (65) 2224 (5456) 53 (51) 3528 (5388) 1303 (–251 to 2858)
TABLE 59 Cumulative costs per patient (£, in 2011–12 prices) by type of service and by group for service users at
36 months
1–3 years: service users
No depression (N= 696) Depression (N= 103)
Difference, mean,
£ (95% CI)n (%) Mean, £ (SD) n (%) Mean, £ (SD)
A&E attendances 242 (35) 183 (267) 43 (42) 159 (120) –24 (–105 to 58)
Day hospital attendances 182 (26) 575 (1202) 20 (19) 1312 (3328) 737 (23 to 1450)
Inpatient stays 255 (37) 6072 (9439) 46 (45) 9584 (18,167) 3511 (–18 to 7041)
Outpatient visits 588 (84) 1669 (2161) 86 (83) 2451 (6411) 782 (91 to 1472)
GP visits 645 (93) 484 (654) 93 (90) 560 (514) 76 (–63 to 215)
PN visits 580 (83) 80 (264) 73 (71) 75 (96) –5 (–66 to 56)
District nurse visits 76 (11) 443 (852) 12 (12) 411 (733) –33 (–550 to 485)
Other medical professional 225 (32) 224 (390) 36 (35) 721 (1298) 497 (285 to 709)
Other care professional 164 (24) 2178 (5111) 31 (30) 2978 (4592) 800 (–1144 to 2745)
Total health-care costs 658 (95) 5282 (8730) 94 (91) 9204 (16,109) 3923 (1770 to 6076)
Informal care (hours per week) 208 (30) 406 (742) 56 (54) 450 (509) 43 (–164 to 251)
Total societal costs 659 (95) 5402 (8804) 94 (91) 9472 (16,219) 4070 (1901 to 6240)
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TABLE 61 Costs per patient (£, in 2011–12 prices) by type of service and by group for service users at baseline
Baseline: service users
No depression (N= 696) Depression (N= 103)
Difference, mean,
£ (95% CI)n (%) Mean, £ (SD) n (%) Mean, £ (SD)
A&E attendances 58 (8) 182 (216) 15 (15) 324 (571) 142 (–42 to 326)
Day hospital attendances 20 (3) 404 (349) 3 (3) 610 (767) 206 (–319 to 731)
Inpatient stays 73 (10) 3108 (3940) 15 (15) 1369 (1239) –1739 (–3790 to 312)
Outpatient visits 452 (65) 493 (860) 70 (68) 737 (1271) 244 (14 to 475)
GP visits 553 (79) 116 (186) 80 (78) 128 (103) 12 (–301224 to 53)
PN visits 332 (48) 21 (47) 52 (50) 29 (37) 8 (–5 to 21)
District nurse visits 21 (3) 119 (245) 6 (6) 98 (160) –21 (–241 to 198)
Other medical professional 72 (10) 242 (329) 18 (17) 613 (1469) 371 (–1 to 743)
Other care professional 74 (11) 1059 (4711) 13 (13) 833 (1159) –226 (–2850 to 2397)
Total health-care costs 649 (93) 922 (1909) 93 (90) 1215 (1728) 293 (–118 to 704)
Informal care (hours per week) 83 (12) 184 (316) 19 (18) 190 (364) 6 (–158 to 170)
Total societal costs 650 (93) 944 (1933) 94 (91) 1240 (1726) 296 (–117 to 710)
TABLE 62 Costs per patient (£, in 2011–12 prices) by type of service and by group for service users at 6 months
6 months: service users
No depression (N= 638) Depression (N= 93)
Difference, mean,
£ (95% CI)n (%) Mean, £ (SD) n (%) Mean, £ (SD)
A&E attendances 54 (8) 163 (313) 15 (16) 214 (290) 51 (–129 to 231)
Day hospital attendances 28 (4) 361 (266) 4 (4) 3069 (5682) 2709 (728 to 4689)
Inpatient stays 52 (8) 2430 (2401) 16 (17) 5686 (7262) 3257 (942 to 5571)
Outpatient visits 348 (55) 446 (469) 60 (65) 487 (596) 41 (–93 to 174)
GP visits 505 (79) 103 (119) 76 (82) 172 (204) 68 (36 to 101)
PN visits 326 (51) 19 (29) 46 (49) 31 (46) 12 (2 to 21)
District nurse visits 10 (2) 327 (561) 5 (5) 236 (198) –91 (–658 to 477)
Other medical professional 54 (8) 163 (363) 16 (17) 502 (656) 339 (87 to 592)
Other care professional 68 (11) 551 (678) 16 (17) 955 (1583) 404 (–101 to 909)
Total health-care costs 583 (91) 702 (1206) 88 (95) 1990 (4168) 1288 (867 to 1710)
Informal care (hours per week) 61 (10) 200 (333) 27 (29) 185 (232) –15 (–155 to 126)
Total societal costs 587 (92) 718 (1222) 88 (95) 2047 (4201) 1329 (904 to 1754)
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TABLE 63 Costs per patient (£, in 2011–12 prices) by type of service and by group for service users at 12 months
12 months: service users
No depression (N= 622) Depression (N= 91)
Difference, mean,
£ (95% CI)n (%) Mean, £ (SD) n (%) Mean, £ (SD)
A&E attendances 51 (8) 141 (198) 12 (13) 192 (236) 51 (–81 to 182)
Day hospital attendances 34 (5) 383 (582) 0 (0) 0 (0) –
Inpatient stays 64 (10) 4644 (7175) 13 (14) 7720 (18,844) 3076 (–2986 to 9138)
Outpatient visits 377 (61) 472 (629) 57 (63) 873 (2006) 401 (141 to 661)
GP visits 468 (75) 115 (134) 71 (78) 189 (307) 75 (33 to 117)
PN visits 282 (45) 26 (52) 37 (41) 21 (23) –5 (–22 to 13)
District nurse visits 18 (3) 280 (420) 5 (5) 233 (171) –48 (–474 to 358)
Other medical professional 62 (10) 194 (337) 15 (16) 416 (709) 222 (–25 to 470)
Other care professional 66 (11) 1109 (2158) 9 (10) 866 (1152) –243 (–1710 to 1224)
Total health-care costs 587 (94) 1102 (3161) 82 (90) 2218 (8332) 1116 (156 to 2076)
Informal care (hours per week) 73 (12) 216 (359) 19 (21) 222 (252) 5 (–169 to 180)
Total societal costs 589 (95) 1125 (3182) 83 (91) 2242 (8301) 1117 (159 to 2075)
TABLE 64 Costs per patient (£, in 2011–12 prices) by type of service and by group for service users at 18 months
18 months: service users
No depression (N= 574) Depression (N= 95)
Difference, mean,
£ (95% CI)n (%) Mean, £ (SD) n (%) Mean, £ (SD)
A&E attendances 41 (7) 110 (84) 13 (14%) 139 (118) 29 (–30 to 88)
Day hospital attendances 52 (9) 343 (375) 12 (13%) 628 (1047) 285 (–72 to 642)
Inpatient stays 71 (12) 4427 (4906) 18 (19%) 7319 (11,793) 2892 (–686 to 6471)
Outpatient visits 316 (55) 529 (885) 51 (54%) 554 (576) 25 (–227 to 277)
GP visits 427 (74) 116 (152) 71 (75) 222 (261) 107 (64 to 150)
PN visits 271 (47) 34 (123) 40 (42) 27 (50) –7 (–45 to 32)
District nurse visits 16 (3) 293 (552) 8 (8) 178 (198) –115 (–536 to 307)
Other medical professional 52 (9) 159 (210) 12 (13) 168 (184) 9 (–123 to 141)
Other care professional 42 (7) 2474 (5997) 11 (12) 1981 (1982) –493 (–4198 to 3211)
Total health-care costs 534 (93) 1272 (3175) 85 (89) 2488 (6653) 1216 (336 to 2096)
Informal care (hours per week) 76 (13) 236 (480) 27 (28) 207 (212) –29 (–219 to 160)
Total societal costs 537 (94) 1298 (3178) 85 (89) 2554 (6664) 1255 (375 to 2136)
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TABLE 65 Costs per patient (£, in 2011–12 prices) by type of service and by group for service users at 24 months
24 months: service users
No depression (N= 538) Depression (N= 95)
Difference, mean,
£ (95% CI)n (%) Mean, £ (SD) n (%) Mean, £ (SD)
A&E attendances 49 (9) 96 (42) 16 (17) 149 (135) 53 (10 to 97)
Day hospital attendances 38 (7) 441 (435) 3 (3) 388 (319) –53 (–575 to 469)
Inpatient stays 78 (14) 2731 (2831) 17 (18) 6418 (8484) 3686 (1368 to 6004)
Outpatient visits 307 (57) 471 (570) 58 (61) 856 (1840) 385 (132 to 637)
GP visits 392 (73) 116 (175) 72 (76) 225 (217) 109 (63 to 154)
PN visits 243 (45) 33 (114) 51 (54) 34 (44) 0 (–31 to 32)
District nurse visits 16 (3) 352 (536) 4 (4) 181 (169) –170 (–750 to 410)
Other medical professional 54 (10) 111 (194) 11 (12) 386 (396) 274 (117 to 431)
Other care professional 26 (5) 1578 (2883) 13 (14) 1523 (1658) –55 (–1811 to 1700)
Total health-care costs 490 (91) 990 (1908) 88 (93) 2329 (4705) 1338 (762 to 1916)
Informal care (hours per week) 71 (13) 145 (166) 27 (28) 227 (242) 82 (–3 to 167)
Total societal costs 494 (92) 1003 (1918) 89 (94) 2371 (4704) 1368 (793 to 1944)
TABLE 66 Costs per patient (£, in 2011–12 prices) by type of service and by group for service users at 30 months
30 months: service users
No depression (N= 498) Depression (N= 100)
Difference, mean,
£ (95% CI)n (%) Mean, £ (SD) n (%) Mean, £ (SD)
A&E attendances 48 (10) 106 (90) 15 (15) 93 (29) –13 (–60 to 34)
Day hospital attendances 42 (8) 672 (2116) 11 (11) 415 (296) –256 (–1549 to 1037)
Inpatient stays 58 (12) 3854 (5537) 18 (18) 6874 (11,270) 3020 (–887 to 6926)
Outpatient visits 285 (57) 468 (665) 49 (49) 886 (1867) 418 (133 to 704)
GP visits 348 (70) 103 (127) 70 (70) 167 (198) 64 (27 to 100)
PN visits 245 (49) 24 (90) 46 (46) 22 (19) –2 (–28 to 24)
District nurse visits 15 (3) 395 (705) 8 (8) 104 (139) –291 (–820 to 239)
Other medical professional 50 (10) 172 (337) 11 (11) 264 (298) 92 (–128 to 313)
Other care professional 29 (6) 1007 (1804) 16 (16) 2207 (2831) 1200 (–192 to 2593)
Total health-care costs 461 (93) 1032 (2656) 87 (87) 2585 (6036) 1553 (768 to 2338)
Informal care (hours per week) 66 (13) 159 (310) 29 (29) 214 (234) 55 (–73 to 183)
Total societal costs 469 (94) 1037 (2645) 89 (89) 2596 (6006) 1560 (786 to 2333)
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TABLE 67 Costs per patient (£, in 2011–12 prices) by type of service and by group for service users at 36 months
36 months: service users
No depression (N= 470) Depression (N= 103)
Difference, mean,
£ (95% CI)n (%) Mean, £ (SD) n (%) Mean, £ (SD)
A&E attendances 57 (12) 120 (210) 15 (15) 99 (46) –21 (–130 to 88)
Day hospital attendances 31 (7) 429 (335) 6 (6) 692 (555) 263 (–76 to 601)
Inpatient stays 54 (11) 3140 (3965) 17 (17) 4675 (10,055) 1534 (–1772 to 4840)
Outpatient visits 280 (60) 480 (781) 61 (59) 1217 (3075) 737 (327 to 1147)
GP visits 339 (72) 107 (187) 73 (71) 291 (1202) 184 (49 to 319)
PN visits 232 (49) 33 (142) 42 (41) 34 (63) 1 (–43 to 45)
District nurse visits 14 (3) 185 (246) 5 (5) 599 (734) 414 (–43 to 871)
Other medical professional 51 (11) 115 (170) 13 (13) 276 (584) 161 (–25 to 346)
Other care professional 25 (5) 780 (849) 15 (15) 2950 (4433) 2170 (336 to 4004)
Total health-care costs 442 (94) 896 (1931) 91 (88) 2559 (6324) 1663 (952 to 2374)
Informal care (hours per week) 52 (11) 181 (267) 26 (25) 224 (333) 44 (–95 to 183)
Total societal costs 442 (94) 917 (1941) 94 (91) 2539 (6253) 1622 (919 to 2325)
TABLE 68 Costs per patient (£, in 2011–12 prices) by type of service and by group for the whole sample at baseline
Baseline: everyone
No depression (n= 696) Depression (n= 103)
Difference, mean,
£ (95% CI)Mean, £ (SD) Mean, £ (SD)
A&E attendances 15 (80) 47 (241) 32 (8 to 56)
Day hospital attendances 12 (89) 18 (149) 6 (–14 to 27)
Inpatient stays 326 (1586) 199 (668) –127 (–438 to 184)
Outpatient visits 320 (721) 501 (1101) 181 (19 to 342)
GP visits 92 (172) 99 (105) 7 (–27 to 41)
PN visits 10 (34) 14 (30) 5 (–2 to 12)
District nurse visits 4 (46) 6 (42) 2 (–7 to 12)
Other medical professional 25 (128) 107 (644) 82 (28 to 136)
Other care professional 56 (301) 105 (485) 49 (–19 to 118)
Total health-care costs 859 (1857) 1097 (1681) 237 (–143 to 618)
Informal care (hours per week) 22 (124) 35 (170) 13 (–14 to 40)
Total societal costs 881 (1883) 1132 (1685) 250 (–135 to 636)
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TABLE 69 Costs per patient (£, in 2011–12 prices) by type of service and by group for the whole sample at
6 months
6 months: everyone
No depression (n= 638),
mean, £ (SD)
Depression (n= 93),
mean, £ (SD)
Difference, mean,
£ (95% CI)
A&E attendances 14 (101) 35 (138) 21 (–2 to 44)
Day hospital attendances 16 (92) 132 (1202) 116 (21 to 211)
Inpatient stays 198 (951) 978 (3641) 780 (438 to 1122)
Outpatient visits 245 (412) 320 (535) 75 (–19 to 168)
GP visits 82 (114) 140 (196) 59 (31 to 86)
PN visits 10 (22) 15 (36) 6 (0 to 11)
District nurse visits 5 (78) 13 (68) 8 (–9 to 24)
Other medical professional 14 (114) 86 (326) 73 (38 to 107)
Other care professional 59 (278) 164 (735) 106 (25 to 186)
Total health-care costs 642 (1170) 1883 (4078) 1242 (846 to 1637)
Informal care (hours per week) 19 (118) 54 (149) 35 (8 to 61)
Total societal costs 661 (1188) 1937 (4112) 1276 (876 to 1676)
TABLE 70 Costs per patient (£, in 2011–12 prices) by type of service and by group for the whole sample at
12 months
12 months: everyone
No depression (n= 622),
mean, £ (SD)
Depression (n= 91),
mean, £ (SD)
Difference, mean,
£ (95% CI)
A&E attendances 12 (68) 25 (105) 14 (–3 to 30)
Day hospital attendances 21 (160) 0 (0) –21 (–54 to 12)
Inpatient stays 478 (2686) 1103 (7398) 625 (–176 to 1427)
Outpatient visits 286 (541) 547 (1638) 261 (91 to 431)
GP visits 86 (126) 148 (282) 62 (27 to 96)
PN visits 12 (38) 9 (18) –3 (–11 to 5)
District nurse visits 8 (84) 13 (64) 5 (–13 to 23)
Other medical professional 19 (120) 69 (320) 49 (14 to 85)
Other care professional 118 (777) 86 (431) –32 (–196 to 131)
Total health-care costs 1040 (3081) 1999 (7933) 959 (70 to 1847)
Informal care (hours per week) 25 (141) 46 (144) 21 (–10 to 52)
Total societal costs 1065 (3106) 2045 (7949) 980 (87 to 1873)
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TABLE 71 Costs per patient (£, in 2011–12 prices) by type of service and by group for the whole sample at
18 months
18 months: everyone
No depression (n= 574),
mean, £ (SD)
Depression (n= 95),
mean, £ (SD)
Difference, mean,
£ (95% CI)
A&E attendances 8 (36) 19 (64) 11 (2 to 20)
Day hospital attendances 31 (149) 79 (415) 48 (3 to 94)
Inpatient stays 548 (2251) 1387 (5785) 839 (184 to 1494)
Outpatient visits 291 (707) 298 (503) 6 (–142 to 155)
GP visits 86 (141) 166 (245) 80 (46 to 115)
PN visits 16 (86) 11 (35) –4 (–22 to 13)
District nurse visits 8 (101) 15 (74) 7 (–14 to 28)
Other medical professional 14 (77) 21 (84) 7 (–10 to 24)
Other care professional 181 (1729) 229 (908) 48 (–308 to 405)
Total healthcare costs 1183 (3080) 2226 (6336) 1043 (235 to 1851)
Informal care (hours per week) 31 (191) 59 (146) 28 (–13 to 68)
Total societal costs 1214 (3090) 2285 (6348) 1070 (260 to 1881)
TABLE 72 Costs per patient (£, in 2011–12 prices) by type of service and by group for the whole sample at
24 months
24 months: everyone
No depression (n= 538),
mean, £ (SD)
Depression (n= 95),
mean, £ (SD)
Difference, mean,
£ (95% CI)
A&E attendances 9 (30) 25 (78) 16 (7 to 25)
Day hospital attendances 31 (161) 12 (83) –19 (–52 to 14)
Inpatient stays 396 (1441) 1148 (4286) 752 (289 to 1216)
Outpatient visits 269 (490) 522 (1493) 254 (94 to 414)
GP visits 84 (158) 170 (212) 86 (49 to 122)
PN visits 15 (78) 18 (36) 3 (–13 to 19)
District nurse visits 10 (108) 8 (47) –3 (–25 to 19)
Other medical professional 11 (69) 45 (179) 33 (13 to 54)
Other care professional 76 (708) 208 (792) 132 (–26 to 290)
Total health-care costs 902 (1842) 2157 (4568) 1255 (720 to 1790)
Informal care (hours per week) 19 (78) 64 (164) 45 (25 to 66)
Total societal costs 921 (1858) 2222 (4589) 1301 (762 to 1839)
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TABLE 73 Costs per patient (£, in 2011–12 prices) by type of service and by group for the whole sample at
30 months
30 months: everyone
No depression (n= 498),
mean, £ (SD)
Depression (n= 100),
mean, £ (SD)
Difference, mean,
£ (95% CI)
A&E attendances 10 (42) 14 (35) 4 (–5 to 13)
Day hospital attendances 57 (636) 46 (161) –11 (–137 to 115)
Inpatient stays 449 (2247) 1237 (5372) 788 (143 to 1434)
Outpatient visits 268 (553) 434 (1374) 167 (4 to 329)
GP visits 72 (116) 117 (182) 45 (17 to 73)
PN visits 12 (64) 10 (17) –2 (–14 to 11)
District nurse visits 12 (136) 8 (47) –4 (–31 to 24)
Other medical professional 17 (118) 29 (126) 12 (–14 to 37)
Other care professional 59 (489) 353 (1370) 295 (141 to 448)
Total health-care costs 955 (2570) 2249 (5693) 1293 (583 to 2004)
Informal care (hours per week) 21 (124) 62 (158) 41 (13 to 69)
Total societal costs 976 (2578) 2311 (5721) 1334 (621 to 2047)
TABLE 74 Costs per patient (£, in 2011–12 prices) by type of service and by group for the whole sample at
36 months
36 months: everyone
No depression (n= 470),
mean, £ (SD)
Depression (n= 103),
mean, £ (SD)
Difference, mean,
£ (95% CI)
A&E attendances 15 (82) 14 (39) 0 (–17 to 16)
Day hospital attendances 28 (136) 40 (204) 12 (–20 to 44)
Inpatient stays 361 (1668) 772 (4347) 411 (–98 to 919)
Outpatient visits 286 (647) 721 (2434) 435 (182 to 688)
GP visits 77 (166) 206 (1019) 129 (32 to 227)
PN visits 16 (101) 14 (43) –2 (–22 to 18)
District nurse visits 6 (52) 29 (195) 24 (3 to 44)
Other medical professional 12 (66) 35 (220) 22 (–1 to 46)
Other care professional 41 (260) 430 (1947) 388 (205 to 571)
Total health-care costs 842 (1884) 2261 (5997) 1418 (765 to 2071)
Informal care (hours per week) 20 (105) 57 (192) 37 (10 to 63)
Total societal costs 862 (1895) 2317 (6014) 1455 (799 to 2110)
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The vast majority of patients in both groups received outpatient care, and care from GPs and PNs.
Outpatient care costs per patient were higher for patients with depression during the study period and
significantly higher at 12, 24, 30 and 36 months, at around double the costs of the non-depressed group.
However, the number of people who utilised the services was similar for both groups at each time period.
Only a few patients used day hospital services at each time point; however, the costs incurred were high
for both groups. This can be attributed to the high cost of some services, such as cataract operation.
Average community care costs per patient were higher by £475 for patients with depression than for those
without depression, and the difference was statistically significant (95% CI £66 to £883). Community costs
and total health-care costs are shown in Figures 13–16. None of the differences in informal care costs
during the study period was statistically significant. Societal costs are shown in Figures 17–21. Indirect
costs included informal care, which was similar between groups, with slightly higher costs incurred by the
depressed group (difference £43, 95% CI –£164 to £251), especially during the last three follow-up
periods (see Figures 16 and 18).
Predictors of costs
Tables 46–49 show the output of the four generalised linear models, having accounted for the impact of
depression status on costs by using the depressive disorder assessed by the CIS-R as an input variable.
The results reveal that health literacy had a significant negative impact on total costs from the health-care
perspective. It would decrease costs by approximately 40%. From both the health-care and societal
perspective, ethnicity was significantly associated with total costs. More specifically, being Asian, black or
an ethnicity other than white is predicted to reduce costs by approximately 45%. Similarly, higher costs
were associated with the prevalence of depressive disorder (measure by the CIS-R), with housing and
relationship problems, and with currently suffering from cancer.
When the health literacy variable was excluded from the first two models, health-care and societal costs
were shown to be significantly and positively associated with having an additional comorbidity other than
cancer, and this included chronic kidney disease. Another new factor that was present in these models was
reported chest pain, based on responses to the Rose angina questionnaire for angina. The association this
had with costs was positive and the magnitude was similar (+23%) from both perspectives. It is notable
that smoking status is not now a significant predictor of total costs. Total health-care costs at baseline are
predicted not to have any impact on the cumulative health-care or societal costs in any of the four models.
Discussion
The aim of the economic analysis was to estimate the cumulative health-care utilisation and costs of
patients with cardiovascular heart disease with and without baseline and subsequent depressive symptoms.
The cumulative cost per patient incurred by depressed patients was approximately double the cost incurred
by non-depressed patients during the 3-year study period. Overall, inpatient care services dominated costs
at baseline and follow-up, while the majority of patients in both groups received outpatient care and care
from GPs and PNs.
Across the study period, total costs were increasing, except in the second half of the second year, when
they declined dramatically (see Figure 21). Differences in costs between depressed and non-depressed
patients were statistically significant at almost all time points during the study period. Statistically
significant predictors of higher societal costs were depressive disorder (CIS-R), white ethnicity, housing
problems, relationship problems, having reported cancer as an additional comorbidity and baseline
health-care costs. The prevalence of depressive disorder measured by the CIS-R instrument predicted
increases in total costs by approximately 50% in all four multivariate models. Inadequate health literacy
was associated with reduced health-care cost and this may reflect poor access to care for this group.
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FIGURE 17 Cumulative informal care costs per patient (£, in 2011–12 prices) by group for service users at
36 months.
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FIGURE 19 Cumulative societal costs per patient (£, in 2011–12 prices) by group for service users at 3 years.
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There are several reasons why costs might have been under- or overestimated in this economic analysis.
With regard to direct costs, medication costs were not taken into account because such data (self-reported)
were available at baseline only. However, some patients were being treated for conspicuous depression and
other comorbidities during the study. Although this is a limitation, antidepressant treatment is generally
inexpensive, given that the most frequently used drugs are ‘off patent’. Another limitation is that indirect
costs included only informal care. The high level of missing data in variables related to employment status
and sickness absence made it impossible to calculate productivity losses, which is a very important
component of indirect costs. Finally, the subgroup analysis was based on depression status as assessed by
the HADS score.
Overall, the results could be considered as robust, as data on the important variables for this economic
analysis (e.g. service use) were mostly complete, with relatively few having extensive missing data. Further
analyses could consider the patterns of depression, examining the varying cost among the different
patterns of depression and anxiety. Other future work could look at the economic impact of comorbid
depression as a disorder rather than as a symptom-based condition. Similarly, the examination of the
relationship between anxiety and costs would be of interest, considering that the majority of patients in
the depressed group of this analysis also presented symptomatic anxiety (HADS-A). These findings could
drive further research to investigating the excess cost of depression (and/or anxiety) in this patient group by
conducting modelling studies on diagnostic and therapeutic approaches that might help to improve
health-care outcomes and reduce total costs.
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FIGURE 21 Mean total societal costs per patient (£, in 2011–12 prices) across time.
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Chapter 6 Summary of the UPBEAT-UK
programme
Introduction
This chapter discusses the overall findings of the entire UPBEAT-UK programme and discusses to what
extent and how the combined findings from the inter-related work packages have worked synergistically
and added to current knowledge about the associations between depression and CHD, and best
approaches to manage people with CHD, chest pain and depressed mood.
This is the first time, to our knowledge, that a programme of inter-related work has been conducted with
a broad range of people with varying levels of CHD, chest pain and depression/anxiety over 3 years in
33 south London general practices. At the same time, this location is a limitation when it comes to
generalising to the country as a whole, as indicated by the lower prevalence of CHD (see Chapter 1,
Patient and public involvement). It is also the first time, to our knowledge, that the perceptions of users
and primary care professionals have been combined to create a new nurse-led form of PC comprising
elements of case management and self-management theory for CHD register patients with chest pain
and depression.
Most previous research on CHD and depression has been conducted with people who are immediately
post cardiac event (usually MI) and who are being seen mainly in secondary care settings. The unique
feature of the UPBEAT-UK programme was that we have been able to look at all new incident cardiac
events and new incident depression over 3 years in a GP-registered CHD population and examine the
factors predicting both cardiac and depressive outcomes. For all four work packages there is, of course,
a limitation in generalisation because these were essentially volunteer practices.
In this chapter, we will discuss the combined achievements of the UPBEAT-UK programme and the
implications for everyday general practice. It is striking that there is little in the way of available current
national guidance for the management of CHD patients with chest pain and depression/anxiety. Existing
guidelines tend to either be very non-specific or concern only one condition. However, many older patients
have multiple conditions and require complex care pathways.
First, we will summarise the most important findings, which have been described and discussed in each
previous chapter.
Overall, we consider the project to have been successful. The main findings were (1) that a much larger
trial than we had anticipated would be needed to estimate to what extent the preference-led intervention
we developed will be successful in treating depression in CHD patients in primary care; (2) an intervention
that would deal with anxiety as well will perhaps improve outcomes; (3) the current primary care practice
setting, with the many competing agendas and the generally limited skill levels, may not yet be geared
towards delivering the type of integrated care that many of these patients need; and (4) perhaps
psychological services such as IAPT are better placed to deliver such care. An IAPT trial seems to be the
way forward.
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Work package 1
The literature review and metasynthesis of existing literature was conducted at the very beginning
of the programme in 2007/8, as this was necessary before we could conduct the qualitative study of
professionals. The findings of the review have been published31 and have since been highly cited by other
authors. It is likely that, since we conducted this review, further relevant research has been published and a
future review should include this.
At the beginning of the programme we were unable to identify previous relevant work. We found several
papers on depression in primary care but none on CHD, chest pain and depression in primary care.
The qualitative study with GPs and PNs also highlighted the paucity of research or guidelines on how best
to manage people with CHD complaining of non-acute chest pain and depression. Consequently, our GP
and nurse respondents had no guidance to cite and felt relatively untrained and ill-equipped in this area.
In addition, while being very well aware of the frequent concurrence of social problems, they were unsure
of what assistance may have been available. With some notable exceptions, GPs and PNs were unsure of
their role in managing social problems.
Work package 2
The most striking finding of the qualitative study with patients was that there was such a breadth of
‘understandable’ psychosocial losses that were described by participants. This then highlighted an
immediate mismatch between described user experience and the lack of relevant confidence and skills in
the main primary care work force.
Work package 1 and 2 indicated the complexities involved with helping patients to try and improve coping
with chronic physical illness and depression in a generalist environment. UK primary care, as busy as it is,
is not easily geared towards providing this type of care.
This type of mismatch is likely to militate against full and frank discussion of such issues in every day
practice. This, combined with a climate of reactive rather than proactive primary care, provided by
increasing numbers of GP-salaried assistants as part of the move away from ‘named’ professional care,
would make it more likely that a ‘collusion of anonymity’ could occur.184
Work package 3
Our pilot RCT findings have coincided with a new national policy from the Department of Health that all
older patients with long-term conditions should now have a ‘named GP’ responsible for their personalised
case management.185 We have shown an indication from our small pilot study that a named nurse
providing PC combining elements of case management and self-management theory in which patient
preference is prioritised appears to enhance both patients’ sense of self-efficacy and reduce the
self-reporting of chest pain.
In testing the feasibility, acceptability and potential impact of named nurse PC, we have demonstrated that
it is acceptable to patients – even if largely by short yet frequent telephone contact, which can be done in
a reasonable amount of time – and it is potentially cost-effective, not least if it reduces reported chest pain
and potentially attendance at a rapid access chest pain clinic or a 999 call-out and transfer by an
ambulance to A&E for further tests.
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We used a pilot RCT design186 to assess the likely benefits and harms of named nurse PC to allow inferences
about the possible causal effects of our new intervention. The MRC framework30 recommends RCTs early in
the development and testing of complex interventions. For pilot studies such as ours it has been suggested
that the analysis should mainly be descriptive or focus on the CI estimates.187 Pilot studies are described by
Arain et al.188 as a smaller version of a main study, to ensure components of the main study work well.
They are ‘focused on the processes of the main study’ such as ‘recruitment, randomisation, treatment, and
follow-up’. Pilot studies can be run as the first phase of the main study and results can be included in the
overall analysis.
Overall the UPBEAT-UK pilot RCT aimed to:
1. identify whether or not UPBEAT-UK nurse personalised case management is feasible and acceptable,
and determine any necessary modifications
2. test procedures for a potential future definitive RCT, especially in relation to eligibility criteria,
randomisation procedures, allocation processes, and recruitment and retention rates
3. test approaches to assessing fidelity, process evaluation and outcome evaluation, to inform the design
of a future potential definitive RCT including choice of primary and secondary outcome measures,
and sample size calculation.
The UPBEAT-UK pilot RCT also needed to establish feasibility of the new nurse-led PC, that is, rigorously
examine the potential usefulness and acceptability of the intervention and estimate relevant parameters
for the evaluation strategy to inform a future definitive RCT.188 Often there is no clear distinction in the
literature between pilot and feasibility studies.189 A literature review found that definitions of feasibility and
pilot studies vary, but studies labelled ‘feasibility’ tend to use a flexible method compared with ‘pilot’
studies in practice. Arain et al.188 suggest that feasibility studies are undertaken before a main study to
‘estimate important parameters’ for the design of a main study, such as the SD of the outcome measure
for sample size calculation, characteristics and feasibility of the outcome measure, people’s readiness to
be recruited and randomised, number of eligible participants, adherence and follow-up rates. Feasibility
studies should ‘not evaluate the outcome of interest’ but instead be powered to estimate parameters such
as recruitment or dropout rates. Feasibility or external pilot studies assess one or more of
the following:186,189
1. the feasibility of key processes, such as eligibility criteria, and their ascertainment, randomisation
procedures and their acceptability, retention and refusal rates, failure/success rates, adherence,
appropriateness of the primary outcome measure or the acceptability of questionnaires
2. potential time and resource problems, such as administrative issues, staff training, the willingness and
capacity of involved clinicians or centres, process times, for example for postage, preparing equipment,
dealing with contingencies such as material breakdown, clinician absence
3. potential human and data management problems, including space for personnel and data collection
forms, data entry and basic properties of the data such as missingness or variability
4. acceptability and safety of the intervention, dose, response, estimated treatment effect and estimated
variance of the treatment effect for sample size calculation
5. the integrity of the study protocol.
We used a pragmatic approach to trial design with a specific emphasis on processes, to ensure external or
ecological validity.190,191 The intervention was conducted in a routine GP setting (general practice or
patients’ homes), using little or no participant selection beyond being on a CHD register in the practice
and the clinical indication of chest pain (exertional non-exertional) and depression, and specifically not
excluding comorbidities that were common in general practice, such as diabetes, and may attenuate the
treatment effect. This approach maximised real-world applicability of the findings, by allowing a direct
translation of the outcomes to routine settings while also explaining processes occurring during the
UPBEAT-UK intervention. The UPBEAT-UK intervention was manualised to allow fidelity evaluation, but was
delivered with some degree of flexibility, for example with respect to session timing, to reflect real-world
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practice and the interests of our two nurses [one (Mark Haddad) is a community psychiatric nurse who has
worked clinically as a community psychiatric nurse in a local south London practice for 20 years and the
other nurse (EB) is a registered general nurse and has a background as a respiratory nurse in a London
teaching hospital with subsequent training as a chartered practitioner health psychologist and who
currently works mainly as a nurse researcher]. Although our pragmatic trial design focused on effectiveness
in the ‘real world’, a more explanatory RCT may have resulted in a clearer idea about what the active
ingredients and causal processes may have been. However, it has been argued that pragmatism and
understanding mechanisms should not be viewed as mutually exclusive190 and our UPBEAT-UK findings
should be able to answer both pragmatic and explanatory questions to some degree. The UPBEAT-UK
pilot RCT was a pragmatic trial with explicit attention to processes, with several advantages and some
disadvantages. We tested the intervention in everyday GP settings and one of the trial nurses (EB) chose to
make home visits to build a better picture of the patient’s environment.
One disadvantage and potential barrier to change we encountered was that the GPs and PNs in the south
London practices proved sometimes to be harder to engage or contact than had been expected, and this
had not been discussed in advance or built in to the study. For example, one of our GPs decided not to
prescribe an antidepressant despite advice that this may be beneficial from one of the trial nurses after
supervision with an academic GP (AT) and two psychiatrists (AM and PW).
Our pilot study was not designed to detect any improvement over and beyond TAU for depressive
symptoms and well-being, as we were not testing treatment effect and were focused on testing feasibility
and acceptability. Our patients in the pilot study prioritised managing pain, lack of exercise and sleep
problems. Strategies for pain relief seem to have resulted in a reduction of reported chest pain although
this would need to be tested in a definitive trial.
Minimisation of selection and allocation bias was addressed by random allocation by the independent
King’s Clinical Trials Unit. Randomisation appeared to achieve equal balancing of individual variables
between groups. We reduced bias by collecting the baseline data before allocation. We addressed bias in
the intervention by ensuring fidelity to the UPBEAT-UK pilot RCT manual was monitored to ensure that
comparability of the intervention by our two nurses who jointly received weekly peer/group supervision
(by AT, AM and PW). We minimised any bias in the follow-up data by ensuring that all participating
patients were followed up and included in the analysis using an intention-to-treat approach to reduce the
impact of selective attrition. We minimised bias in outcome data collection by the use of standardised
objective assessments, rater training and supervision, and self-rating scales where possible and by using
research assistants blind to treatment allocation.
A limitation common in similar trials was that blinding was achieved at only some levels: ideally the
research participant, the care provider, the assessor and the statistician should all be blind. Although
blinding participants and care providers prevents performance bias, that is, the preferential receipt of
additional treatment in one group, it was not possible to achieve, as is so often the case.192 Blinding
research assistants ensures independent judgement about outcome193 but is difficult in practice, for
example because participants disclose their allocation. We blinded our research assistants and asked them
to record which group they thought participants were in and to notify us of any unblinding, which did
happen on occasion. Our statistician became unblinded early on when the number of participants in the
intervention group was mentioned in discussion – we had different numbers in each group (40 and 41) so
it became obvious which group was which.
Although these methodological considerations are less relevant for the interpretation of a pilot study, such
as UPBEAT-UK, non-blinded GPs and PNs, may cause post-randomisation confounding and biased
outcomes through differential intensification of routine care in a definitive trial.192 Differential
intensification may have occurred when participants in the experimental treatment were sensitised to
certain issues and talked about them to their GP or nurse. Equally, GPs and nurses who knew about a
person’s assignment to the control condition and were convinced of the benefits of the experimental
SUMMARY OF THE UPBEAT-UK PROGRAMME
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treatment may have encouraged access to additional non-study care, leading to intensification of routine
treatment in the control group and thus decreasing the effect size of the intervention. The choice of a
control condition is important for the trial’s internal validity, which can be threatened when the TAU group
receives additional health-promoting behaviour, especially in trials of psychosocial interventions; although it
is perfectly possible that the patients could have easily told their GPs or PNs if they saw them, there did not
seem to be much interaction between them.194 We used a TAU control and obtained printouts of GP
consultations, referrals and treatment of both groups to assess what was received by the control group
participants. As the UPBEAT-UK intervention was conducted independently of the usual GP practice staff, it
is unlikely that there was any contamination. This would need careful consideration in any future definitive
trial. TAU implies that anyone on GP CHD registers with chest pain and depression would routinely receive
treatment, which may not be the case in reality. A more accurate term may have been ‘usual care’, which
may or may not have happened. Comparing the UPBEAT-UK named nurse PC directly with existing general
practice care for people on CHD registers with chest pain and depression may be problematic and may not
even be possible if GP or nurse routine care involves individualised multiaspect multiprofessional case
management for people with CHD and depression. It seems likely that we superimposed the experimental
UPBEAT-UK treatment onto existing practice (whatever that is) to see if UPBEAT-UK nurse personalised
case management has any potential added value that could be further tested in a definitive trial using a
larger, more powered sample.
Recipients of UPBEAT-UK nurse PC would have received more attention (i.e. from the trial nurse) than the
comparator group participants. They may have wanted to please their trial nurse after 6 months by
inflating their self-rated improvement on the final outcome measure, which could be a possible limitation.
Further non-specific factors may have been present, such as therapeutic alliance. We examined this by
looking for any differences between our two nurses. A limitation of the study was that we did not record
or rate consultations to assess alliance or attention. This makes it hard to assess the active ingredients.
Although our pilot was designed to assess feasibility and acceptability, rather than treatment effect on
depression, a range of variables and events outside our PC may influence depressed mood. Confounding
factors that have been empirically shown to impact on depression in people with CHD include medication
changes, concurrent social problems and life events. Theoretically, these influences should be evenly
distributed across randomised participants. However, their impact may still differ between groups
depending on the chosen interventions and problems to be addressed. Hence, while it may be neither
feasible nor necessary to control for all possible influences on depressed mood, a definitive trial might still
aim to systematically assess the most prevalent influences on depressed mood. This would be a challenge,
however, in a patient preference-led intervention such as UPBEAT-UK PC. Our GPs and nurses indicated
that they knew that such problems abounded in their patients on CHD registers but were often at a loss to
know what could be done about adverse social conditions.
All of these challenges will need to be addressed in a definitive RCT. Our pilot work does not address
implementation issues involved in transferring the intervention to clinical practice. Use of a model such as
May’s Normalisation Process Theory195 could be used to critically appraise the intervention. This would
inform optimal implementation following demonstration of efficacy in a definitive RCT.
Work package 4
The aim of the cohort was to study the relationship over time between depression and symptoms of
cardiac disease (chest pain) and outcomes (interventions, MI). We found the prevalence and incidence of
depression to be lower than might be expected in such a cohort, but that of anxiety unexpectedly high.
Nevertheless, the comorbidity of depression and anxiety in patients with CHD is worth taking into account,
since patients suffering from conditions have a higher incidence of adverse outcomes and management
strategies in these patients have so far failed to reduce this incidence.
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It has long been noted that many patients referred for investigation of chest pain have concurrent anxiety
and depression syndromes.196 Chest pain is indeed a recognised symptom for the diagnosis of a panic
attack.173 Case-level anxiety or depression has been stated to be a contraindication to expensive cardiology
investigation, as few are found to have coronary disease.178 Most of the work on the association of chest
pain with psychiatric disorders has been carried out in secondary care cardiology patients. To our
knowledge there are few studies of the different types of chest pain experienced in people with known
CHD in primary care. Our study population is different and there are no published studies on this topic
in CHD register patients. In the UPBEAT-UK study, 44% of patients on GP CHD registers reported current
chest pain. This was higher than previously reported.162 This is an important finding, although it could
reflect a selection bias in the opt-in recruitment process. Two-thirds of the reported pain was exertional,
suggesting cardiac origin, and exertional pain was a strong predictor of MI and death. These patients with
continuing exertional pain are under primary care follow-up, but not all were referred to secondary care.
There is potentially a case to be made for more emphasis on referral to secondary care, with patients
continuing to report exertional chest pain during their primary care follow-up appointments.
Our study of associations at baseline shows that both exertional and non-exertional chest pain were
associated with psychosocial factors such as depression and anxiety. Causality between chest pain and
psychosocial factors cannot be determined during cross-sectional analysis. However, the great strength of
this cohort data set is that it is longitudinal and multiwave. This allows us to be clearer about the direction
of the association, and to see whether risk factors are equally powerful if they are distal (baseline) or
proximal (last measured data point). To our knowledge, there is no previous study in which the Rose
questionnaire has been used serially every 6 months for 3 years.
There is a different risk factor profile for those with exertional pain over this time, compared with the
smaller proportion of people with non-exertional pain. For the former, baseline depression, anxiety and
impaired quality of life play a part, with anxiety as the more dominant risk factor as it persists even after
using multivariate models, which include quality of life. For non-exertional pain, the profile of females with
asthma and shorter time on the register at baseline is the one more strongly associated.
Although anxiety may seem understandable in patients with CHD and chest pain, our study suggests that
this may be a malign additional symptom that needs to be considered in addition to depression. Therefore,
GPs and PNs monitoring these patients should be aware of the role of anxiety in addition to chest pain in
predicting continuing suffering and decreased quality of life.
Limitations of the cohort methodology include the self-selection of the general practices participating and
the selection by response rate of 27%. We cannot gauge the bias resulting from the response rate, as we
were not allowed access to data on any patients who refused to participate. The patients were interviewed
every 6 months, reporting on how they were currently as well as over the previous 6 months, introducing a
possible recall bias. The 6-month intervals could be underestimating the number of experiences of anxiety
and depression, as patients could have a brief episode of either condition, which we would not have
detected by this method. The physical health information of these patients has come from patient recall,
use of the Rose angina questionnaire and GP records. Each of these could inaccurately represent the
health status of the patient. We did not have the resources to have a physical examination of each patient,
hence the need to rely on these proxies.
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The role and utility of general practitioner coronary heart
disease registers for research
This was the first complex programme of research on patients registered on GP CHD registers. We have
been unable to find comparable data from other studies, as most previous research has been conducted in
secondary care settings. The advantage of using GP CHD registers is that patients are readily accessible
through their GP practices, which maintain these registers, and this has been a key benefit to research
from the advent of the QOF. This made it much simpler for us to recruit patients with CHD in a primary
care setting. However, we tested the accuracy of the CHD registers with our cardiologist team members,
an exercise which had not been done before, and we can report for the first time that the accuracy of
CHD registers was approximately 85%. The registered population, we have discovered, contains a
heterogeneous group in terms of the degree of CHD and cardiac intervention they have received, and
recency or history of onset. Registers could also be used to select specific groups of patients (e.g. MI).
This makes them a unique and epidemiologically enriched population to study the effect of any factors
of cardiac outcome. Our sample was older, contained more males, had high levels of comorbidity
(e.g. 25% diabetic), and multiple social problems and was less likely to be from black and minority ethnic
communities. The sample, therefore, reflects a typical general practice population and thus differs from
previous research in this area.
The disadvantage of using GP CHD registers for epidemiological research, however, is that the members
are survivors. Consequently, there is a survivor cohort bias. The fact that our sample was 27% of the
potential CHD register population was not because of the CHD registers but because of the required
opt-in procedure. Unfortunately, we are unable to examine this bias because we cannot access information
about or interview the patients who chose not to opt in to the research. This is a common problem in
primary care research. It is possible that those patients who did opt in to UPBEAT-UK were more
symptomatic in terms of chest pain and anxiety, and perhaps patients who did not opt in may have been
more depressed than those who did opt in. If those who did opt in were less depressed, it is possible they
felt that the trial was less relevant to them. This is cross-sectional so we cannot infer causality, but further
modelling could help elucidate the complex inter-relationships and pathways between chest pain, anxiety
and depression. Chest pain was found to reduce health-related quality of life, and further study is needed
to fully understand the impact. It is noteworthy that our PC intervention was found to reduce the
likelihood of reporting chest pain at both 6 and 12 months. Further research would require sophisticated
modelling techniques that model hypothesised causal relationships.
The relative importance of anxiety and depression in this
patient group
When we originally applied for funding there was a lot of interest in depression and CHD. While we found
that there was a modestly high prevalence of depression, the high incidence rate and episodic nature was
more noteworthy. Surprisingly, we did not find from our data any evidence that depression is a strong
predictor of adverse cardiac outcome. This is not consonant with previous research from secondary care.
This may reflect the characteristics and possible selection bias in our sample. On the other hand, the high
prevalence rates for anxiety in our sample were unexpected. It is possible that more anxious people want
to be recruited into such trials. Anxiety rates stayed high throughout the 36 months. Baseline anxiety
disorder was a stronger predictor of adverse cardiac outcome and cardiac death than baseline depression.
This finding needs further assessment and it is potentially very important for further research to examine
the possible links between anxiety and cardiac pathology, as much previous research has focused on
mechanisms linking depression and cardiac disease. These findings also have implications for clinical
practice and raise questions about the need for anxiety being given equal emphasis with depression in
terms of case finding. Our cohort data set could be used to develop a valid anxiety scale for use by
practitioners to follow up people with anxiety and CHD.
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In our pilot RCT, patients were helped by the nurses to prioritise perceived problems relating to their CHD
and depression: one of the top five problems prioritised by the patients was anxiety (another of the top
five problems was insomnia, which may have been anxiety related) and we also found some evidence of
anxiety as a mediator for depression improvement. In a future trial, more active treatment, such as a more
formal type of CBT or problem-solving treatment for anxiety and depression, should be tested, particularly
when associated with chest pain.
The programme as a whole and how the findings from each of
the work packages informed each other
This programme has been successful because of a multidisciplinary team with research and clinical
backgrounds working together for over 6 years, combining qualitative and quantitative approaches in an
active dialogue with regular meetings.
Some common features emerged from the varied approaches: the importance of social problems, chest
pain as an unpleasant symptom with adverse effects, and depression and anxiety. While professionals
often see the last two as independent conditions to pick out and treat, depression and anxiety are often
not seen as such by patients. For patients, these conditions are merged with their physical ill health and
social difficulties and they want an integrated approach to treatment. This inevitably locates their
treatment best in primary care. We postulate that the method in our pilot RCT addresses the need for such
an integrative approach. Motivation for patients is important, and the high patient adherence to our PC
demonstrates the need for continuity of care from a case manager. Feedback from our trial participants
showed how much continuity was appreciated. A combination of goal attainment and a focus on
symptom resolution for chest pain, anxiety and depression seems important.
We were unable to employ PNs on the pilot RCT as originally intended because many of them informed us
that they had no spare capacity, as well as considering themselves not to have the sufficient mental health
or behavioural health training for such an intervention. It became apparent that a new intervention would
need new integrated systems of care involving the whole practice team rather than depending entirely on
one group of professionals or one treatment approach. Our nurses often found it difficult to contact
members of the practice team and regular meetings with practice staff would have improved
communication. PNs have a long tradition of case management for patients on registers (e.g. asthma,
diabetes) and many would need enhanced training in behavioural management and psychosocial care.
There is current national interest in enhancing the role of IAPT to provide integrated care for patients with
long-term conditions and 13 national pathfinder pilots are under way, one of which is in the area of CHD.
Much of this role is likely to fall to PWPs, who are often graduate psychologists with very little, if any,
clinical training in relation to physical health problems (long-term conditions). PWPs, although well trained
in providing low-intensity treatments and guided self-help approaches for anxiety and depression, would
need much additional training and supervision in CHD prevention and management.
Our findings showed that overall costs were higher for those participants who were depressed at baseline,
by approximately £5000 (i.e. almost double the cost of non-depressed participants). Differences between
the two groups were significant across some services and non-significant across others, but the data
highlight that people with depressive symptoms can use health services at a high rate and there are
subsequent societal costs associated with this.
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Conclusions
Nearly half of all patients on GP CHD registers were found to have current chest pain, and this was strongly
associated with concurrent social problems. Patients who reported chest pain at the outset of the study
were more likely to have further chest pain over the following 3 years and to have more adverse cardiac
outcomes such as needing stent insertion, bypass graft surgery, having a MI or dying of a cardiac cause.
While depression was common, episodic and associated with increased costs, anxiety disorder was more
common and found to be a stronger predictor of worse cardiac outcome and mortality than depression.
Recommendations for further research
We propose several avenues for further research to build on our findings.
1. There is a pressing need to better understand the links. More sophisticated models linking the patterns
of depression, anxiety and chest pain are needed to understand the associations between anxiety, chest
pain and adverse cardiac outcome. We have a unique cohort data set to allow us to achieve this.
2. GPs and nurses seem currently uncertain how best to manage patients’ symptoms in the context of the
many psychosocial problems in their CHD patients. PC promoting self-management proved to be
acceptable and feasible, improved patient self-efficacy, reduced chest pain and was associated with
fewer overall costs than usual care (e.g. fewer A&E attendances). PC combining case management and
self-management with an extra emphasis on anxiety needs to be further piloted and definitively tested
with PN, working closely with colleagues in practices. Many nurses told us they had little extra current
capacity so this would need to be built into practice plans.
3. PC combining self-management with an extra emphasis on anxiety could also be piloted and definitively
tested with PWPs in IAPT although they would need training and supervision in long-term conditions
and behavioural change techniques.
4. Further research should identify the training needs of staff to support the roll-out and deliverability of
the intervention.
5. The cohort data set is available for further analyses for researchers both in and out of King’s College
London. Already we are collaborating with the Department of Psychological Medicine at King’s College
London (Professor M Hotopf) and with the Department of General Practice at the University of
Amsterdam (Professor H van Marwyck). The longitudinal nature of the data makes them a rare and
valuable resource for hypothesis testing. The analyses for this report, reflecting our funded aims,
concerned anxiety and depression, and their relationship to cardiovascular outcomes. Other variables
(e.g. physical comorbidity, social stresses and risk behaviours such as smoking and alcohol) were
included as covariables in that relationship but not studied over time in their own right. To emphasise,
CHD register patients are insufficiently studied, given the frequency of reported chest pain.
6. Self-reporting through the installation of an application on a mobile phone or tablet could allow
patients to record each incident of chest pain with concurrent mood and social circumstances. This
information would certainly inform GP management better than patient recall every few months and
could lead to a patient‘s greater self-efficacy.
7. The result of the pilot RCT does not as yet justify a move to a larger trial but its acceptability and
feasibility without additional cost suggest that these comorbid patients would appreciate this approach.
We would propose, as the next step, another small feasibility study in which an IAPT worker was
compared with a PN in the therapeutic role. An up-to-date metasynthesis should be carried out to
inform this and the content of the intervention should be as effective for anxiety as for depression.
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Implications for practice
The implications arising from these research results are for the primary care teams who follow up patients
on the CHD register.
Chest pain in general and angina specifically remains a common experience in these patients despite the
time that has elapsed since the event that placed them on the register. We have shown that chest pain
produces high risk for another cardiac event. It is thus important that those reporting pain are not lost to
follow-up in the practice.
Anxiety is more common than depression in these patients and, although usually comorbid with
depression, is the more potent predictor of the two of subsequent cardiac events. Consideration could be
given to the inclusion of the assessment of anxiety in these patients by the primary care team who could
provide a strategy of management if necessary.
These older patients appreciated an approach to dealing with their low or anxious mood that focused on
their own needs using psychological support. All the indications were that additional medication to that
being taken for their physical conditions were unwanted.
The qualitative research suggested that a ‘narrative of loss’ underlay low mood in many patients. Their
cardiovascular disease had led to loss of occupational role, social engagement or ability to be independent
and in men loss of self-worth accompanying diminished sexual performance. This insight might enable a
therapeutic point of contact to be established with some patients.
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Appendix 1 Search strategy for the metasynthesis
of published qualitative and quantitative literature
1. exp Depression/ or depression.mp
2. depress$.mp.
3. 1 AND 2
4. primary care.mp. OR Primary Health Care/
5. general practice.mp. OR Family Practice/
6. Health Personnel/
7. Medical staff/
8. Nurses/
9. general practitioners.mp. OR Physicians Family/
10. 4 OR 5 OR 6 OR 7 OR 8 OR 9
11. “Attitude of Health Personnel"/ OR Attitude/ or attitude.mp.
12. belief.mp.
13. perception.mp. OR Perception/
14. 11 OR 12 OR 13
15. 3 AND 10 AND 14
16. limit 15 to English language and yr “2000 - 2008”
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Appendix 2 Checklist devised to assess the
quality of observational studies
(Answer items 1–5 ‘yes’ or ‘no’.)
Screening: was there a clear aim?
1. Was the selection of participants appropriate? (Consider source population, inclusion or exclusion
criteria, methods of selection.)
2. Was the measurement of variables appropriate? (Consider validity and reliability of instruments/
measures used.)
3. Was there appropriate control of bias? (Consider sources of bias, were appropriate methods outlined to
deal with any issues such as recall bias, interviewer bias, non-responders, note response rate.)
4. Was the use of statistics appropriate? (Consider primary outcome stated a priori, note sample size.)
5. Was the study free of conflict of interest? (Consider declarations of conflict of interest or identification
of funding sources.)
6. List any other limitations of the study.
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Appendix 3 Topic guide for general practitioners
and practice nurses
Context
Can you tell me a little about the practice and the population you serve?
Probes: SES [socioeconomic status], ethnicity, challenges, special interests, additional services, special
interest in mental health, practice population size.
Coronary heart disease
How much of a problem is CHD in this practice?
Probes: high-risk groups; age; ethnicity; gender.
How do you manage your CHD patients?
Probes: recording, role of other professionals, frequency of visits, are there particulate difficulties in
managing these patients?
Coronary heart disease and depression
Defining depression in coronary heart disease
It appears from research that many people with CHD may also be depressed. What is your experience
of this?
Probes: direction of causality; which factors are important: symptoms, family, SES, gender, exercise; factors
specific to CHD compared with other illnesses; do you routinely consider depression in these patients? Is it
a special problem?
What are your views on the inclusion in the Quality and Outcomes Framework (QOF) of depression
screening in patients with CHD?
Probes: is it a good/bad idea, workable in practice/difficult to do, relevant/irrelevant.
How would you make a distinction between distress and depression in someone with CHD?
Probes: for instance, distress that is perhaps a normal reaction to an adverse life event, and depressive
illness that may require management? Criteria used; causes; patient factors; severity; course; outcome.
Do the patients share your views?
Current management of depression in coronary heart disease
Are you currently treating any of your patients for CHD and depression?
Probes: severity of CHD; severity of depression; risk factors; did the patient seek help for their depression?
What was it about this patient that made you decide to treat them?
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How do you feel about treating patients with CHD and depression?
Probe: is it any different from managing depression in other patients?
How do you/would you manage depression in someone with CHD?
Probes: available resources – medication, talking therapy, IAPT, lifestyle changes, complementary therapies,
voluntary agencies, cardiac rehabilitation services; role of other professionals; successes; barriers; are there
any issues specific to people with CHD compared with other illnesses? Is CHD treatment or depression
treatment altered by comorbidity?
What would you hope to happen as a result of treating someone with CHD for depression?
Probes: improvement in mood; improvement in physical health; adherence to treatment; priorities.
What about discussing depression and treatment for depression with your CHD patients? Are there
particular issues?
Probes: barriers; patient concerns; patient factors – ethnicity, gender, SES, age.
Future treatment of depression in coronary heart disease
We are aiming to design a programme of care for people with both CHD and depression. What options
would you like to see included?
Probes: which would be most important? Who would deliver; role of other professionals/agencies; who
would you refer; are any of these options especially suited to particular groups of patients? CHD specific
versus generic.
Can you foresee any difficulties with any of the potential options?
How many of your current patients would benefit?
How do you think your CHD patients would feel about these options?
Any other issues
Finally, are there any other issues that we haven’t addressed and that you would like to mention?
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Appendix 4 Instruments used in the
UPBEAT-UK programme
Two measures were included at the behest of local GPs as part of an agreement for co-operation. They(Psychological Outcome Profiles Questionnaire and Rapid Estimate of Adult Literacy in Medicine) were
analysed separately and led to publications, which are listed in the acknowledgments.197,198 The third
(Guy’s Hospital Questionnaire) was suggested by the cardiologist on the team but was abandoned because
it was too difficult to administer over the telephone.
Instrument Author(s) Description of instrument
Section of UPBEAT-UK
used
BIPQ Broadbent et al.,
2006123
9-item scale designed to rapidly assess the
cognitive and emotional representations of illness
Cohort study, RCT
Modified Rose
angina questionnaire
Rose, 1962113 Questionnaire investigating on chest pain, which
is widely used to determine the presence of
angina in clinical populations
Cohort study, RCT
REALM Davis et al.,
1993156
A screening instrument designed to be used in
public health and primary care settings to identify
patients with low reading levels. It provides
reading grade estimates for patients who read
below a ninth grade level. The REALM can be
administered in 1–2 minutes by personnel with
minimal training
Cohort study
PSYCHLOPS Ashworth et al.,
2004122
PSYCHLOPS is a brief one-page mental health
outcome measure and can be used during the
course of any psychotherapeutic intervention.
It is patient generated and can be self-completed.
It has questions on problems, function and
well-being
Cohort study
CSRI forms 1 and 2 Beecham and
Knapp, 2001127
The CSRI is a questionnaire for collecting
retrospective information about study
participants’ use of health and social care
services, accommodation and living situation,
income, employment and benefits. The service
receipt section is the largest part of the
questionnaire. The data collected through the
CSRI can be used to calculate service costs and
total costs of care
RCT
SPQ Corney and
Clare, 1985120
A brief self-report questionnaire identifying social
problems, difficulties and dissatisfactions. The
SPQ covers housing, occupation, finance, social
and leisure activities, child/parent and marital
relationships, relationships with relatives, friends,
neighbours and workmates, and legal problems
Cohort study, RCT
Life events
questionnaire
Brugha and
Cragg, 1990154
Cohort study
Short Form
Questionnaire-36
items
McHorney et al.,
1993199
The SF-36 is a multipurpose, short-form health
survey with only 36 questions. It yields an 8-point
scale profile of functional health and well-being
scores as well as psychometrically based physical
and mental health summary measures and a
preference-based health utility index
Cohort study
SF-12 Ware et al.,
1996118
Abbreviated version of the SF-36 comprising only
12 items
RCT
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Instrument Author(s) Description of instrument
Section of UPBEAT-UK
used
EQ-5D Hurst et al.,
1997125
The EQ-5D assesses respondents’ subjective
quality of life – in reference to the assessment
date only – across five life domains: mobility,
self-care, usual activities, pain/discomfort and
anxiety/depression. Overall health state is
measured by a sixth item, which asks
respondents to indicate their own health state on
a scale from 0–100 (where 0= ‘the worst
imaginable health state’ and 100= ‘the best
imaginable health state’). Respondents are asked
to take into account both their physical health
and mental health when indicating the overall
health state
Cohort study, RCT
PHQ-9 Kroenke et al.,
2001116
Brief self-administered diagnostic instrument to
detect depression
Cohort study, RCT
PHQ-2 Kroenke et al.,
200380
The PHQ-2 is a shorter version of the PHQ-9 with
two screening questions to assess the presence
of a depressed mood and a loss of interest or
pleasure in routine activities; a positive response
to either question indicates further testing is
required
RCT
HADS Zigmund and
Snaith, 1983114
The HADS is a 14-item self-report scale for
detecting states of depression and anxiety in
outpatients. Respondents receive separate scores
for depression and anxiety by summing
scores from the appropriate items, with higher
scores indicating higher levels of depression/
anxiety. The HADS is useful for detecting change
in a respondent’s emotional state, as well as for
assessing presence or absence of clinically
significant degrees of anxiety and depression
Cohort study, RCT
General Health
Questionnaire-12
item
Goldberg and
Williams, 1988151
A self-administered screening questionnaire
designed to detect those with a diagnosable
psychiatric disorder
Cohort study
Specific Activity Scale Goldman et al.,
1981119
Cohort study, RCT
Morisky Adherence
Questionnaire –
adapted version
Morisky et al.,
1986121
A structured four-item self-report adherence
measure addressing the barriers to medication
taking
RCT
List of Threatening
Experiences
Questionnaire
Brugha and
Cragg, 1990154
Brief questionnaire investigating the presence
and impact of a range of common stressful life
events on respondents
RCT
CIS-R Lewis, 1994152 Interviewer completed psychiatric assessment Cohort baseline
Warwick–Edinburgh
Mental Well-being
Scale
Tenant et al.,
2007117
Self-report well-being scale RCT
CSRI, Client Service Receipt Inventory; PSYCHLOPS, Psychological Outcome Profiles Questionnaire; REALM, Rapid Estimate
of Adult Literacy in Medicine; SF-36, Short Form Questionnaire-36 items.
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Appendix 5 The UPBEAT-UK study cohort
audit trail
18 July 2013
Summary: Contains every action undertaken on the UPBEAT COHORT data set since receiving the data set
Original data sets: J:\Programme Grant\Rachel\UPBEAT cohort\Data
Final data sets: J:\Programme Grant\Rachel\UPBEAT cohort\Data\Final data sets
Syntax: J:\Programme Grant\Rachel\UPBEAT cohort\Data\Syntax
Other information: J:\Programme Grant
Data version Action Syntax file
1 Data set set up (separately for each time point)
Original data sets downloaded from MACRO by the Data Manager (Christopher Rowson) and emailed as a .csv file
Rachel Phillips was responsible for receiving all extractions up to and including the 24-month data
RP also wrote the instructions for cleaning the data sets and data checking processes
Paul Williams took over for the 30-month until 48-month (final) data sets, using these instructions
Original data sets as .csv files can all be found in the ‘Data’ folder under the relevant subfolders
Paul Williams was also responsible for collating the data sets and merging in any additional data
1.1 Data cleaning and scale scoring
The same operations were undertaken for each data extraction (each time point)
All data cleaning were carried out in STATA version 11.2
The instruction document (Document to outline the ordering of do files for UPBEAT data.doc) describes the cleaning
process that transforms the .csv file into a cleaned STATA data set. e.g. for 30 month:
30month_UPBEAT_Live20120821.csv Extraction to STATA format 0_insheet_30months.do
thirty_month.dta Full cleaning process (including the start of data
cleaning)
1_30month.do
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Data version Action Syntax file
1.2 Data checking
The instruction document (Document to outline the ordering of do files for UPBEAT data.doc) also describes the data
checking process that checks for: data entry errors, correct number of participants, correct dates for the time between
baseline and time point)
Any data errors that were flagged when conditions were not met were noted in the document (upbeat data
discrepancies v2.2.xlsx) and amendments were written into the cleaning.do file)
e.g. for 30 months:
30month.dta Data errors flagged, recorded and amendments
made to.do file
1_30month.do
A list of ID numbers was then obtained and this was checked by the researchers to see whether or not this list matches the
list of participants recorded on the ACCESS database
Any mis-matches flagged were recorded in the document (Access and Macro Follow ups at 30months FIXED.docx) and
also (Date discrepancies CORRECTIONS.doc)
Any resulting amendments were translated into STATA code and the STATA data set was changed accordingly
30month.dta Changes to be made to the participants in the
data set of the time point
30m_amendments.do
If in the case the interview had been stored in the incorrect time point, the same.do file (30m_ammendments.do) extracts
the data set, places it in the correct folder, and merges the record into the correct time point. In which case, the record
would be stored as a separate data set in that folder, e.g.:
30month_P14007.dta
Correct dates of the interviews were checked by calculating differences between their interview date and the interview date
of their baseline visit. Any participants with substantial differences (> 1 month early, > 4 months late) were investigated
All reporting of date errors was recorded in the document (Date discrepancies CORRECTIONS.doc)
30month.dta Merge 30 month and baseline time point variables
and create merged data set called base_30month.dta
Merging 30 months.do
base_30month.dta Check time difference between time points, check
outliers with researchers
initial_30months.do
30month.dta Make amendments to data set, resulting in a
cleaned final data set with the same name
30month_correctdates.do
A data cleaning checklist was compiled to keep track of progress for weekly meetings (Data cleaning check.xlsx)
2 data set set up (complete cohort data set)
The process for combining the data sets was as follows: (1) make all the data sets (of each time point) compatible;
(2) create a variable to distinguish the data sets; then (3) append these data sets
By appending data sets of the same observations, and mostly the same variables but different time points, we essentially
create a data set in long format with many rows per participant. Matching occurs on the variables, not the unique
identifiers as is normally done with merging. Appending has the advantage in this instance of creating a data set with
fewer variables than what would have been produced in the wide format
1. Making the data sets compatible
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For each data set, variable names were shorted to remove the suffix containing the time point information
Any variable names that were not the same in all the time points were renamed accordingly for synchronisation
PYSCHLOPS variables that contained information about previous time points were dropped
Data sets used were from the folder: (J:\Programme Grant\Rachel\UPBEAT cohort\Data\Final data sets)
base_medic_complete.dta
6month.dta
12month1.dta
18month.dta
24month.dta
30month.dta
36month.dta
42month.dta
48month.dta
2. Create a variable to distinguish time points
The variable <time point>was created, containing sequential values per data set (per time point)
data sets were saved locally
base.dta
6.dta
12.dta
18.dta
24.dta
30.dta
36.dta
42.dta
48.dta
3. Append these data sets
All data sets were appended to the master data set (baseline) simultaneously.
base append all other time points into this data set, and
save as upbeat_cohort.dta
upbeat_cohort_merge.do
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2.1 Data cleaning and scale scoring
The process of data cleaning on the cohort data set involved (1) dropping all empty fields, (2) renaming and ordering
variables appropriately, (3) ordering the data by patid and time point, and (4) inserting information into missing fields
(e.g. gender was only recorded at baseline and so this information was carried across to other time points)
upbeat_cohort.dta Data cleaning (1–4) upbeat_cohort_clean.do
HADS anxiety missing values (> 55) to be classed
as missing on variables (hads_anx anx_cat anx)
upbeat_cohort_clean.do
Create ROSE classifications variable (called
rose_short)
upbeat_cohort_clean.do
Labels for GP practices upbeat_cohort_clean.do
Relabeling age variables to make explicit these
were age at baseline (demographics questions
collected only at baseline). The creation of a new
age variable to record participant age throughout
the data collection
upbeat_cohort_clean.do
Relabeling comorbidity variables to make explicit
these were age at baseline (demographics
questions collected only at baseline)
upbeat_cohort_clean.do
upbeat_cohort.dta Check to see whether or not the all dates and
time point make sense
upbeat_cohort_inspec.do
2.2
Merging additional data: (1) loss information
(2) cardiac investigations information
(3) depression pattern information
Data from sources other than MACRO were entered into the cohort data set as follows
2.2.1 (1) Loss information
Information regarding [(1) deaths, (2) withdrawals, and (3) loss to follow ups] on the whole sample was collected by
Alison Smith and Rebecca Lawson
Specific categories were decided upon during weekly UPBEAT meetings with the whole team
Data was entered onto an excel spreadsheet (Cohort Main Spreadsheet – Deaths,LTFU,Withdrawal.xlsx)
The codebook for reasons of drop out is reported in the document (CODES FOR COHORT.doc)
Data was imported into the upbeat cohort, with the following specification:
1. The addition of variables describing reasons for drop out. Deaths are coded in a separate variable to loss to follow up
and withdrawal. Also note that this has been split further into variables to use for a 36-month analysis and for a
48-month analysis. This is because if someone died at 42 months, they would be included as alive in the 36-month
analysis but not at the 48-month analysis
2. The variable <loss_event> classifies records into whether or not an event has been recorded that has resulted in their
permanent removal from the study (i.e. does not participate at a later date)
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3. Due to the coding of these events to replicate the sampling design (i.e. every 6 months), deaths were recorded at the
time point at the end of the 6-month ‘waiting’ window. I.e. if Person A was measured in July (baseline), January
(6 months) then died in March; this would be coded into the July time point. This is needed for the longitudinal
analyses. For the survival analyses, specific dates are given for each event
4. As a result of point 3 above, additional records have been created to contain these events. Using the same example as
above, Person A would have records for baseline, 6 months and 12 months. If Person A died the following year he
would have records for baseline, 6 months and 24 months
5. The variable used to define the individual sampling windows was <visit_date_hyp> (hypothetical visit date). This is
essentially the corrected visit date <visit_date_c> i.e. date of interview, with 6-month additions (from baseline visit date)
for each time point that was missing
6. Withdrawals were coded into the nearest time point that satisfied the criteria 2 months<withdrawal or LTF< 4 months.
This was because by the nature of this sort of event, it must have only occurred for the time period for which contact
was attempted to be made. The reason for the skewed window was to allow up to 4 months of recon acting. Dates are
attached to each event so as to allow the most accurate time data for survival type analyses
7. There is no ‘56 month’ time point as only 4 deaths and would have populated this time point, and the dates of these
events were relatively close to the ‘hypothetical visit date’ (within a few months) and considering there was a window of
1 month before to 4 months after for a participant to be contacted, I do not think this misrepresents the data. Creating
a new time point may be misleading
upbeat_cohort.dta Merge in the Loss data from (Cohort Main
Spreadsheet – Deaths,LTFU,Withdrawal.xlsx)
upbeat_cohort_loss.do
Fill in demographic data into these new records upbeat_cohort_loss.do
Save data set as upbeat_cohort_v2.dta upbeat_cohort_loss.do
2.2.2 (2) Cardiac investigation information
Information regarding cardiac investigations were collected from the GP notes for every participant in the cohort study and
were inputted into an encrypted Microsoft Access database by Dr Jorge Palacios (Upbeat_Cohort_Med_Notes_2.mdb)
The specific data to be inputted and the specific definitions of cardiac investigations were decided before the hard copies
were examined, with exception to the ‘Rapid Access Clinic’ category*. It was decided that data on rapid access would
provide important information as to the severity of chest pain problems that a participant was experiencing (by the
reasoning that if they used this service, then they must have experienced a level of severity higher than ‘ROSE Exertional
pain’ but lower than the severity that required an intervention or even the severity defined by a cardiac event. This was
decided upon by the UPBEAT team during weekly meetings. The GP notes were re-examined to gather this information and
all data were inputted into the Access database before any analysis of cardiac investigation data occurred
* It was later suggested by the UPBEAT team that this ‘Rapid Access’ classification may not provide information regarding
cardiac severity in the manner it was first thought to, and suggestions were made to remove it due to the following
reasons: (1) it presented a very heterogeneous group of participants who had various reasons for accessing rapid access,
of which the reasons were not recorded; (2) the results from the Rapid access service were not recorded so this could not
be validated. Based on these two reasons, it cannot be used to determine with adequate accuracy the severity of heart
problems as the other categories; and (3) participants access to the service was disparate among locations (as defined by
GP practice) leading to potentially biased results dependent on where the participant lived
Access data was exported to a STATA data set file (data_cardiac_investigations.dta)
A codebook for the cardiac investigations was saved as a STATA data set file (tbl_cardiac intervention type.dta)
Data was imported into the upbeat cohort before any analysis, with the following specification:
1. Data were available for every cardiac investigation per participant from 2005 (earliest example) until the data the notes
were collected. Participants could therefore have a large number of candidate records that could be fit into multiple
time points
2. To simplify this information, it was decided by the team that the investigations should be recorded in two ways (1) the
first cardiac investigation to occur within two time points would be recorded per person, and (2) the most severe cardiac
investigation to occur within two time points would be recorded per person
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3. For consistency with the coding of other event data (deaths), cardiac investigations were coded into time points in the
same manner – recorded into the time point at the end of the 6-month ‘waiting’ window between interviews. I.e. if
Person A was measured in July (baseline), accessed rapid access in August, had a MI in September, and then
interviewed again in January (6 months): the coding under the ‘first’ definition would place the rapid access event
into the January (6 month) time point. The coding under the ‘severe’ definition would place the MI event into the
January (6 month) time point
4. A difference between this data and the deaths data was that if a participant had a recorded cardiac investigation before
baseline (exactly 6 months window leading up to baseline); this was allowed to be recorded in the baseline time point
5. Ordinal variables were created to define severity of heart problems. This was defined a priori to any analysis*.
The ordinal variable had the following construction:
0 no chest pain
1 chest pain
2 exertional chest pain
3 rapid access
4 Bypass graft or angioplasty
5 MI
6 Cardiovascular death
The classification of a participant within a time point depended on their most severe data for that time point.
Cardiovascular deaths (cardiac/stroke/vascular) were chosen over cardiac only deaths due to low numbers in order to
increase statistical power. This ordinal variable was duplicated for the two definitions of cardiac investigation (1) first
(2) severe. *After discussions regarding the appropriateness of the ‘rapid access’ classification, the two versions (first and
severe) classifications were split further to include/exclude this rapid access
data_cardiac_investigations.dta Clean data and save data set as
cardiac_all_wide.dta
upbeat_cohort_cardiac
outcomes
upbeat_cohort_v2.dta Keep only variables: (id, time point and visit date).
Reshape wide. Merge in the cardiac investigations
data (cardiac_all_wide.dta)
upbeat_cohort_cardiac
outcomes
Visit dates for time points 0 (baseline) –
8 (48 months) were available in wide format.
An additional variable was created to mark the
date exactly 6 months prior to their baseline visit.
All cardiac investigations were assigned to their
appropriate time point based on the window
(Tn-1 to Tn)
upbeat_cohort_cardiac
outcomes
These cardiac investigations were then used to
create the appropriate variables (1) first
investigation per person per time point was coded
into a variable, and (2) the most severe
investigation per person per time point was coded
into another variable. Dates of such investigations
were retained alongside each of these. All other
information was dropped. This data set was saved
as cardiac_long.dta
upbeat_cohort_cardiac
outcomes
Merge in the cardiac investigations data
(cardiac_long.dta)
upbeat_cohort_cardiac
outcomes
Outcome variables created for the ordinal cardiac
problems (from no chest pain – chest pain –
cardiac investigations – cardiovascular death). The
two versions utilise the two definitions of cardiac
investigation (1) first in time point (2) most severe
in time point
upbeat_cohort_cardiac
outcomes
Cleaning of variables as new records per person
were added
upbeat_cohort_cardiac
outcomes
Save data set as upbeat_cohort_v3.dta
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2.2.3 (3) Depression pattern information
Depression episodes as defined by the HADS depression scale (cut off 8 or more= positive) were extracted from the upbeat
cohort into an Excel spreadsheet for the purpose of descriptively reporting the patterns of depression throughout the
cohort up to 36 months
It was decided by the team that the combination of different patterns (start, end, fluctuating) and missingness should be
collapsed as succinctly as possible
These coding for this was performed in Microsoft Excel in the file (depression table with analysis 2.0.xls)
A version of this that contained only the information on patterns and missingness was saved as a comma delimited file to
be imported into STATA (dep_pat.csv)
The 3 variables chosen to describe a participant’s pattern of depression episodes were
1. Pattern: consisting of 6 different patterns, labelled in a way to describe depression at baseline, depression at 36 months
(4 patterns) and 2 patterns describing fluctuating episodes
2. Missingness: marking whether or not there was any missing data during the 36 months and where the missing
data occurred
3. Any depression: marking whether or not any episodes of depression were recorded
upbeat_cohort_v3.dta Merge in the patterns data from (dep_pat.csv) upbeat_cohort_dep_patterns
Data cleaning upbeat_cohort_dep_patterns
Save data set as upbeat_cohort_v4.dta upbeat_cohort_dep_patterns
3 Creating a wide version of the data set
To create a wide data set, first the long data set needed to be reduced as it contained 940 variables. A wide version of
which would contain (8 × 940 variables) and it was decided appropriate to reduce this for simplicity
The method for creating a wide version of the data set consisted of (1) retaining only key variables, (2) add suffix ‘_’ to the
end of variable names, and (3) reshape wide
A list of key variables of immediate interest was selected to be retained in the wide version of the data set (to save space).
These variables along with others as requested were retained
upbeat_cohort_v4.dta (1) retain only the key variables upbeat_cohort_wide.do
(2) add suffix ‘_’ to the end of variable names upbeat_cohort_wide.do
(3) reshape wide upbeat_cohort_wide.do
Save data set as upbeat_cohort_v4_wide.dta upbeat_cohort_wide.do
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